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ABSTRACT

"Chasing a Ghost"
Addressing the Aggregation/Opalescence
Relationship in an IgG 1 Antibody
by
John Champagne
University of New Hampshire, May, 2009
This study was conducted to address the aggregation/opalescence relationship of
an IgG 1 therapeutic antibody under a variety of conditions. The opalescence
characteristics of three antibodies, Mab 1,2 and 3, were examined as a function of salt
dependence, protein concentration and temperature, using a variety of biophysical
techniques. The high molecular weight species were initially identified using batch static
and dynamic light scattering and separated by asymmetric flow field flow fractionation.
When the salt dependence was examined, any structural changes were characterized
using differential scanning calorimetry, circular diehroism and fluorescence, while the
association state and temperature dependence was measured by viscometry. The
resulting non-ideality was determined using multi-angle light scattering over a range of
NaCl and protein concentration, and then used to assess the nature of the noncovalent
association. In addition, the valence of the antibody therapeutics was directly measured
using capillary electrophoresis and assessed as a predictive tool of non-ideal behavior.

xm

The antibody that exhibited the highest degree of opalescence, and therefore was
the main focus of the study, was Mab 1, with Mab 3 exhibiting a lower degree of
opalescence and Mab 2 acting as a control. The results suggest that the opalescence
phenomenon of Mab 1 was due to a salt induced non-mass-action driven self-association
which is mainly entropic in origin and is driven predominantly by NaCl. The
intermolecular interactions appear to be facilitated by enhanced flexibility of Fc region
and the independent Fab folding domain on Mab 1. The opalescence phenomenon also
appears to be a relatively small fraction of discrete HMW material which is freely
reversible and results in a liquid-liquid or liquid-solid phase transition which is either
clear or cloudy depending on A2. Finally, it was determined that there is a discrepancy
between the measured and calculated valence of the IgGl antibodies in the study and this
may be used as a predictive tool of non-ideal behavior. Together, this information was
used to propose a model of the opalescence phenomenon of Mab 1 based on an
electrostatic interaction involving mainly the CDR region on the Fab.

CHAPTER I
INTRODUCTION

Antibody Structure and Function
Antibody Structure
In humans, antibodies may be classified as members of five families or isotypes,
which have been named immune globulin alpha (IgA), delta (IgD), epsilon (IgE), gamma
(IgG) and mu (IgM) (Frazer, 1999). The structural differences between the isotypes are
summarized in Table 1.1, and include differences in molecular weight, stoichiometry,
carbohydrate content, serum concentration and half life. The most prevalent antibody
isotype in the human body is IgG, which comprises approximately 85% of the
immunoglobulin in serum. As the majority of the therapeutic antibodies are of the IgG
isotype, this work was a study on the issues pertinent to this family of immunoglobulins.
The basic structure of an intact IgG immunoglobulin is a Y-shaped molecule
which comprises four polypeptide chains, including two identical light chains and two
identical heavy chains where the chains are held together with a series of disulphide
bonds. The IgG heavy chains may be categorized into four sub-classes: 1, 2,3 and 4,
each with a molecular weight of approximately 55 kDa, with the intact IgG molecule
having a total molecular weight of-150 kDa (Figure 1.1). Each of the heavy and light
1

N>

Monomer, Dimer
7-11%
1.5-2.6

Stoichiometry

Carbohydrate
Content (%)

Serum Cone.
(mg/mL)
0.04

9-14%

Monomer

175 kDa

IgD

2.5

0.0003

12%

Monomer

190 kDa

IgE

23

9.5-12.5

2-3%

Monomer

150 kDa

IgG

0.7-1.7

12%

Pentamer,
Hexamer

950 kDa1150 kDa

IgM

Table 1.1: The characteristics of the five families or isotypes of human antibodies are listed. The data refers to human
immunoglobulins in normal human subjects.
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(Days)

Serum Half Life

160 kDa-400 kDa

Molecular Weight

IgA

Table 1.1: Characteristics of the Human Immunoglobulin Isotypes

Figure 1.1: The Four Sub-Classes of IgG Immunoglobulins
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Figure 1.1: The characteristics of the four sub-classes of IgG immunoglobulins are
depicted. Although their biological roles are vastly different, they are structurally similar
with an average molecular weight of 150 kDa. The most prominent structural differences
are the number of disulfide bonds at the hinge region. Gamma 1 and Gamma 4 isotypes
have two disulfide bonds while Gamma 2 has four and Gamma 3 has 13. Also depicted
is the site of attachment by carbohydrate side chains (*) and the major cleavage points for
Pepsin ( ) and Papain ( ).

3

chain segments contains a variable region (also known as the complementarity
determining region or CDR) and a constant region which are considered responsible for
the diversity of antigen binding and the consistency in antibody structure (Lobo E. D.,
2004). The light chains consist of VL and CL domains, and the heavy chain consists of
VH, CHI, CH2 and CH3 domains. Furthermore, in humans, there are two light chain
variants (K or X) which both have a molecular weight of-25 kDa. Each of the domains
on the light chain consists of about 100 residues, are similar in their primary structure,
and are independent stable structural units (Creighton, 1993). All immunoglobulin
domains (on the light and heavy chains) have essentially the same conformation,
designated the immunoglobulin fold, consisting of two layers of anti-parallel P-sheets
linked by a disulfide bond (Harris, 1998). The polypeptide chains between the domains
are susceptible to proteases with the most susceptible being the hinge region linking the
two Fab arms to the Fc base. After cleavage by Pepsin, the F(ab')2 fragment contains two
copies each of the VL, CL, VH and CHI domains, held together by the hinge region, while
the Fc fragment has two copies each of the CH2 and CH3 domains. After cleavage by
Papain, the Fab fragment contains only one copy of the VL, CL, VH and CHI domains
(Figure 1.2).
The domains in an IgG immunoglobulin interact with each other in a variety of
ways. The two CH2 domains and CH3 domains interact with each other in the Fc region
and with each arm of the Fab region, there is interaction between the CHI and CL domains
and the VH and VL domains. All pairs of the C domains associate in a similar manner in
which the members of one of their pairs of p-sheets associate isologously, while in
4

Figure 1.2: The Structure of IgG 1, Fab and F(ab'>2 Fragments

From www.invitrogen.com

Figure 1.2: The structure of an IgG 1 and the Fab and F(ab')2 fragments are depicted.
The intact IgG is composed of two heavy chains and two light chains. Each of the heavy
and light chain monomers has a constant region (VH) and a variable region (VL). The
intact IgG antibody has a molecular weight of-150 kDa which consists of ~50 kDa for
the Fab fragment, and -110 kDa for the F(ab')2 fragment. Also highlighted are the
results of the Pepsin and Papain digests.

5

contrast, the V domains associate by means of the other P-sheet (Creighton, 1993). There
are also less stable interactions that occur between domains that are present in the
primary structure, with the segments linking the polypeptide chains having varying
degrees of flexibility. Especially flexible is the hinge region which links the Fc and
F(ab')2 portion of the molecule and this flexibility also makes the two Fab arms
particularly mobile. It is also thought that hinge-dependent Fab-Fab and Fab-Fc
flexibility may be important in triggering further effector functions such as compliment
activation and Fc receptor binding (Campbell, 2003). Exploring the flexibility of the IgG
1 immunoglobulin isotype in more detail reveals that of the four IgG subclasses, IgG 1
has the shortest hinge region (six amino acids shorter than IgG 2) and has been shown to
be the most rigid (Harris, 1998) (Vermeer, 2000).

Antibody Structure/Function
The function of an IgG immunoglobulin is to recognize antigens which are not
normally present in the host organism. This is achieved through the antigen-binding sites
that are located at the end of the two Fab arms and are situated between the VL and VH
domains. Different binding sites are generated by the amino acid side chains located on
the three irregular loops between the P-strands of both the light and heavy chains. These
variable regions, or CDR regions, depend on the conserved structure of the rest of the
immunoglobulin fold to act as a scaffold in which to stabilize their conformation.
Through these residues on the three loops of the CDR region, there are genetic variations
that can be generated on the order of 108-1010 antibody molecules with different
6

specificities (Creighton, 1993). Accordingly, the CDR region is also known as the hypervariable region, and may represent the only variation between different IgG antibodies of
the same isotype.
In the process of producing an IgG antibody to recognize a specific antigen,
progeny cells can adapt to changes in the immunological response. Initially, the
antibodies that are produced are of low affinity (Kd = 10~5-10"7), but with time, antibodies
of increasing affinity are produced. As antibodies of high affinity and specificity are
produced, individual cells can be isolated and cloned to produce additional homogeneous
antibodies. This protein engineering makes it possible to produce the antibody
therapeutics that allow for the desired selectivity required for a specific antigen. These
homogeneous antibodies are known as monoclonal antibodies and have become an
important class of drugs for treating numerous human diseases.

Issues with Protein Aggregation
Pharmaceutical Importance
Over the past 15 years, the development of monoclonal antibodies has resulted in
their evolution as an important class of therapeutic treatments for a range of human
diseases including cancer, allergic diseases, asthma, and organ transplantation (Campbell,
2003) (Gelfand, 2001) (Loertscher, 2002). Currently it is estimated that over 30% of all
protein therapeutics presently under development are full length, fragmented, or
conjugated versions of monoclonal antibodies (http://www.phrma.org). As monoclonal
antibodies are generated as a result of a normal immune response against an antigen, with
7

high affinity and specificity, they are ideal candidates for targeted therapy. As of 2007,
there were more than 20 monoclonal, and Fc fusion products approved and licensed by
the US Food and Drug Administration (FDA) with more than 100 additional therapies in
development (http://www.phrma.org). It is estimated that by the year 2010, sales relating
to antibody therapeutics will account for more than $30 billion dollars (IMS Midas, Data
Monitor Apr 2007).
Due to the size and relative instability of monoclonal antibodies, only limited
routes of patient administration have been developed successfully. The majority of
approved monoclonal antibody therapeutics, especially for oncology indications, are
administered by the intravenous route (Grillo-Lopez, 2003). The intravenous route has
been preferred because this form of administration allows complete systematic
availability, rapid delivery of antibodies to the systemic circulation, and achievement of
high concentrations (Lobo E. H., 2004). Additionally, relative to other parenternal routes
of administration, the intravenous route allows the administration of larger volumes.
However, this route is not convenient for patients, often requiring hospitalization and
thereby greatly increasing the cost of therapy. Consequently, as monoclonal antibody
therapy is targeting diseases that require several mg/kg dosing, often on a regular basis, it
has become necessary to develop an alternate delivery route that can be administered in
an outpatient environment. Subcutaneous administration has proven to be the preferred
route used by physicians, and by patients who are able to self-administer at home. This
form of administration is generally limited to small injection volumes, and for many of
the antibody therapeutics that require high dosing, it is often necessary to develop high
8

protein concentration formulations (Liu, 2005). As many of the antibody therapeutics
require an average weekly dosing rate of ~2 mg/kg, a patient weighing 65 kg (the average
body weight for patients), would require a weekly dose of 130 mg. Unfortunately, it has
been shown that for subcutaneous administration, an injection volume of more than 1.5
mL is not well tolerated (Gelfand, 2001). This would then necessitate a protein
concentration for a weekly dose to be in excess of 100 mg/mL or 130 mg of protein in
less than 1.5 mL volume.

Immunological Issues with Aggregation
As antibody molecules are large and complex, the development of therapeutic
formulations at the high concentrations required can lead to a variety of complex, protein
stability issues. These issues include not only maintaining the physical and chemical
stability of the therapeutic throughout its proposed shelf life, but also having physical
properties that are compatible with the manufacturing, storage, delivery and efficacy
(Shire, 2004). In response to these high protein therapeutic formulations, the FDA has
become keenly interested in the effects on antibody stability and the resulting
immunogenic consequence in patients (Rosenberg, 2006) (Carpenter, 2008). In a recent
FDA report regarding protein therapeutics, it was stated that "among the qualitative
factors critical in inducing antibody responses are molecular weight and solubility". The
review goes on to report that although low molecular weight aggregates such as dimers
and trimers appear inefficient in inducing immune responses, large multimers whose
molecular weight exceeds 100 kDa are efficient inducers of an immune response.
9

However, it should be noted that multimerization is the key to immunogenicity, as
protein monomers with a high molecular weight (such as an antibody monomer of 150
kDa) are not necessarily more immunogenic than monomelic proteins with a lower
molecular weight (Rosenberg, 2006). Moreover, it has been long known that any protein
therapeutic that develops a non-dissociable aggregate which is insoluble, will be rapidly
endocytosed by antigen-presenting cells which initiate immune responses (Frei, 1965).
Consequently, it was concluded that "protein product aggregates are potential inducers of
immune responses to therapeutic protein products" and that manufacturers of therapeutic
products should ensure that their products contain minimal product aggregates.
Furthermore, the FDA report goes on to state that manufacturers must employ several
orthogonal methods for assessment of protein aggregates, or changes in levels of product
aggregates (Rosenberg, 2006).

The Antibody Opalescence Phenomenon
Description of the Opalescence Phenomenon
The visual appearance of a liquid protein therapeutic is an important criterion of
quality for both physicians and patients. The appearance is usually evaluated in terms of
two properties; color and clarity. While color can be objectively quantified with regard
to the intensity and wavelength position of relevant chromophores associated with the
protein, clarity is a far more complex property to describe. A protein solution containing
no appreciable particulate matter will appear to the eye as clear. However, the presence
or formation of large aggregates (either soluble or insoluble), as is often encountered with
10

antibody therapeutics, will introduce a definite element of subjectivity to the description
of the solutions clarity. In the more commonly seen case where the protein aggregates
are small enough to be uniformly suspended, there will be a significant increase in the
light scattered at all wavelengths by the solution. During a visual inspection of a liquid
protein therapeutic, this phenomenon is typically (and subjectively) reported as having
varying degrees of turbidity, cloudiness or "opalescence".
When formulating IgG 1 antibody therapeutics at high concentrations (10-100
mg/mL), they will often have a visually opalescent appearance. The apparent similarity
of these opalescent solutions to the appearance of solutions containing large aggregated
proteins raises concerns about the quality and efficacy of the antibody therapeutic, the
potential to cause immunogenicity or injection site reactions, and the long term stability
when formulated at high concentrations.

Proposed Model of Assembly
Although the IgG 1 antibody opalescence phenomenon is believed to be quite
widespread throughout the biopharmaceutical industry, there have been few published
reports that have examined the possible causes. Of the few reports that do exist, most
focus on the techniques used to characterize the resulting opalescence phenomenon
(Carpenter, 2008) rather than attempting to understand the underlying physical causes. It
has even been suggested that the opalescent appearance is entirely unrelated to
noncovalent association of the IgG 1 antibody, but rather "is a simple consequence of
Rayleigh scatter" (Sukumar, 2004).
11

Based on previous analysis of protein turbidity (Champagne, 2000), it was
proposed that the observed antibody opalescence phenomenon was due entirely to the
formation of large asymmetric or symmetric structures as a result of specific (nonrandom) protein-protein interactions. Theses protein-protein interactions are believed to
be concentration and NaCl dependent and consist of weak noncovalent associations. In
addition, these interactions are thought to be fully reversible, and as such, do not alter the
overall structure or stability of the antibody. The interactions appear to follow two routes
of assembly and form either randomly associated agglomerates which have a cloudy
appearance or highly ordered associations which can ultimately result in a clear gel state.
In either case, the protein-protein assembly appears to undergo a NaCl induced separation
into two metastable liquid phases of widely different concentration. This liquid-liquid
phase separation also results in increased solution viscosities further strengthening the
theory of higher-order protein-protein interactions.

Techniques Proposed for Opalescence Characterization
During this study, a range of first principle techniques were employed in the
characterization of the antibody opalescence phenomenon. It was crucial to use first
principle techniques as they directly measure the fundamental properties of molecules
such as mass, charge, shape and size, optical properties and functional properties. In
addition, fundamental laws govern these properties, conservation principles apply, the
linkages to energetics are well defined and most importantly, the data stand on their own.

12

Through the visual observation of the opalescence of Mab 1, it was evident that
several techniques would be necessary to adequately characterize this phenomenon. The
techniques deemed essential for this analysis included, but were not limited to, Rayleigh
light scattering (also used to measure non-ideality), analytical ultracentrifugation,
differential scanning calorimetry, and the use of capillary electrophoresis to directly
measure the valence on the antibody. A brief description of each aforementioned
technique was provided to highlight the importance of each as it related to this study.
RAYLEIGH LIGHT SCATTERING: The light scattered from dilute solutions
containing macromolecules or colloidal particles can be used to determine the molecular
weight, size, and any interactions that occur between the species (Doty, 1950). Many
factors influence these measurements including the destructive interference of the
scattered light, the refractive index increment of the solute, and the refractive index of the
solvent (Camerini-Otero, 1978). In 1871, Lord Rayleigh derived an equation that
described the relationship between the intensity of the incident beam of polarized light
and the intensity of the scattered radiation by a small particle in a vacuum at specified
angles (Wyatt, 1993). This equation features a fourth-power dependence on the
wavelength of the incident light, the intensity of which is usually several orders of
magnitude higher than that of the scattered radiation intensity. Subsequently referred to
as "Rayleigh scattering" this theory was applied by Debye and Zimm as a first principle
method to determine the weight average molecular weight (Mw), the corresponding zaverage square radii (rg2) and a measure of the thermodynamic non-ideality (A2) for
macromolecules in solution (Debye, 1944) (Zimm, 1945). Thisfirstprinciple use of
13

Rayleigh scattering is referred to as static or "classical" light scattering and is typically
measured utilizing a multi-angle light scattering instrument. Alternatively, if the light
scattering intensity is measured over time, the resulting intensity fluctuations can be used
to directly determine the translational diffusion coefficient (Dj) for a macromolecule in
solution. Referred to as dynamic light scattering, this technique can be used to then
convert the measured Dy to a hydrodynamic radius fa) through the Stokes-Einstein
equation (Tanford, 1961).
Recently, there has been considerable interest in the potential use of the
thermodynamic non-ideality or second virial coefficient as a diagnostic of solution
conditions commensurate with protein solubility. A measure of a positive second virial
coefficient implies a dominance of intermolecular repulsive forces between protein
molecules while a measure of a negative second virial coefficient implies a dominance of
intermolecular attractive forces (Tanford, 1961). A more complete review of
thermodynamic non-ideality is available through many sources including, Edsall and
Wyman (1958) and Tanford (1961). Static light scattering was used in this study to
measure the second virial coefficient, although it has been identified that these
measurements may not be a direct determination of the actual osmotic virial coefficient
as constraints of constant temperature and pressure were not imposed (Deszczynski,
2006).

ANALYTICAL ULTRACENTRIFUGATION: Analytical ultracentrifugation is a
method of analysis that relies on the principle property of mass and the fundamental laws
14

of gravitation (Laue T.M., 1999). Because of this, it requires no standards for
comparison. Sedimentation can be used to explore the behavior of molecules in solution
over a broad range of solute concentration and in a variety of solvent conditions. Low
concentrations of solute can be used to characterize tight associations, while high
concentrations can be used to characterize the thermodynamic behavior of molecules. A
more complete review of analytical ultracentrifugation is available through many sources
including, Cassasa and Eisenberg (1964), Laue and Stafford (1999), Laue (1992), Shuster
and Laue (1994), Tanford (1961), Yphantis (1964), Yphantis and Roark (1972), Yphantis
and Waugh (1956), WilliamsJ.W., Van Holde,K.E., Baldwin,R.L. and Fujita,H. (1958).
Through the use of sedimentation velocity, the hydrodynamic properties of a molecule
moving in a gravitational field are described by its sedimentation coefficient (S) and the
rate at which the concentration boundary spreads to provide a measure of the translational
diffusion coefficient (DT) (Laue, 2001). The ratio of S/DT provides a direct measure of
the buoyant molecular weight (Mb), from which the molar mass (Mz) of a macromolecule
in solution can be calculated (Svedberg, 1940).
DIFFERENTIAL SCANNING CALORIMETRY: In recent years the
development of differential scanning calorimetry has evolved into a technique that can be
used to assess the thermal and conformational stability of a protein under different buffer
conditions (Wen, 2007). The melting temperature of a protein, or of individual domains
can be obtained from the DSC profile, and if the reaction is reversible the thermodynamic
parameters of the unfolding can also be determined. In addition to this information,
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unfolding is often accompanied by an exotherm that corresponds to the aggregation and
precipitation of the unfolded protein (Vermeer, 2000).
CAPILLARY ELECTROPORESIS: Capillary electrophoresis was used as a
method to determine the protein valence in a variety of buffer conditions. The
measurement of the valence (Z) was determined based on the electrophoretic mobility (u)
of a protein in an electric field. Although there are two definitions for the electrophoretic
mobility, experimental and hydrodynamic, the CE determines a measure of the
hydrodynamic definition. It is this definition of electrophoretic mobility that is equal to
the effective charge (Q*) divided by the frictional coefficient (f), where Q* is equal to the
corresponding apparent valence (Z*) multiplied by the proton elemental charge (e), and
the frictional coefficient is determined by analytical ultracentrifugation or dynamic light
scattering (Chase, 2008). Finally, there is a conversionfromZ* to Z due to counter-ion
shielding, the coupling of ionic flows and the deformation of the electric field in the
vicinity of the protein (Chase, 2008). For a complete review of this technique there are
several sources available including, Durant (2003), Moody (2005) and Chase (2008).

16

Obj ectives of This Study
The objective of this study was to address the aggregation/opalescence
relationship of an IgG 1 antibody therapeutic. In order to understand the origin of the
opalescence appearance and its relationship to noncovalent association, three IgG 1
antibodies (Mab 1, Mab 2 and Mab 3) were investigated as a function of concentration
and NaCl dependence. Mab 1 was used as the model for the aggregation/opalescence
relationship with Mab 2 exhibiting no opalescence phenomenon and serving as a control.
Mab 3 also served as a control and although it exhibited the opalescence phenomenon, it
was to a much lesser extent than Mab 1. Furthermore, due to the correlation between the
antibody opalescence phenomenon, protein aggregation and the possible immunogenic
consequences, it was also a goal of this study to assess various techniques to help predict
this behavior in future antibody therapeutic candidates.
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CHAPTER II

MATERIAL AND METHODS
Antibody Preparation
Protein Expression and Purification
Three recombinant humanized monoclonal antibodies with different
complimentary determining regions (CDRs) were obtained for this study. The
antibodies were all expressed in Chinese Hamster Ovary (CHO) cell lines and were
constructed from the same IgG 1 human framework with K light chains. Labeled as Mab
1, Mab 2 and Mab 3, the proteins were purified from the whole cell isolate by a series of
chromatography methods including affinity chromatography using Protein A,
hydroxyapatite chromatography (cHA), ion exchange chromatography (CEX-HPLC) and
size exclusion chromatography (SEC-HPLC). The antibodies were initially concentrated
in the column buffer, dialyzed into the final buffer and subsequently brought to the final
concentration of-75 mg/mL using a process of ultrafiltration/diafiltration. The resulting
antibody solution was then stored in one liter Teflon containers at -80 °C. All the
chemical reagents used in this research were analytical grade or higher and deionized
reverse osmosis water was used throughout this study.
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Assessment of Protein Purity
Analyses were conducted on all the antibody samples used in this study to
determine the extent of protein purity. Methods performed on all of the antibody samples
included SDS-PAGE, CEX-HPLC and SEC-HPLC. Peptide mapping and iV-linked
oligosaccharide analysis were also performed on each of the samples. The results of each
method were then compared to assess sample to sample homogeneity across each of the
antibodies used throughout the study. The composition of the protein solution after the
purification steps is presented in the Results section for Mab 1 only, due to the aim of this
study.
SDS-PAGE: Inyitrogen Novex gels were used, 4-20% Tris-Glycine catalog
#EC6025. All samples were diluted to 1 mg/mL in water. In the case of non-reducing
samples, a 10 uL aliquot of each diluted sample was mixed with an equal volume of 2X
non-reducing buffer, heated for five minutes at 100 °C, and loaded on the gel. For
reduced samples, an equal volume of 2X reducing buffer (100 mM DTT) was added to
each diluted sample (final concentration: 50 mM DTT), mixed, heated for two minutes at
100 °C, and loaded on the gel. Gels were run at 150 V for 1 lA hours. Coomassie
staining was performed by placing gels in 0.05% Coomassie blue solution for 1 Vi hours
and then de-stained for three hours with periodic shaking until clear. BioRad broad range
SDS-PAGE markers were used (catalog #161-0317). A standard solution of Bovine
Serum Albumin (1 mg/mL) was also prepared using protein purchased from Sigma
Chemical Co. Lot 041K7613. Each of the protein samples was compared to assess purity
and to determine the degree of non-dissociable aggregates present.
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SIZE EXCLUSION CHROMATOGRAPHY (SEC-HPLC): Size exclusion
chromatography experiments were conducted using a TosoHaas G3000SWXL, catalog
#08541, 7.8 mm x 30 cm, 5 urn, 250A column on an Agilent 1100 HPLC system (Agilent
Technologies, Palo Alto, CA). The column was loaded with 20 uL of protein at 2.5
mg/mL. The samples were eluted at ambient temperature with a mobile phase of 10 mM
Na2HP04,250 mM NaCl, pH 7.3 with an isocratic flow rate of 0.75 mL/min. The elution
peaks were monitored at 280 nm by a UV multi-wavelength detector (Agilent
Technologies).
CATION EXCHANGE CHROMATOGRAPHY (CEX-HPLC): Cation exchange
chromatography experiments were conducted using a Dionex ProPac WCX-10, catalog
#054993,4 mm x 250 mm, column on an Agilent 1100 HPLC system (Agilent
Technologies, Palo Alto, CA). The column was loaded with 35 j^L of protein at ~2
mg/mL. In preparation for injection, all antibody samples were diluted into the initial
mobile phase (mobile phase A). The samples were eluted at ambient temperature using
an isocraticflowrate of 1 mL/min, following a specific elution gradient between mobile
phase A (10 mM MES pH 6.5) and mobile phase B (10 mM MES pH 6.5, 400 mM
NaCl). The elution step consisted of the following gradient. At time 0 to 5 minutes the
gradient was 100% mobile phase A and 0% mobile phase B. From five minutes to 50
minutes, the gradient changed and eventually consisted of 50% mobile phase A and 50%
mobile phase B. The gradient then changed, from 50 minutes to 55 minutes, to 0%
mobile phase A and 100% mobile phase B. Finally, the gradient changed abruptly, from
55 minutes to 56 minutes, to 100% mobile phase A and 0% mobile phase B, ending with
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thisfinalgradient after 75 minutes of total run time. The elution peaks were monitored at
280 nm by a multi-wavelength UV detector (Agilent Technologies).
ACHRO-K PEPTIDE MAPPING: The reduction/alkylation step was performed
in 2 mL Starstedt vials using a total of 500 ^L of protein at a concentration of 2 mg/mL.
The volume of the reduced and alkylated preparation was brought to 750 pL with a final
DTT concentration of 3.125 mM. The 1 M stock solution of DTT was made up prior to
use and stored at -20 °C until needed. The volume was then adjusted to 1 mL with a
solution of 6 M guanidine hydrochloride (GdnHCl), 50 mM Tris-HCl, pH 8.2, and the
samples were incubated in a 40 °C heating block for one hour. The reduced samples
were removed from the heating block and alkylated by adding 100 pL of freshly prepared
1 M iodoacetic acid (IAA) solution for a final LAA concentration of 5.5 mM. The
samples were then incubated in the dark at ambient temperature for an additional hour
and the reaction was quenched by the addition of 5 uL of the 1 M DTT stock solution.
To remove excess reagents, the entire volume of each reduced and alkylated antibody
sample was then buffer exchanged into 50 mM Tris-HCl, pH 9.0 using two Amersham
Biosciences HiTrap Desalt columns in series. The resulting protein concentration was
then determined by UV absorbance, using the mobile phase (50 mM Tris-HCL, pH 9.0)
to blank the instrument. The digestion step followed with approximately 60 ug of the
protein sample mixed with Achro-K, at an enzyme substrate concentration of 1:20, and
brought up to a total volume of 1 mL using 50 mM Tris-HCL, pH 9.0. The final
chromatography step was performed using a Waters Symmetry CI8, catalog
#WAT106151,4.6 mm x 250 mm, column on an Agilent 1100 HPLC system (Agilent
Technologies, Palo Alto, CA). The column was loaded with 900 [iL of protein for a total
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sample load of 54 jag. The samples were eluted at 30 °C using a flow rate of 1 mL/min,
following a specific elution gradient between mobile phase A (0.05% TFA (v/v) in water)
and mobile phase B (0.05% TFA (v/v) in 95% acetonitrile). The elution step consisted of
the following gradient. At time zero to five minutes the gradient was 96% mobile phase
A and 4% mobile phase B. From 5 minutes to 100 minutes, the gradient changed and
eventually consisted of 60% mobile phase A and 40% mobile phase B. The gradient then
changed, from 100 minutes to 100.1 minutes, to 0% mobile phase A and 100% mobile
phase B and ran to 102 minutes. The gradient then was changed again, from 102 minutes
to 102.1 minutes, to 96% mobile phase A and 4% mobile phase B, ending with this final
gradient after 120 minutes of total run time. The elution peaks were monitored at 214 nm
by a UV multi-wavelength detector (Agilent Technologies).
N-LINKED OLIGOSACCHARIDE ANALYSIS: The oligosaccharide analysis
was performed by initially diluting the protein samples to approximately 2 mg/mL using
25 mM ammonium formate pH 7.4. The samples additionally were buffer exchanged
into the same volatile buffer using Amicon Ultra 30,000 MWCO protein concentrators.
After recovery, each sample was digested with 5 uL of PNGase F (NEB, glycerol free)
and incubated overnight at 37 °C. The samples then were dried down by speed vacuum
centrifugation and reconstituted in purified water. Samples were then analyzed using
High pH Anion Exchange Chromatography on an all PEEK Agilent 1100 HPLC system
(Agilent Technologies, Palo Alto, CA) with Pulsed Electrochemical Detection (HPAECPED) analysis. Separation on the HPAEC-PED system was performed with a Dionex
CarboPac® PA100 guard column (2 mm x 50 mm) and an analytical column (2 mm x 250
mm). A linear gradient was used throughout the 60 minute run consisting of mobile
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phase A (100 mM NaOH) and mobile phase B (100raMNaOH, 500 mM sodium
acetate). The elution progress was monitored using a Dionex ED-40 electrochemical
detector (Dionex Corporation, Sunnyvale, CA).

Opalescence Characterization
Preparation of Sample
Solutions of Mab 1, Mab 2 and Mab 3 antibodies used in the opalescence
characterization were prepared by dialyzing the stock protein solution for 24 hours in 10
mM Histidine, Sigma Chemical Co. Lot 113H5725, pH 6, using Pierce Slide-A-Lyzer®
10K MWCO Dialysis Cassettes. Samples were then similarly prepared by dialysis into
10 mM Histidine buffer, pH 6, containing the various NaCl concentrations used
throughout this study. After dialysis, the pH was checked and the solution was sterilized
using a Whatman Anotop® 25 mm, 0.20 ^un, PES syringe mount filter, Catalog #68092022. The protein concentration was determined by measuring the absorbance at 280 nm
using a Spectramax Plus UV-Vis spectrophotometer equipped with a plate reader. The
absorbance was determined at a wavelength of 280 nm and was corrected for light
scattering by subtracting the absorbance at 320 nm. The concentration was then
calculated using an extinction coefficient of 1.55 (mLmg'1cm"1) for Mab 1,1.36 (mL
mg^cm"1) for Mab 2 and 1.45 (mL mg^cm"1) for Mab 3 as determined theoretically by
quantitative amino acid analysis.
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Visual Appearance and Description
Although it was initially thought to be of great importance to properly
characterize the degree of protein opalescence, the scope of this study shifted to examine
the unique opalescence of a single model antibody. The degree at which the actual
opalescence assignments are used throughout this study is minimal but it is important to
understand how the assignments were derived and subsequently used for opalescence
comparison between the three model antibodies examined.
The method to asses and describe the visual appearance of the unique protein selfassociation characterized in the study was based on the guidelines employed by the
European Pharmacopeia (Ph. Eur, 1980). The guidelines describe a test for clarity and
degree of opalescence of liquids that are specific in terms of visual description. It is
important to note that this method does not attempt to distinguish between the types of
particles that are giving rise to the observed opalescence.
PREPARATION OF REFERENCE SUSPENSION: The reference suspensions
were prepared as described in the European Pharmacopeia (Ph. Eur, 1980) with the
following modifications:
A. Hydrazine sulfate solution: 1.0 g hydrazine sulfate (J.T. Baker, cat #2177-04,
"Baker analyzed") was dissolved in 100 mL deionized reverse osmosis water
and allowed to stand for four-six hours.
B. Hexamethylenetetramine solution: 2.5 g hexamethylenetetramine (Aldrich
Chemical Co. cat #H1,130-0) was dissolved in 25 mL deionized reverse
osmosis water.
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C. Primary opalescent suspension: 15 mL of solution A was added to 25 mL of
solution B and the mixture was allowed to stand for 24 hours.
D. Standard of opalescence: 15 mLofthe primary opalescence suspension (G)
was diluted to 1000 mL with deionized reverse osmosis water. [This
suspension was prepared fresh and stored for 24 hours at most].
E. Reference suspensions: 5 mL of solution D was added to 95 mL of deionized
reverse osmosis water to produce reference suspension 1,10 mL of solution D
was added to 90 mL of deionized reverse osmosis water to produce reference
suspension II, 30 mL of solution D was added to 70 mL of deionized reverse
osmosis water to produce reference suspension III, 50 mL of solution D was
added to 50 mL of deionized reverse osmosis water to produce reference
suspension IV.
The protein sample in question was then compared visually to the freshly
prepared reference suspensions using identical vials of colorless, transparent, neutral
glass with a flat base and an internal diameter of 15 to 25 mm, the depth of the solution
layer being at least 40 mm. All solutions were compared in a specially prepared light box
which had light holes designed to illuminate each vial equally from the bottom. The
samples were compared approximately five minutes after preparation and viewed
vertically against a black background. These conditions insured that each of the
reference suspensions could be easily distinguished for accurate opalescence
assignments.
DESCRIPTION OF THE RESULTS OF THE VISUAL INSPECTION: The
European Pharmacopeia has characterized opalescence in four very specific categories.
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1. Clear (Ph. Eur, 1980) "A liquid is considered clear if its clarity is the same as
that of purified water or of the solvent used when examined under the
conditions as described above, or if its opalescence is not more pronounced
than that of reference suspension I".
2. Slightly Opalescent (Ph. Eur, 1980) "A liquid is slightly opalescent if its
opalescence is more pronounced than in the preceding case, but not more
pronounced than that of the reference suspension II".
3. Opalescent (Ph. Eur, 1980) "A liquid is considered opalescent if its
opalescence is more pronounced than in the preceding case, but not more
pronounced than that of the reference suspension III".
4. Very Opalescent (Ph. Eur, 1980) "A liquid is considered very opalescent if its
opalescence is more pronounced than in the preceding case, and may be more
pronounced than that of the reference suspension IV".
XJV SPECTROSCOPY TO DETERMINE CATEGORY OF OPALESCENCE:
In contrast to the European Pharmacopea methods of visual characterization of
opalescence, UV spectroscopy allowed a less subjective measure of the degree of
opalescence. UV spectroscopy was carried out using a Spectramax Plus UV-Vis
spectrophotometer equipped with a plate reader. The protein samples and reference
suspensions were placed in individual wells in a 96 well plate along with a well
containing purified water. The relative optical density (OD) of the reference suspension
and protein solutions were measured against the purified water at a wavelength of 400 nm
and recorded. In order to determine the degree of opalescence, the OD values of the
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protein samples were then compared to the OD values of the reference suspensions to
allow placement into the appropriate category.

Static Multi-Angle Light Scattering (MALS) Studies
SIZE EXCLUSION CHROMATOGRAPHY-MALS: Size exclusion
chromatography experiments were conducted using a TosoHaas G3000SWXL, catalog
#08541,7.8 mm x 30 cm, 5 um, 250A column on an Agilent 1100 HPLC system (Agilent
Technologies, Palo Alto, CA). The column was loaded with 100 [iL of protein at 1
mg/mL. The samples were eluted at ambient temperature with a mobile phase of 10 mM
Na2HP04,100 mM NaCl, pH 7.15 with an isocratic flow rate of 0.2 mL/min. The elution
peaks were monitored at 280 run by a UV multi-wavelength detector (Agilent
Technologies), a DAWN®-HELEOS Multi Angle Light Scattering (MALS) detector
(Wyatt Technology, Santa Barbara, CA) equipped with a 60 mW GaAs linearly polarized
laser, operating at a wavelength of 658 nm, and an Optilab rEX™ differential refractive
index detector (Wyatt Technology, Santa Barbara, CA) that utilizes an LED light source
operating at a wavelength of 658 nm. The data from the UV, MALS and dRI were
collected and analyzed using Astra® V software (Wyatt Technology, Santa Barbara, CA).
The complete static light scattering data set at multiple angles (10° -160°) and the dRI
data (using a dn/dc value of 0.185 mL/g) then was used to create a Debye plot to derive
the absolute weight average molecular weight for the eluting SEC species.
BATCH-MALS: The weight average molecular weight of the antibody samples
as a function of protein and salt concentration were measured along with the root mean
square radius (Rg) at ambient temperature and at multiple angles (10° -160°) using a
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DAWN®-EOS™ Multi Angle Light Scattering (MALS) detector and an Optilab DSP™
differential refractive index detector. The samples were introduced into the MALS
detector, with the flow cell still in place, using a Razel™ syringe pump model #A-99, and
a 3 mL Norm-Ject® all polymer syringe, VWR part number 53548-006, flowing at 0.2
mL/min. A buffer blank was initially injected to establish a baseline and then the protein
samples were injected in adequate volumes to establish a flat plateau for each
concentration. In addition to Debye plots, Zimm Plots we also generated from the excess
Raleigh ratio of the protein solutions to measure the effects of non-ideality, also known
as second virial coefficient or A2.
FIELD FLOW FRACTIONATION-MALS: In order to overcome the significant
separation limitation of size exclusion chromatography, asymmetric flow field flow
fractionation (AFFF) was also employed. An Eclipse™ II field flow fractionation
instrument (Wyatt Technology, Santa Barbara, CA) was coupled to a UV multiwavelength detector (Agilent Technologies), a DAWN®-HELEOS Multi Angle Light
Scattering (MALS) detector and an Optilab rEX differential refractive index detector.
The solvent flow through the AFFF was achieved by the use of an HPLC isocratic pump
and autosampler (Agilent Technologies) and delivered to the separation channel by the
use of two needle valves. The protein samples were loaded onto the AFFF in various
quantities depending on the degree of opalescence. Samples with a lower degree of
opalescence were loaded at 50 ug to 100 |ig and samples with a higher degree of
opalescence were loaded at 10 ug; to 50 ug. Separation was achieved at ambient
temperature using a 21 cm aqueous channel with a 10 KDa regenerated cellulose
membrane and a 350 uM standard width spacer. To examine the salt dependence on the
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protein opalescence, two buffers were used in the AFFF analysis consisting of 10 mM
Histidine, pH 6, and 10 mM Histidine, 100 mM NaCl, pH 6. After the injection, the
samples were initially focused for two minutes at a cross flow of 0.2 mL/min and then
eluted using a channel flow of 1 mL/min and a cross flow of 5 mL/min over ten minutes,
followed by a cross flow gradient to 0.1 mL/min over 30 minutes.

Sedimentation Velocity Studies
All sedimentation velocity experiments were conducted using a Beckman XL-I
analytical ultracentrifuge equipped with an on-line Raleigh optical system (Laue, 1992), a
UV absorption optical system and a An-50 Ti 8-hole titanium rotor. The cells consisted
of a 2-sector, 12 mm charcoal-filled Epon, velocity centerpiece and matched quartz
windows contained in wide-aperture window holders. Protein samples were diluted to 1,
0.5 and 0.125 mg/mL using a buffer containing 10 mM Histidine, 10 mM NaCl, pH 6 and
another buffer containing 10 mM Histidine, 150 mM NaCl, pH 6. The samples then were
filled into the velocity cells along with their appropriate buffer blanks and allowed to
equilibrate before running. Centrifugation was run at 35,000 rpm at 20 °C, and the scans
were collected using the UV-absorption optical scanning system, scanning at a
wavelength of 280 nm. Data were collected using the Beckman XL-I version 4.5
program and the distribution of the different species was obtained using the non-linear
curve fitting program SEDFIT (Schuck, 2000). The program Sednterp was used to
calculate the partial specific volume (v) of the antibodies in solution and the buffer
density (p), for each ionic strength, as described (Laue, 1992). The data were arranged
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using ORIGIN to graph the C(S2o,w) distribution overlays for each antibody
concentration.

Electro-Separation
A unique method of inducing opalescence was initially derived to study the
opalescence phenomenon. This method used an apparatus that was built in the lab using
a 15 mL conical tube with the conical end removed. The tube was further modified by
drilling nine, 1/16" diameter holes along the length of the tube in linear, equidistant
spacing, used for sampling purposes. The two open ends of the tube were fitted with #00
rubber stoppers that were modified with platinum electrodes passing through, and the
electrodes at the wide end of the stopper were connected to a power supply using wires
fitted with alligator clips. Prior to fitting the modified stoppers into the ends of the tube,
a 12,000 MWCO Spectra/Por® 1 Molecularporous Regenerated Cellulose Dialysis
Membrane was draped over each so that once inserted, the electrodes at the narrow end of
the stopper would not come into contact with the contents of the tube. The tube was
filled carefully with the antibody sample at a concentration of approximately 10 mg/mL
and held horizontally during the experiment using a ring stand and ring stand clamps
Figure 2.1. Constant voltage (80 volts) then was applied to the apparatus using a Heofer
r

PS-1200 DC power supply until the current stabilized and the opalescence phenomenon
was observed (approximately ten minutes). The power supply then was turned off and a
10 uL sample was removed at each sampling port for further analysis. The samples were
diluted 1:10 and the optical density (OD 2so) was measured along with the pH and
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Figure 2.1: The Electroseparation Device Designed to Induce
Opalescence

Figure 2.1: The electroseparation device was designed to induce opalescence by passing
an electrical current through the IgG 1 sample solution. The platinum electrodes were
isolatedfromthe sample solution by the use of semi-permeable membranes. Once
opalescence was induced the holes drilled along the top of the device allowed a sample of
the solution to be recovered for further analysis. It should be noted that although a fair
amount of time was placed on conducting these unique experiments, the results were
merely used to study the opalescence phenomenon through manual induction and to craft
further analysis of the naturally occurring opalescence, through more traditional
biophysical techniques.
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conductance. Attempts were made to further analyze each sample using sedimentation
velocity but were unsuccessful.

Salt Induced Opalescence
Salt induced opalescence was examined after the results of the Electro-Separation
experiments. Solutions of Mab 1, Mab 2 and Mab 3 antibodies used in the salt induced
opalescence characterization were prepared by dialyzing the stock protein solution for 24
hours in 10 mM Histidine, Sigma Chemical Co. Lot 113H5725, pH 6, using Pierce SlideA-Lyzer® 10K MWCO Dialysis Cassettes. Samples were similarly prepared by dialysis
into 10 mM Histidine buffer, pH 6, containing the various NaCl concentrations used
throughout this study. In addition to NaCl dependence, other salts also were examined in
the 10 mM Histidine buffer including 100 mM KC1 and 100 mM Sodium Citrate. The
resulting opalescence that occurred was used for all subsequent characterization results in
this study.

Dynamic Light Scatterine Studies
The hydrodynamic radius of the IgG 1 samples in this study were measured using
a DynaPro Titan (Wyatt Technology, Santa Barbara, CA) and the DynaPro™ Plate
Reader Plus (Wyatt Technology, Santa Barbara, CA). Both of the DLS instruments
employed a solid state GaAs laser tuned to X&o, and operating at an output power
between 5 and 50 mW. When required, the filtration of samples was performed using a
Whatman Anotop® 10, 0.1 fiM pore size Anopore syringe tip filter, catalog #6809-1012
(Whatman pic, Maidstone, KY), fitted to a 3 mL Norm-Ject® all polymer syringe, VWR
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part number 53548-006. Data were collected using a proprietary multi-mode optical fiber
and analyzed using Dynamics™ software, that utilizes a multi-tau correlator collecting 248
channels at 0.48 us.
D YNAPRO™ TITAN ANALYSIS: The Titan sample cell holder consisted of a
12 u.L quartz cuvette with a one cm path length, and a built in air-cooled Peltier with
condensation control. During analysis, the IgG 1 samples were prepared over a range of
concentrations and NaCl conditions used throughout this study and the sample
temperature was maintained at 25 °C (± 0.03 °C). The scattered light intensity was
collected at an angle of 90° and the laser power was adjusted manually until there was a
total scattering intensity of approximately 8 x 105 counts/second. Data were collected
over a 20 second time frame with five data sets averaged together to give a total collected
time of 100 seconds.
DYNAPRO™ PLATE READER PLUS: The Plate Reader Plus sample holder
consisted of a Greiner™ Bio-One 384 SensoPlate, catalog #781892, 50 uL microplate that
was black with a clear flat glass bottom (Greiner Bio-One, Inc, Monroe, NC), and a built
in air-cooled Peltier with condensation control. During analysis, the Mab 1 sample was
diluted from a stock solution of 77 mg/mL in 10 mM Histidine, pH 6 to a concentration
range of 2,4 and 6 mg/mL, each, in buffers containing 10 mM Histidine, pH 6, with 0,25
and 50 mM NaCl. To examine the temperature dependence on the NaCl concentration
for the Mab 1, the temperature of the Plate Reader was increased from 4 °C to 70 °C in 4
°C increments, waiting at each increase for the temperature of the plate to equilibrate.
Each sample was prepared three times and the data were collected over a two second time
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frame with five data sets averaged together to give a total collected time often seconds.
Additionally, the temperature dependence on the viscosity of the solvent was corrected
for based on an aqueous model.

Digestion / Fragmentation
PEPSIN DIGEST: This preparation describes the procedure for peptic digestion
of IgG 1 molecules and the subsequent purification of their F(ab')2 fragments by SECHPLC.
To prepare the digestion buffer, 20 mM sodium acetate pH 4.0 was prepared
dissolving 1.64 g of sodium acetate (Fluka catalog #94318) in -900 mL of water, using
acetic acid to titrate the solution to pH 4.0. The volume was brought up to one liter, the
buffer was filtered with a 0.2 um (pore size) bottle-top filter and stored at room
temperature.
The IgG 1 samples (10 mg/mL each in 10 mM Histidine, pH 6) were buffer
exchanged into the digestion buffer (4 mL x 2) using centrifugal filter devices (Millipore
catalog #UFC801024), and the final volumes were adjusted to 1 mL. For each Mab, 0.25
mL of immobilized pepsin (Pierce catalog #20343) (50% slurry) was equilibrated with
digestion buffer (4 mL x 2) in a glass borosilicate test tube and the final volume was
adjusted to 0.5 mL. The IgG 1 samples in the digestion buffer were combined with the
immobilized pepsin in a 16 x 100 mm borosilicate glass tube (Fisher catalog #14-961-29)
along with a stir bar, and sealed with parafilm. Samples were incubated at a temperature
of 37 °C with constant stirring (Pierce Reacti-Therm heating/stirring module). Based on
time course experiment results, all IgG Is were digested in 20 mM sodium acetate pH
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4.0, at 37 °C for 12 hours. Immobilized pepsin was separated by centrifugation, and the
supernatant was buffer exchanged into 10 mM Na2HP04, 100 mM NaCl, pH 7.15, and
the final volume was-0.5-1 mL.
PURIFICATION OF THE PEPSIN DIGEST: SEC-HPLC was chosen for the
purification of the F(ab')2 fragments because it is a mild separation technique which
operates independently from small changes in their environment such as ionic strength,
pH and temperature. The buffer-exchanged crude peptic digest, in PBS-CMF, was
filtered using a Whatman Anotop® 10, 0.1 yM pore size Anopore syringe tip filter, fitted
to a 3 mL Norm-Ject® all polymer syringe, into an HPLC vial. The analytical scale SECHPLC was run by injecting 50 \xg of intact IgG 1 followed 50 uL of crude digest to
estimate the extent of digestion and retention time relative to the undigested IgG 1. SEC-HPLC purification was performed using a TosoHaas G3000SWXL, catalog #08541, 7.8
mm x 30 cm, 5 urn, 250A column on an Agilent 1100 HPLC system (Agilent
Technologies, Palo Alto, CA). The samples were eluted in 20 minutes at ambient
temperature with a mobile phase of 10 mM Na2HP04, 100 mM NaCl, pH 7.15 using an
isocratic flow rate of 0.75 mL/min. The elution peaks were monitored at 214 nm by a
UV multi-wavelength detector (Agilent Technologies). For the preparative SEC-HPLC,
the injection volume was increased according to the height of the F(ab')2 peak (major
peak) observed in analytical scale chromatograms. The F(ab')2 fraction was manually
collected from multiple injections and pooled. Protein concentration was determined
spectrophotometrically (A280) using calculated absorptivity (mg/mL)"1cm"1 for the F(ab')2
fragments.
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PAPAIN DIGEST: The preparation of Fab, (Fab)2, and Fc fragments,
followed Pierce protocol #20341 "Procedure for IgG 1 Digestion to Generate Fab
Fragments", exceptions are noted.
To start the sample preparation, the IgG 1 samples were dialyzed into the papain
sample buffer (20 mM sodium phosphate, Na2HP04,10 mM EDTA, pH 7.0) before
papain digestion using an Amicon 10 kDa MWCO membrane spin tube. Approximately
11 mg of each of the samples (250 |^L of 45 mg/mL) were spun at 6500 x g for 30
minutes for two buffer exchange cycles. The final volume of the sample after the buffer
exchange was brought to approximately 350 uL, the samples were diluted 1:10 and the
optical density (OD 28o) was measured. The antibody samples were then diluted to a final
concentration of approximately 33 mg/mL in preparation of the digest step.
The bead immobilized papain (Pierce catalog #20341) was shipped in a storage
solution containing 50% glycerol, 0.1 M sodium acetate, 0.05% sodium azide, pH 4.4.
The bead immobilized papain solution was dialyzed into a papain digest buffer
containing 20 mM cysteine-HCL added to the papain sample buffer with the pH adjusted
to 7.0 before use. The wash volume ratio recommended by Pierce was 0.5 mL
immobilized papain to 4 mL papain digest buffer. The following modified procedure was
followed:
1. Added 1.5 mL immobilized papain to a 15 mL conical tube
2. Added 12 mL papain digest buffer and mixed by inversion
3. Spun at 3500 x g for three minutes
4. Removed supernatant
5. Repeated with another 12 mL papain digest buffer
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6. Resuspended immobilized papain with 0.5 mL papain digest buffer so the
final volume was ~1 mL (0.5 mL papain + 0.5 mL papain digest buffer)

The digestion of the antibody samples was performed by mixing 300 |iL of each
antibody sample (~10 mg) with 67 uL of papain sample buffer and 500 \iL of the papain
digest buffer. The digests were placed in starstedt tubes allowing for space in the tubes
for the digest volume to mix and then placed on a table top shaker for 24 hours at room
temperature. After the digestion was complete, the samples were stored at 2-8 °C for two
days. The papain was then separated from the sample by spinning the stardset tubes on a
bench top centrifuge at 8000 RPM for three minutes. Supernatant was removed and the
immobilized papain was discarded. Theoretical concentration after the papain digestion
was calculated to be approximately 6 mg/mL for each of the antibody samples but the
optical density (OD 280) was not measured.

PURIFICATION OF THE PAPAIN DIGEST: The purification of the papain
digested IgG 1 samples was then performed by Protein-A HPLC. The theory is that the
Fab and (Fab)2 fragments elute in the flow through and the Fc fragment binds to the
protein-A column allowing for the first step in purification of the antibody fragments.
The chromatography was performed using an Applied Biosystems PA Immuno-Detection
Sensor Cartridge, catalog #2-1001-00, column on a Waters 2695 HPLC system (Waters
Corporation, Milford, MA). The column was loaded with 50 uL of protein for a total
sample load of 300 jag. The samples were eluted at 4 °C using a flow rate of 1 mL/min,
following a specific elution gradient between mobile phase A (50 mM NaH 2 P04,150
mM NaCl, pH 7.0) and mobile phase B (0.5% H 3 P0 4 , 100 mM NaH 2 P0 4 , 400 mM
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NaCl). The elution step consisted of the following gradient. At time zero tofiveminutes
the gradient was 100% mobile phase A and 0% mobile phase B. From seven minutes to
12 minutes, the gradient changed to 0% mobile phase A and 100% mobile phase B.
Finally, the gradient was changed back to 100% mobile phase A and 0% mobile phase B
and the elution continued for a total run time of 15 minutes. The elution peaks were
monitored at 280 nmbya UV variable-wavelength detector (Waters Corporation). Both
the flow through and the elution fraction were collected from multiple injections. The
collected fractions were pooled, buffer exchanged into the appropriate buffer system and
concentrated. Buffer exchange and concentration was performed using Amicon 10 kDa
MWCO membrane spin tubes spun at 6500 X g to reduce the initial volume to -100 (xL.
Then 4 mL of the 10 mM Histidine, pH 6, buffer was added and spun for two exchange
cycles until the final volumes were approximately 500 uL. Finally, the optical density
(OD 28o) for each fractionated sample was measured using a Spectramax Plus UV-Vis
spectrophotometer equipped with a plate reader. The absorbance was determined at a
wavelength of 280 nm and was corrected for light scattering by subtracting the
absorbance at 320 nm. The concentration was then calculated using an extinction
coefficient of 1.65 (mL mg^cm"1) for Fab (Mab 1), 1.37 (mL mg^cm"1) and for Fc (Mab
1) as determined theoretically by quantitative amino acid analysis. The Fab and Fc
samples that were analyzed for Mab 2 and Mab 3 were supplied by a collaborator.
PURIFICATION OF THE POST PROTEIN-A PAPAIN DIGEST BY SECHPLC: Thefinalpurification was performed using a TosoHaas G3000SWXL, catalog
#08541, 7.8 mm x 30 cm, 5 um, 250A column on an Agilent 1100 HPLC system (Agilent
Technologies, Palo Alto, CA). The column was loaded initially with an analytical load of
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10 jag and then with a purification load of 300 (j,g of the fractioned samples. The samples
were eluted in 20 minutes at ambient temperature with a mobile phase of 10 mM
Na2HP04,100 mM NaCl, pH 7.15 using an isocratic flow rate of 0.75 mL/min. The
elution peaks were monitored at 280 nm by a UV multi-wavelength detector (Agilent
Technologies). Since each fragment had some undigested material, the fragments were
further purified into Fab, (Fab)2, and Fc. Thefragmentswere collected from several runs,
pooled, and concentrated using Amicon 10 kDa MWCO membrane spin tubes, spun at
6500 x g to reduce volume. Solutions of the purified Fab, (Fab)2, and Fc fractions were
then dialyzed for 24 hours in 10 mM Histidine, Sigma Chemical Co. Lot 113H5725, pH
6, using Pierce Slide-A-Lyzer® 10K MWCO Dialysis Cassettes. Samples were then
similarly prepared by dialysis into 10 mM Histidine buffer, pH 6, containing the various
NaCl concentrations used throughout this study. The proteinfractionconcentration was
determined as previously described.

Differential Scanning Calorimetry (DSC) Studies
The thermal stability of the antibody samples and thefractionatedprotein samples
was assessed using a MicroCal VP-Capillary Differential Scanning Calorimeter
(Microcal LLC, Northhampton, MA). Samples were run at a volume of 350 micro liters
and a concentration of approximately 1.5 mg/mL using a 90 °C/hr scan rate spanning the
temperature rangefrom20 to 90 °C. Triplicate scans were performed at each
temperature with a ten minute equilibration at 20 °C and no equilibration at 90 °C. It is
also important to note that the system was completely washed out after each protein run.
Samples were buffer subtracted and converted into concentration normalized scans. The
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data was then analyzed using Origin software ver. 7.0 in order to fit the thermal
transitions.

Non-Ideality Analysis
INSTRUMENTATION: An experimental instrument known as the Calypso was
developed by Wyatt Technology to deliver a series of un-fractionated samples of
different concentrations in order to characterize the affinities of macromolecular
interactions, or virial coefficients. The Calypso system comprises three computercontrolled syringe pumps that utilize dc-servo motors for a smooth, pulse-free delivery
and a built-in multi-channel vacuum degasser. The three syringe pumps were able load
buffer and stock sample solutions, subsequently dispensing them at different preprogrammed rates so as to generate a succession of concentration ratios. The syringes
delivered the sample mixtures through a four port union, an in-line Whatman Anotop 25,
0.1 uMfilterto a mixing chamber andfinallyto a DAWN®-EOS™ Multi Angle Light
Scattering (MALS) detector and an Optilab DSP™ differential refractive index detector,
installed in parallel as indicated schematically in Figure 2.2. The flow rate to each of the
two detectors connected in parallel was adjusted using a metering valve to ensure that the
refractive index measured at a particular time point corresponded to the composition of
solution scattering light at the same point. The data was collected and analyzed using the
CALYPSO data analysis program and Astra® V software.
EXPERIMENTAL PROCEDURE: The setup employed in this study consisted of
one syringe containing our IgG 1 sample and one syringe containing the buffer of interest
so that the desired dilutions could be made. Following baseline measurements of the
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Figure 2.2: The Parallel Detector Configuration of the Calypso
Instrument with the MALS and Concentration Detector
Calypso host computer
Calypso SP3
Mixing point
"y
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Figure 2.2: The Calypso instrament comprises a set of three computer-controlled
syringe pumps and a built in multi-channel vacuum degasser, together with associated
tubing,filtersand valves. The schematic displays a Calypso instrument which is
configured in the parallel configuration. In the parallel configuration, the sampleflowis
first mixed and then split between the two detectors at afixedratio which is optimized to
guarantee equal concentrations in each detector upon injection.
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buffer alone, there was a stepwise change of solute concentration that varied linearly
upwardfromzero concentration (pure buffer) to the concentration of the IgG 1 stock
solution, and then downwardfromthe concentration of the IgG 1 stock solution to zero
concentration, typically over a series often concentrations. Upon collecting the data, the
resulting plateaus are assigned a concentration based on the refractive index detector, and
the multi-angle light scattering data was used to assign the value of the Rayleigh ratio at a
zero scattering angle. This data was then combined to generate a Zimm plot which is
capable of calculating values of Mw, Rg and A2 for the IgG 1 species.

Viscosity Measurement
The viscosity of the antibody samples was measured using an Anton PAAR
rheometer (Anton PAAR, Ashland, VA) equipped with a CP 25-1 cone/plate measuring
system. Approximately 100 ^L of sample was loaded onto the lower measuring plate and
allowed to come to thermal equilibrium. The rheometer was set at a constant sheer rate
of 898"s, speed 150 min"1, and a constant temperature of 25 °C. Ten points were averaged
per sample and the data was measure in units of centipoise. The viscosity of Mab 1 was
measured over a concentration range of 1, 5,10,20, 30,40, 50, 55 and 60 mg/mL at 4
and 25 °C in a buffer containing 10 mM Histidine, 50 mM NaCl, pH 6. The viscosity
effects of NaCl on the three IgG 1 antibody samples were also measured at a
concentration of 5 mg/mL in a buffer containing 10 mM Histidine, pH 6 with 0, 50 and
100 mM NaCl.

42

Circular Dichroism Analysis
The CD spectra were recorded on JASCO J-815 spectropolarimeter (JASCO Inc.
Easton, MD) equipped with peltier-controlled temperature regulation and a one cm path
length cuvette for recording near-UV spectra. The antibody samples to be tested were
dialyzed for 24 hours in 10 mM Histidine, Sigma Chemical Co. Lot 113H5725, pH 6,
using Pierce Slide-A-Lyzer® 10K MWCO Dialysis Cassettes. Samples were then
similarly prepared by dialysis into 10 mM Histidine buffer, 100 mM NaCl, pH 6 and
brought to a final concentration of 4 mg/mL. The near-UV CD spectra were recorded at
a temperature of 25 °C from 250 to 360 nm (in 0.5 nm steps) with an integration time of
two seconds at each wavelength and the baseline was corrected against a cuvette
containing buffer alone. The CD data thus obtained were expressed in terms of molar
ellipticity (deg cm2 dmol"1) [9] and graphed against wavelength (nm).

Congo Red Studies
The binding of Congo Red (CR), Sigma Chemical Co. Lot C6767, to the IgG 1
samples was examined at room temperature in buffer conditions of 10 mM Histidine, pH
6, ± 100 mM NaCl. The samples were diluted to ~1 mg/mL and incubated in 50 uM CR
for two hours (Chiti et. al. 2001) (Sirangelo et. al. 2002) (Srisailam et. al. 2002) and then
filtered using a Whatman Anotop® 10 mm, 0.20 jam, PES syringe mount filter.
Absorption spectra were acquired using a Spectramax Plus UV-Vis spectrophotometer
equipped with a plate reader at 25 °C in 2 nm increments, from 300 nm to 650 nm, at a
scan rate of 300 nm/min. The protein samples and were placed in individual wells in a 96
well plate with the spectra of corresponding buffer without CR, used as a blank.

43

Urea Analysis
Urea was used to study the nature of the self association observed in the IgG 1
samples. A 5 mg/mL solution of Mab 1 used in the urea characterization was prepared
by dialyzing the stock protein solution for 24 hours in 10 mM Histidine, 100 mM NaCl,
pH 6, using Pierce Slide-A-Lyzer® 10K MWCO Dialysis Cassettes. After dialysis, the
pH and concentration was checked and the solution was sterilized as described
previously. For the study, a range of urea concentration from 0 mM, 0.03 mM (1:1), 0.3
mM (10:1) and 200 mM (6000:1), were mixed into the Mab 1 sample to study the effects
of hydrogen bond disruption. In addition, 200 mM Arginine was also mixed into the
Mab 1 sample to compare the effects of urea to lower the viscosity. The samples were
incubated for one hour at room temperature and the hydrodynamic radius of the IgG 1
samples in this study were measured using a DynaPro Titan as previously described.
The Mab 1 samples were then incubated for 24 hours at 4 °C and the dynamic light
scattering measurements were repeated. The urea study was not performed on the Mab 2
and the Mab 3 samples due to the fact that they did not display significant levels of highorder association when analyzed by dynamic light scattering under the initial buffer
conditions.

FTIR Structural Analysis
The structural analysis was performed on the three IgG 1 antibodies using Fourier
Transform Infrared (FTIR) spectroscopy. Mab 1, Mab 2 and Mab 3 were analyzed at a
concentration of 77 mg/mL, 60 mg/mL and 54 mg/mL respectively, in a buffer
containing 10 mM Histidine, pH 6 ± 100 mM NaCl. Samples were stored at 4 °C and
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analysis run with the samples at both 4 °C and 20 °C. All FTIR spectra were recorded on
a Bruker Tensor 27 from 1000-4000 cm-1 using a resolution of 2 cm-1 and 128 scans.
The crystal was cleaned with water, and ethanol prior to sample solution application. The
temperature of the ATR unit was maintained at 4 °C and 20 °C with an external water
bath and purged continuously with nitrogen or house air. After a 40 minute equilibration,
200 ul of sample was spread uniformly over the germanium crystal. A blank buffer
spectra was also collected. The data were collected with OPUS software (Ver. 5) and the
spectra of the three antibody runs were overlaid for each experiment.

Capillary Electrophoresis Studies
Capillary electrophoresis was used in the valence determination of the IgG, 1
samples in this study. The instrument used to conduct the electrophoresis experiments
was the Beckman Coulter ProteomeLab™ PA800 (Beckman Coulter, Inc. Fullerton, CA),
using an eCAP amine capillary (part #477431), that was rinsed with the amine
regeneration solution (part #477433) as per the protocol described by Beckman. Data
were acquired using the 32 Karat software (ver. 7.0) and further analyzed using ZUtilities
(ZUtilities: http://rasmb.bbri.org/rasmb/AQS/ZUtilites).
Initially, the expected valence of the antibody samples was calculated based on
the amino acid sequences, in the buffer solutions, using the program Sednterp (Sednterp:
www.iphilo.mailway.com/dowload). Then following the setup recommended by
Beckman, the total length of the capillary was determined as was the length of the
capillary to the detector. Additionally, the maximum voltage to be used with each buffer
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in the study was determined by constructing an Ohm's law plot. A typical valence
measurement protocol is as follows:
1. Determine the expected valence of the molecule from the amino acid
composition at the pH of the buffer solution selected for the study. For
positively charged molecules, use an amine capillary and for negatively
charged molecules, use a bare capillary. If the valence is entirely unknown,
start with a bare capillary.
2. Record the total length of your selected capillary and the length to the detector
as well as the maximum voltage (measured by the Ohm's law plot) that can be
used with the running buffer.
3. Run the samples with and without the electroosmotic flow (eof) marker (e.g.
DMSO, benzyl alcohol at 0.02%) at the highest voltage measured using the
Ohm's law plot. A good protein concentration is between 0.3 and 0.5 mg/mL
and a typical time of injection to get a good peak is between five and ten
seconds.
4. After the first attempt, if the sample and the marker peak are not easily
identifiable and/or do not have adequate resolution, try lowering the run
voltage or increasing the ionic strength of the running buffer.
5. An option is to perform additional runs including the sample and the eof
marker using several different voltages. Record the migration time for each
sample and eof marker peak plus the voltage used.
6. Using dynamic light scattering, determine the hydrodynamic radius (Rh) and
the diffusion coefficient of the sample in the CE running buffer.
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7. Measure the ionic strength, and the radius of the counter-ion in the running
buffer.
8. Calculate the velocity of the sample by determining the migration time of each
peak and subtracting the migration time of the eof marker. This result is the
mobility of the sample corrected for the electro-osmotic flow of the CE run.
9. Calculate the final valence (Z* and Z) of the samples using the software
program ZUtilities.
The conditions that were used for the valence determination are as follows, with a
typical 32 Karat software experimental protocol shown in Figure 2.3.
The conditions used for this study:
1. Solvent: Buffer A contained 100 mM MES buffer, 100 mM NaCl, pH 6.
Buffer B contained 100 mM MES buffer, 10 mM NaCl, pH 6. The
conductivity of Buffer A was measured to be 14.5 mS/cm and the
conductivity of Buffer B was measured to be 0.28 mS/cm. In addition, 0.1
mM urea was spiked into each of the buffers to study the resulting effects on
charge.
2. Sample concentrations: The samples that were used in this study consisted of
the intact IgG 1 antibodies with Mab 1 =0.511 mg/mL, Mab 2 = 0.532
mg/mL and Mab 3 0.55 mg/mL and the F(ab')2 fragments (see section on
Digestion / Fragmentation) with Mab 1 F(ab')2 = 0.569 mg/mL, Mab 2 F(ab')2
= 0.631 mg/mL, Mab 3 F(ab')2 = 0.782 mg/mL.
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3. Sample Valence (based on AA sequence at pH 6): Mab 1 = 22.162, Mab 2 =
28.288, Mab 3 = 42.378; Mab 1 F(ab')2 = 9.297, Mab 2 F(ab')2 = 17.5, Mab 3
F(ab')2 = 31.892.
4. Neutral marker: 0.02% dimethyl sulfoxide (Pierce, Rockford, IL)
5. Run temperature: 20 °C
6. Detector wavelength: 214 nm
7. Total capillary length: 61.6 cm
8. Length to detector: 50.8 cm
9. Voltage used: 10 kV for buffer A and 30 kV for buffer B
10. Diffusion coefficient: Mab 1 = 3.45xl0"7 cm2/sec, Mab 2 - 4.74xl0"7
cm2/sec, Mab 3 = 4.48xl0"7 cm2/sec; Mab 1 F(ab')2 = 3.38xl0"7 cm2/sec, Mab
2 F(ab')2 = 2.85xl0"7 cm2/sec, Mab 3 F(ab')2 = 3.62xl0"7 cm2/sec, determined
from dynamic light scattering data using a DynaPro™ Plate Reader Plus..
11. Stokes radius (Rh): Mab 1 = 5.1 nm, Mab 2 = 5.1 nm, Mab 3 = 5.1 nm; Mab
1 F(ab')2 = 4.6 nm, Mab 2 F(ab')2 = 4.6 nm and Mab 3 F(ab')2 = 4.7 nm,
calculated from the molecular weight of the AA sequence as determined using
Sednterp and using the Stokes Einstein relationship for a globular model as
implemented in Dynamics™. The Rh for NaCl = 0.122 nm.
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CHAPTER III

RESULTS
Antibody Purification

Characterization of Protein Purity
For this study, the three recombinant humanized IgG 1 monoclonal antibodies
were expressed in the CHO cell lines, purified by a series of chromatography steps and
then finally brought to a concentration of ~75 mg/rnL. To assess protein purity, several
characterization techniques were employed however, due to the aim of this study, only
the results from the Mab 1 are shown. It is important to note that both Mab 2 and Mab 3
were assessed, with similar results of purity.
SDS-PAGE: Figure 3.1 shows the migration position of the purified Mab 1 using
SDS-PAGE analysis following non-denaturing and denaturing preparation. It was
evident from the non-reducing preparation that the most abundant species present was the
purified Mab 1 monomer. The reducing preparation shows two major, distinct bands,
representing that of the light chain (~25 kDa) and the heavy chain (-48 kDa). However,
due to the impurity of the initial protein isolate, several other minor bands appear on the
gel which represents both small Mw species and non-dissociable aggregated species.
These minor bands were seen routinely in all the non-reduced SDS-PAGE analysis of the
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Figure 3.1: Reducing and Non-Reducing SDS-PAGE Results of Mab 1
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Figure 3.1: Lane 1 represents the Mw markers, lanes two through six represent reduced
purified Mab 1 and lanes eight through 12 represent non-reduced purified Mab 1 (each 10
uL injection was repeated five times). The overall banding pattern of the Mab 1 in each
reducing lane is similar and indicates that in addition to the bands representing the
purified Heavy Chain and Light Chain, there are non-dissociable aggregates present
(bands migrating around 116 to 200 kDa). The overall pattern of the Mab 1 in each nonreducing lane is also similar with small amounts of low Mw species species present. It
should be noted that the non-dissociable aggregates were removed in a subsequent cHA
purification step.
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three IgG 1 samples and their origins are currently unknown. Therefore, a clean
separation of the IgG 1 samples from the impurities using an additional hydroxyapatite
chromatography (cHA) step was required prior to subsequent opalescence
characterization. It is also important to note that the majority of the minor bands seen in
the non-reduced preparation were eliminated following the reducing preparation,
indicating disulfide bonding.
SEC-HPLC: To further asses purity of the CHO expressed recombinant
humanized IgG 1 monoclonal antibodies, SEC-HPLC was performed. Five samples of
the Mab 1 were examined after the additional cHA purification step and the
chromatograms overlaid in Figure 3.2. In general, the profiles show approximately 98%
monomer and about equal amounts of low Mw and high Mw species present. The subtle
run to run variations that are displayed in the chromatograms are considered normal and
well within the error of the technique. These results indicate that the cHA purification
step was adequate to purify the IgG 1 samples for further opalescence characterization.
CEX-HPLC: A total of five samples of the Mab 1 antibody were also analyzed
by CEX-HPLC in order to assess the degree of basic and acidic species that remained
after the additional cHA purification step. The resulting chromatograms are shown in
Figure 3.3 with labels to indicate the main species from the acidic and basic species.
Although there is a fair amount of acidic and basic species present, the results are
considered typical for the degree of purification used for this study.
ACHRO-K PEPTIDE MAPPING: The peptide mapping step was performed on
only three batches of the final cHA purified Mab 1. The results of the peptide mapping
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Figure 3.2: Overlay Details of the SEC-HPLC Profiles of Mab 1
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Figure 3.2: The SEC elution profiles of the five purified Mab 1 samples following the
cHA step as recorded at an absorbance wavelength of 280 nm. It is clear from these
results that the cHA purification step was successful in purifying the Mab 1 monomer to
around 98% pure, with approximately 1% LMW and 1% HMW species also identified.
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Figure 3.3: CEX-HPLC Profile of Mab 1
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Figure 3.3: Comparison CEX-HPLC runs for five of the Mab 1 sample after final cHA
purification. The results indicate that in addition to the main IgG 1 peak, there are some
basic and acidic species that remain. These results are typical for the purification steps
that were employed and were similar for all of the IgG 1 samples that were used
throughout this study.
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were then compared to show that the final IgG 1 samples are identical in the amino acid
composition (Figure 3.4). It should be noted that the results were also similar for both
the Mab 2 and Mab 3 samples.
N-LINKED OLIGOSACCHARIDE ANALYSIS: The three types of complex TVlinked biantennary glycans that are associated with the Mab 1 antibody are the GO, Gl
and G2 structures, which respectively contain zero, one or two galactose residues on their
outer JV-linked biantennary arms. The three samples tested by high pH anion exchange
chromatography (HPAEC-PED) in Figure 3.5 show the presence of three peaks
representative of the GO, Gl and G2 glycoforms, and are comparable to Mab 1 that has
been analyzed previously (data not shown). Although the samples do appear to have
varying levels of glycoforms present, the difference is not considered to be significant.
The IgG 1 samples used in this study, including Mab 2 and Mab 3, were therefore
considered comparable in their degree of glycosylation.

Opalescence Characterization
Visual Appearance and Description
The visual appearance of the IgG 1 samples used in this study was originally
examined and characterized through the use of the European Pharmacopeia reference
suspensions as described in Figure 3.6. With the use of these standards, it was possible
to assign a degree of protein opalescence (although somewhat subjectively) when initially
characterizing the effects of NaCl and pH. Figure 3.7 shows the opalescence
assignments that were performed on Mab 1 at the start of this study. Vial A contained
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Figure 3.4: Peptide Mapping Chromatograms of Mab 1
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Figure 3.4: A peptide map was performed on three of the final purified Mab 1 samples.
It is important to note that each of the samples were reduced, alkylated, desalted and run
on the same day for this comparison. From the chromatographic results, it appears as
though all three Mab 1 samples tested were comparable in their amino acid sequence.
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Figure 3.5: HPAEC-PED Chromatograms of Mab 1

Figure 3.5: The JV-linked oligosaccharide "fingerprint" profiles of Mab 1 were
compared for glycosylation heterogeneity. The profiles show the three major peaks
associated with the GO, Gl and G2 structures on the JV-linked biantennary arms.
Although the three samples tested do not appear to have identical glycoform levels, the
difference is not thought to be significant. Therefore, the samples of Mab 1 tested are
considered comparable.
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Figure 3.6: The European Pharmacopeia reference suspensions are seen here labeled as
I, II, III and IV. The opalescence assignments went as I was considered "clear", II was
assigned as "slightly opalescent", III was considered "opalescent" and IV was labeled as
"very opalescent". The EP standards were prepared fresh, stored in neutral glass vials
with a flat base, and illuminated with a specially prepared light box so that they could be
used to characterize the degree of protein opalescence. It is important to note that
although these standards were helpful in initially assigning the degree of antibody
opalescence, they were subject to interpretation and were quickly replaced by less
subjective optical measurement.
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Figure 3.7: Initial Antibody Opalescence Assignment Using EP
Standards
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Figure 3.7: This figure is an example of the initial characterization of the Mab 1
antibody. Vial A contains the storage buffer of 10 mM Histidine, pH 6, there is slight
foam on the top due to shaking. Vial B contains the Mab 1 antibody at an approximate
concentration of 60 mg/mL and a purity of >99% (it was assigned an opalescence rating
of II or slightly opalescent). Vial C and D contain the EP reference suspensions III and
IV respectively.
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just the storage/formulation buffer (10 mM Histidine, pH 6) used throughout the study
and is seen as a control as it does not display any appreciable opalescence. Vial B is the
Mab 1 antibody in 10 mM Histidine, ph 6, at a concentration of 60 mg/mL and a purity of
>99%. This sample already appears to display a degree of opalescence and through the
use of the EP reference suspensions III and IV in vials C and D respectively. Vial B is
labeled as slightly opalescent and therefore is assigned an EP rating of n. This figure
was intended to show the difficulty and limited nature of initially using the EP reference
suspensions as the only way of assigning the degree of opalescence. In Figure 3.8, an
attempt was made to characterize the effects of NaCl and Tween 80 on the opalescence of
Mab 1, using the EP reference suspensions. Initially, a 1 M stock solution of NaCl was
added into a solution of Mab 1 which was at a protein concentration of 65 mg/mL in 10
mM Histidine, pH 6 (Figure 3.8 A). Results indicate that at a NaCl concentration of only
2 mM, the degree of opalescence was already increasing, changing the initial EP
appearance from <III to III. As the concentration of NaCl that was added to the Mab 1
increased, from 1 to 8 mM, the opalescence also increased, with a final EP value of >IV
was assigned to the protein solution at 8 mM NaCl. Using the Mab 1 in 10 mM
Histidine, pH 6 (assigned an EP value of <III), Tween 80 was added from a stock
solution to examine the ability of the polysorbate to remove the opalescence (Figure 3.8
B). It was shown that the initial EP value did not change with the addition of the Tween
80 (from 0% to 32%) even though the protein concentration of Mab 1 was diluted from
65 mg/mL to 55.4 mg/mL. Figure 3.9 was a further attempt to characterize the
opalescence dependence of Mab 1 onpH and NaCl concentration. Mab 1 was examined
at a concentration of 10 mg/mL and assigned a degree of opalescence in each solvent
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Figure 3.8: Characterizing the Effect of NaCl and Tween 80 on Mab 1
Opalescence Using EP Reference Suspensions
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Figure 3.8: Using EP standards to characterize the effects of NaCl and Tween on
opalescence, stock solutions of 1 M NaCl or Polysorbate 80 (0.5% and 10%) were spiked
into Mab 1 at a protein concentration of 65 mg/mL in 10 mM Histidine, pH 6. Initially
the opalescence of Mab 1 was explored over a NaCl range of 0 to 8 mM (A). Also, the
ability of Polysorbate 80 to remove the subsequent opalescence was explored using Mab
1 in 10 mM Histidine, pH 6, with an opalescence value of III (B).
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Figure 3.9: Characterization on the Effect of NaCl and pH on
Opalescence of Mab 1 Using EP Reference Standards
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Figure 3.9: The effects of NaCl and pH on the opalescence of Mab 1 was examined
at a protein concentration of 10 mg/mL and assigned a degree of opalescence based
on the EP standards. Note that in some cases, it was necessary to extend the EP
values to that of "5" and "6" due to the high degree of opalescence.
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condition based on the EP standards. It is important to note that in some cases, it was
necessary to extend the EP values to that of "5" and "6" due to the high degree of
opalescence (these values were arbitrarily assigned). Samples at pH 4.0 through 6.0
generally had less opalescence at NaCl concentrations of 0 and 2 mM NaCl, with the pH
effect essentially lost at ^ 10 mM NaCl. In the presence of 75 and 150 mM NaCl, most
samples between pH 4 and 7 had the same degree of opalescence and eventually
precipitated at 150 mM NaCl. Overall, samples measured at pH 8 scored high in
opalescence at any NaCl level but precipitated immediately upon the addition of 150 mM
NaCl. Based on these results, it was then decided that the initial "formulation" buffer of
10 mM Histidine, pH 6 was the most appropriate for use in this study.

Static Multi-Angle Light Scattering (MALS) Studies
The effects of NaCl on the opalescence of Mab 1 were analyzed using multi-angle
static light scattering. The weight average molecular weights of the antibody solutions
were measured at 25 °C using static light scattering at angles of 32° to 147° combined
with concentration detection by UV or RI, measured in series.
SIZE EXCLUSION CHROMATORGAPHY-MALS: The effects of NaCl on the
self-association of Mab 1 was analyzed by SEC-MALS and a typical graphical
presentation of the experimental results is shown in Figure 3.10. The chromatographic
profile is a result of the light scattering signal at an angle of 90° and is seen with the Mw
distribution of each of the selected peaks in the elution. The monomer peak is clearly
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Figure 3.10: SEC-MALS Chromatogram of Mab 1 at 100 mM NaCl
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Figure 3.10: The effects of NaCl on Mab 1 opalescence was analyzed using SECMALS. The TosoHaas G3000SWXL column was loaded with 100 jig of protein with a
mobile phase of 10 mM Na2HP04,100 mM NaCl, pH 7.15, with an isocratic flow rate of
0.2 mL/min. The results of the analysis were then plotted as molar mass (g/mol) vs. time
(min), with the Mw distribution shown for the selected peak regions. A buffer blank was
also performed to identify the "ghost peak" that appeared during each injection. It is
important to note that after each injection, the pressure of the HPLC system would
increase gradually, limiting the use of the column to ~25 injections.
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seen at -57 minutes at around 98% of the material in solution along with the dimer peak
at -47 minutes, at around 2% of the total material in solution. There is an additional peak
at -32 minutes and is due to the column shedding the silica matrix as is clearly seen in
the inlayed chromatogram of the buffer blank. The SEC-MALS results indicate that even
in buffer conditions containing 100 mM NaCl, the Mab 1 antibody does not appear to
contain any higher order associated material beyond the dimer. It is important to note
that these results were consistently seen by Mab 2 and Mab 3 at all NaCl concentrations
tested. It should also be noted that after each Mab 1 injection, the pressure of the HPLC
system would increase gradually, limiting the use of the TosoHaas G3000SWXL column
to -25 injections before reaching the pressure limit of the column. This may indicate
fouling of the guard column by large aggregates.
BATCH-MALS: In order to examine the presence of any additional higher order
species present in the Mab 1 sample, batch-MALS was also employed. Figure 3.11
shows the light scattering profile of the 90° detector along with the RI concentration
profile for each of the five concentrations tested, in the 10 mM Histidine buffer, pH 6.
The results for each of the concentrations tested show a weight average molecular weight
that represents the monomer and dimer species in solution. In addition, the RMS radius
was also measured by angular dependence for each of the concentrations tested and
indicated that there is an average RMS radius from 11 to 14 nm. Figure 3.12 shows the
light scattering profile of the 90° detector along with the RI concentration profile for each
of the five concentrations tested, in the 10 mM Histidine buffer, 150 mM NaCl, pH 6. As
with Figure 3.11, the results for each of the concentrations tested show a weight average
molecular weight that represents the monomer and dimer species in solution. However,
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Figure 3.11: The NaCl dependence of Mab 1 was analyzed using batch MALS. The volume for each injection was approximately 1
mL, and the injections were performed using a syringe pump, at a flow rate of 0.2 mL/min. After each injection plateau was
established, a syringe containing only buffer was introduced to bring the signal back to baseline. In this study, five samples were
injected at the concentrations listed, without any NaCl in the Histidine buffer, and the Mw and RMS radius calculated for each using
MALS.
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Figure 3.12: The NaCl dependence of Mab 1 was analyzed using batch MALS. The volume for each injection was approximately 1
mL, and the injections were performed using a syringe pump, at a flow rate of 0.2 mL/min. After each injection plateau was
established, a syringe containing only buffer was introduced to bring the signal back to baseline. In this study, five samples were
injected at the concentrations listed, with 150 mM NaCl in the Histidine buffer, and the Mw and RMS radius calculated for each using
MALS.
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Figure 3.12: Batch Multi-Angle Light Scattering Analysis of Mab 1 (150 mM NaCl)

unlike Figure 3.11, the RMS radius measured for each of the concentrations tested shows
an increased size varying from 50 to 64 nm.
FIELD FLOW FRACTIONATION-MALS: In order to characterize the apparent
higher order species seen in the batch-MALS analysis, FFF-MALS was also employed.
While the Mw distribution of the antibody samples had been determined using SECMALS, the analysis was limited due to the potential interaction with the column
stationary phase. Figure 3.13 shows the weight average molecular weight distribution
for Mab 1 in 10 mM Histidine, 100 mM NaCl, pH 6, overlayed on the light scattering
profile of the 90° detector. The results indicate that in addition to the monomer peak (at
—150 KDa) there is an additional "aggregate" peak that spans a Mw distribution from 106
to over 108 Daltons. The distribution of the RMS radius was also measured (data not
shown) resulting in a Rg range for the "aggregate" peak from 20 to 200 nm.

Sedimentation Velocity Studies
Sedimentation velocity analysis was carried out on the Mab 1 antibody at three
concentrations and in a buffer containing 10 mM Histidine, pH 6, ± 150 mM NaCl. The
C(S2o, w) profile is seen in Figure 3.14 for the sedimentation velocity run performed
without NaCl. At each of the concentrations tested, the majority of the species in
solution appeared to be that of the monomer with the average Mw of the "aggregate"
species approaching only a dimer. In Figure 3.15, the C(S2o, w) profile is seen for the
sedimentation velocity run performed with 150 mM NaCl. As in Figure 3.14, the
majority of the species in solution, at each of the concentrations tested, appeared to be
that of the monomer with only a small amount of dimer present. These results indicate
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Figure 3.13: This figure represents the weighted averaged molar mass vs. time of Mab 1 in Histidine buffer with 100 mM NaCl. The
main antibody monomer peak is easily identified, as is a high Mw "aggregate" peak. The sample injection amount was 50 ug, with
two samples overlaid to show reproducibility. The inlay image shows the 90° light scattering trace on the top graph and the
differential refractive index trace on the bottom graph.
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Figure 3.15: Sedimentation Velocity Study of Mab 1 With 150 mM NaCl

that the percent of high molecular weight material did not increase with an increase in
Mab 1 concentration or the addition of NaCl. Similar results were seen in all of the
sedimentation velocity runs performed on Mab 2 and Mab 3 under the same conditions.
It should be noted that there was no apparent loss of material due to potentially
aggregated species in solution.

Electro-Separation
The results of the electro-separation experiments were neither very scientifically
rigorous, nor were they used to any great extent beyond the initial attempts to induce and
understand the opalescence phenomenon. Figure 3.16 shows a cartoon depiction of the
opalescence behavior of Mab 1 while being fractionated (or induced) by the electric field,
in different NaCl concentrations. At 0 mM NaCl (Figure 3.16 A), the results of the
experiment produced an opalescence "cloud" at the cathode shortly after the electric field
was established. It should also be noted that after the appearance of the opalescent
"cloud" the electric field was reversed, the opalescent cloud disappeared, and then it
reformed at the other end of the chamber. When the pH was taken at the ends, it
appeared as though the protons in the buffer had moved against the electric field and
were collecting near the anode. The conductivity taken at each of the ends of the
chamber also suggested that there was a severe imbalance of the buffer ions. It should
also be noted that the initial concentration of the Mab 1 (10 mg/mL) had now increased in
the opalescent "cloud" approximately 5 X and there was a negligible amount of protein at
the opposite end of the chamber. When the same experiment was performed in a buffer
containing 500 mM NaCl (Figure 3.16 B), the opalescence "cloud" appeared very rapidly
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Figure 3.16: Electroseparation Induced Opalescence of Mab 1
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Membrane

Conductivity: 0.86 mS/cm
pH: 5.46
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pH:7.14

500 mM NaCI

Conductivity: 44.9 mS/cm
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Conductivity: 46.2 mS/cm
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Figure 3.16: The effects of an electric field on Mab 1 is depicted. The first sample
contained Mab 1 at an initial concentration of 10 mg/mL in 10 mM Histidine, pH 6 (A).
The second sample contained Mab 1 at an initial loading concentration of 10 mg/mL in
10 mM Histidine, 500 mM NaCI, pH 6 (B). The figure depicts the opalescence of the
sample (in gray) as it was induced by the electric field. The samples were run at a
constant voltage of 80 volts until the current stabilized (approximately ten minutes). The
conductivity and pH was then measured at each end of the device and recorded.
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and evenly dispersed across the length of the chamber. The pH and conductivity
measured at each end of the chamber reflected a routine (and expected) migration pattern
of ions in the buffer with the pH being acidic at the anode, and basic at the cathode. The
conductivity was also measured at each end of the chamber and appeared to represent a
balanced distribution of buffer ions in solution. It is unclear exactly what the results
seem to indicate following this experiment and, in fact, the data leave more questions
than answers. Although the subsequent experimentation avoided further utilization of
this technique, the results helped to craft a framework of characterization based on charge
determination as a factor in the opalescence phenomenon.

Salt Induced Opalescence
The effects of salt on the opalescence of Mab 1 was further explored visually, and
the results are seen in Figure 3.17. For this study, the control was the antibody sample in
buffer containing 10 mM Histidine, pH 6. After one hour at room temperature, the
effects of the salt on the opalescence are already apparent (Figure 3.17 A). Each of the
salts in the study appear to drive opalescence to some degree, however, it is clear that the
sample in 100 mM NaCl was the most opalescent. In order to examine if the sodium or
chloride ion had more of an effect on the opalescence, 100 mM Na2HPC>4 and 100 mM
CaCU were specifically chosen as alternative salts. However, it is clear from these results
that after one hour, the alternative salts that were tested do not contribute to the
opalescence of Mab 1 as strongly as NaCl. The same vials were then stored overnight at
2-8 °C and re-examined (Figure 3.17 B). The vial containing the NaCl appeared to have
formed a firm, but turbid, gel while the opalescence seen in the 100 mM CaCb did not
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Figure 3.17: Salt Induced Opalescence of Mab 1

Figure 3.17: The salt induced opalescence of Mab 1 was studied as a function of
differing salts. The protein concentration used in this study was 63 mg/mL, and the
buffer was 10 mM Histidine, pH 6, with all salts at 100 mM. The samples were prepared
and examined after one hour at room temperature (A) and then the samples were stored
overnight at 2-8 °C (B) and re-examined. It should be noted that the same samples were
stored at 2-8 °C for two addition weeks with the result of a gel also forming in the buffer
containing Na2HPC>4.
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appear to increase and the opalescence in the 100 mM Na2HP04 appeared to increase
only slightly. It should be noted that the same samples were stored for an additional two
weeks at 2-8 °C with the result of a similar gel also forming in the vial containing 100
mM Na2HPC>4. The opalescence in the sample containing 100 mM CaCb did not appear
to change from the initial examination. It is also important to note that the individual ion
concentration in each of the salts chosen was not equal, and these differences alone may
have contributed to the observed changes in opalescence.
Further characterization on the opalescence effect of NaCl on Mab 1 was
characterized and the results are seen in Figure 3.18. From the initial study (Figure 3.18
A), there appears to be a linear effect on the opalescence from 0 to 20 mM NaCl as
measured by the apparent OD^o- However, as the NaCl concentration was increased
from 0 to 150 mM NaCl, and compared to a known salt that does not appreciably
increase opalescence (CaCk), the dramatic effect of NaCl on the opalescence is evident
(Figure 3.18 B). The opalescence as measured by OD400 appears to reach a maximum
opalescence of ~0.55 OD at a NaCl concentration of ~40 mM but then gradually declines
back to an opalescence value of ~0.20 OD at a NaCl concentration of 150 mM NaCl. All
this while the opalescence of the Mab 1 in CaCb does not appear to rise above ~0.18 OD
regardless of the salt concentration. To further examine the unique behavior of the NaCl
induced opalescence of Mab 1, a comparison was made to the Mab 2 antibody in Figure
3.19. It is easy to visualize the effects of NaCl on the opalescence of Mab 1 as they are
examined in 15 mL conical tubes (Figure 3.19 A). In 0 mM NaCl, the antibody is clear,
then, quickly changes to form two distinct phases in 25 mM NaCl, where the bottom
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Figure 3.18: Measuring the Opalescence of Mab 1 as a Function of Salt
Concentration
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Figure 3.18: Opalescence was monitored as a function of NaCl concentration for Mab 1
at a concentration of30mg/mL, using UV detection at 400 nm (A). The OD^onm was
plotted against several NaCl concentrations to examine the linearity. Opalescence was
further examined as a function of both NaCl and CaCk for Mab 1 over an extended salt
concentration range after each sample was dialyzed and kept at 4-8 °C for 24 hours (B).
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Figure 3.19: Comparison of NaCl Induced Opalescence of Mab 1 and
Mab2
A

OmM

25mM

50mM

lOOmM

150mM

Figure 3.19: The effect of NaCl on the opalescence of Mab 1 and Mab 2 were
compared. Both Mab 1 (A) and Mab 2 (B) were tested at a concentration of 30 mg/mL in
10 mM Histidine, pH 6, at the NaCl concentration listed. The samples were dialyzed
overnight at room temperature and stored at 4 °C prior to the measurements. It is
important to point out that Mab 1 at 25 mM and 50 mM NaCl separated into two distinct
phases at the top and bottom of the conical tube, but remained homogeneous and highly
opalescent at 100 mM and 150 mM NaCl. Mab 2 remained clear throughout all of the
NaCl concentration.
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phase is starting to appear opalescent. At 50 mM NaCl, the two phases are opalescent but
the bottom phase appears to be more opalescent. Finally, at 100 and 150 mM NaCl, the
tubes appeared homogeneous but highly opalescent, even forming the initial stages of a
gel state at 150 mM NaCl. In contrast, the Mab 2 antibody remained visually clear
throughout all of the NaCl concentrations tested (Figure 3.19 B).
Following the visual characterization of NaCl induced opalescence of Mab 1, the
concentration was measured (for each phase if applicable) along with the conductivity,
chloride content and pH and the results are seen in Table 3.1. In the concentration
column, the tube at 0 mM NaCl reflects the starting concentration of 43.7 mg/mL with no
"phase separation". At 25 mM NaCl, there already appears to be a phase separation with
the top phase at 9.6 mg/mL and the bottom phase at 103.5 mg/mL. At 50 mM NaCl,
there is also a phase separation with the top phase at 10.9 mg/mL and the bottom phase at
75.3 mg/mL. At 100 mM NaCl, there does not appear to be a phase separation but the
top of the tube was measured to be 17.8 mg/mL, while the concentration at the bottom of
the tube was measured to be 52.2 mg/mL. At 150 mg/mL, the antibody solution was too
viscous to be drawn into the pipette, as it was already developing the initial stages of gel
formation, and therefore the concentration was not measured.
In the column containing the measured chloride ion concentration, the tube at 0
mM NaCl had a chloride ion content of 7.2 mM. At 25 mM NaCl, the top phase
contained a chloride ion concentration of 26 mM, and the bottom phase contained a
chloride ion concentration of 31.2 mM. At 50 mM NaCl, the top phase contained a
chloride ion concentration of 50.4 mM, and the bottom phase contained a chloride ion
concentration of 54.8 mM. At 100 mM NaCl, the top of the tube contained a chloride ion
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Table 3.1: Following the NaCl induced opalescence of Mab .1, the concentration was measured along with the conductivity, chloride
content and pH, at a protein concentration of ~30 mg/mL.
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NA
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Table 3.1: Conductivity of NaCl Induced Opalescence of Mab 1

concentration of 94.4 mM, and the bottom of the tube contained a chloride ion
concentration of 104.4 mM. As previously stated, at 150 mg/mL, the antibody solution
was too viscous to be drawn into the pipette, as it was already developing the initial
stages of gel formation, and therefore the chloride ion concentration was not measured.
In the column containing the measured conductivity, the tube at 0 mM NaCl had a
r

conductivity of 0.59 mS/cm. At 25 mM NaCl, the top phase had a conductivity of 2.6
mS/cm, and the bottom phase had a conductivity of 2.1 mS/cm. At 50 mM NaCl, the top
phase had a conductivity of 5.3 mS/cm, and the bottom phase had a conductivity of 3.8
mS/cm. At 100 mM NaCl, the top of the tube had a conductivity of 8.6 mS/cm, and the
bottom of the tube had a conductivity of 8.4 mS/cm. At 150 mg/mL, the antibody
solution was very viscous but the overall conductivity was measured to be 13.4 mS/cm.
In the column containing the measured pH, the tube at 0 mM NaCl reflected the
initial pH of 6.05. At 25 mM NaCl, the top phase had a pH of 6.05, and the bottom phase
had a pH of 6.14. At 50 mM NaCl, the top phase had a pH of 5.96, and the bottom phase
had a pH of 6.05. At 100 mM NaCl, the top of the tube had a pH of 5.96, and the bottom
of the tube had a pH of 5.89. Finally, at 150 mg/mL, overall pH was measured, despite
the solution viscosity, to have a value of 6.04.
In order to further explore the effect of NaCl on the antibody opalescence, a

protein concentration dilution study was performed to assess the potential reversibility of
Mab 1 as compared to Mab 2 and Mab 3, in 0 and 50 mM NaCl (Figure 3.20). Upon the
serial dilution of Mab 2 and Mab 3, in 0 and 50 mM NaCl, and Mab 1, in 0 mM NaCl,
from 80 mg/mL, the OD4oo appeared to be linear. During the serial dilution the Mab 1
antibody at 50 mM NaCl, the bottom phase dropped from an OD400 value of-1.5 (at 85
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Figure 3.20: Measuring the Dilution Effect of Mab 1, Mab 2 and Mab 3

Figure 3.20: The dilution effect was measured for Mab 1, Mab 2 and Mab 3 using UV
detection at 400 nm. The NaCl concentration range was chosen due to the fact that Mab
1 became very opalescent and eventually formed a gel in all solutions above 50 mM
NaCl. The phase separation of Mab 1 was disrupted by gentle mixing prior to dilution. It
is important to note that neither Mab 2 or Mab 3 became very opalescent at any of the
NaCl concentrations tested.
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mg/mL) to 0 in a non-linear fashion. When the two phases were gently mixed, the drop
in OD400 from a value of 1 (at -30 mg/mL) to 0, was even more precipitous. These
results are consistent with the Mab 1 forming reversible complexes.

Dynamic Light Scattering Studies
To further examine the solution characteristics of the association state of the
antibodies when NaCl is added, dynamic light scattering was employed. The results for
Mab 1 are seen in Figure 3.21 at a protein concentration of 5 mg/mL and a NaCl
concentration of 0 and 100 mM NaCl. At 0 mM NaCl, 100% of the material is in the
monomeric form as is indicated by the Mw determination of 147 KDa. There is an
additional peak that is seen in the histogram but the concentration is negligible (less than
0.1%). At 100 mM NaCl, -96% of the material has a Mw of-229 KDa, with a small
percent at a Mw of-1.6 x 107 KDa and the remainder of the material at a Mw of 0.1 x
1012 KDa. It is important to note that each of the histogram peaks in the sample
containing 100 mM NaCl were very polydisperse as is indicated by their overall width.
The results for Mab 2 are seen in Figure 3.22 at a protein concentration of 5 mg/mL and
a NaCl concentration of 0 and 100 mM NaCl. At 0 mM NaCl, 100% of the material is in
the monomeric form as is indicated by the Mw determination of 139 KDa. There is an
additional peak that is seen in the histogram but the concentration is negligible. At 100
mM NaCl, 100% of the material is also in the monomeric form as is indicated by the Mw
determination of 134 KDa. There is also an additional peak that is seen in the histogram
with a negligible concentration. The results for Mab 3 are seen in Figure 3.23 at a
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Figure 3.21: Dynamic Light Scattering Characterization of the Mab 1
Association State as a Function of NaCl Concentration
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Figure 3.21: The association state of Mab 1 as a function of NaCl concentration was
measured using dynamic light scattering at the time of preparation. The antibody
samples were diluted to 5 mg/mL in a buffer containing 10 mM Histidine, pH 6, and the
same buffer containing 100 mM NaCl. The width of the histogram peaks represent the
degree of polydispersity for each.
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Figure 3.22: Dynamic Light Scattering Characterization of the Mab 2
Association State as a Function of NaCl Concentration
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Figure 3.22: The association state of Mab 2 as a function of NaCl concentration was
measured using dynamic light scattering at the time of preparation. The antibody
samples were diluted to 5 mg/mL in a buffer containing 10 mM Histidine, pH 6, and the
same buffer containing 100 mM NaCl. The width of the histogram peaks represent the
degree of polydispersity for each.
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Figure 3.23: Dynamic Light Scattering Characterization of the Mab 3
Association State as a Function of NaCl Concentration
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Figure 3.23: The association state of Mab 3 as a function of NaCl concentration was
measured using dynamic light scattering at the time of preparation. The antibody
samples were diluted to 5 mg/mL in a buffer containing 10 mM Histidine, pH 6, and the
same buffer containing 100 mM NaCl. The width of the histogram peaks represent the
degree of polydispersity for each.
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protein concentration of 5 mg/mL and a NaCl concentration of 0 and 100 mM NaCl. At
0 mM NaCl, 100% of the material is in the monomelic form as is indicated by the Mw
determination of 131 KDa. As was seen in the earlier two antibody measurements, there
is an additional peak that is seen in the histogram but the concentration is negligible. At
100 mM NaCl, 100% of the material is also in the monomelic form as is indicated by the
Mw determination of 141 KDa, however, the width of the histogram peak suggests that
the sample distribution is relatively polydisperse.
In order to explore the temperature dependence of Mab 1 aggregation as a
function of NaCl concentration, a plate based DLS measurement was employed and the
results are seen in Figure 3.24. For the Mab 1 sample at a concentration of 4 mg/mL
(Figure 3.24 A), the results indicate that the addition of 150 mM NaCl lowers the thermal
stability by ~5 °C as is seen by the change in the onset of the Rh increase from 48 °C to
53 °C. For the Mab 1 sample at a concentration of 6 mg/mL (Figure 3.24 B), the results
are identical to the results of the 4 mg/mL experiment and indicate that the addition of
150 mM NaCl lowers the thermal stability by ~5 °C. For both concentrations, there also
appears to be a decrease in the apparent Rh with an increase in temperature, by
approximately 2 nm. It is important to note that the results of the DLS measurements
were not corrected for changes in viscosity due to concentration and ionic strength but
were corrected for the temperature dependence of the viscosity. Analysis results of the
temperature dependence of Mab 1 as a function of NaCl concentration can be described
as an apparent lowering of the overall free energy of the system that accompanies the
mixing of a solution from its components in their pure state (Tanford, C, 1961). These
theories of the transfer of free energies were also described in detail by Timasheff s
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Figure 3.24: Plate Reader DLS Characterization of the Temperature
Dependence of Mab 1 as a Function of NaCl
Concentration
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Figure 3.24: The temperature dependence (from 4 °C to 70 °C) of Mab 1 as a function
of NaCl concentration was measured using a dynamic light scattering plate reader. The
antibody samples were diluted to concentrations of 4 mg/mL (A) and 6 mg/mL (B) in a
buffer containing 10 mM Histidine, pH 6, ± 150 mM NaCl. Each of the samples runs
were performed in triplicate and the results were plotted as the apparent hydrodynamic
radius (nm) vs. temperature (°C).
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preferential interaction model that provides a thermodynamic treatment of protein
stability as a function of solvent-solute interactions (Timasheff, 1998).

Digestion / Fragmentation
The results of the size exclusion chromatography separation of the pepsin
digestion purification of the f(ab')2 fragments are seen in Figure 3.25. The main SEC
peaks were collected for Mab 1 as seen in chromatogram A, for Mab 2 as seen in
chromatogram B, and for Mab 3 as seen in chromatogram C. In order to measure the
hydrodynamic radius, dynamic light scattering was used (Figure 3.26). The measured
hydrodynamic radius for Mab 1 was 4.6 nm (Figure 3.26 A), for Mab 2, the
hydrodynamic radius was 4.6 nm (Figure 3.26 B), and for Mab 3, the hydrodynamic
radius was 4.7 nm (Figure 3.26 C).

Differential Scanning Calorimetry (DSC) Study
The thermal profiles for the intact IgG 1 antibodies were performed using
differential scanning calorimetry to assess any differences in the thermal stability. The
thermograms of Mab 1, Mab 2 and Mab 3 from 25 °C to 90 °C, in 10 mM Histidine, pH 6
are seen in Figure 3.27. For Mab 1, there are three thermal transitions with the "T onset"
at 55 °C, the first thermal transition at 69 °C, the second thermal transition at 76 °C and
the third thermal transition at 84 °C. For Mab 2, there are three thermal transitions with
the "T onset" at 59 °C, the first thermal transition at 70 °C, the second thermal transition
at 75 °C and the third thermal transition at 84 °C. Finally, for Mab 3, there are also three
thermal transitions with the "T onset" at 56 °C, the first thermal transition at 70 °C, the
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Figure 3.25: SEC Chromatograms of the Pepsin Digestion Purification
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Figure 3.25: The pepsin digestion was performed on Mab 1 (A), Mab 2 (B) and Mab 3
(C). The SEC elution profile was monitored using UV detection at a wavelength of 214
nm. The main peaks were collected manually, pooled together and the protein
concentration was determined spectrophotometrically (A280) using calculated absorptivity
(mg/mL^cm"1 for the F(ab')2 fragments.
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Figure 3.26: Dynamic Light Scattering Characterization of F(ab') 2
Fragments

Figure 3.26: The dynamic light scattering results for the f(ab')2 fragments are seen for
Mab 1 (A) to be 4.6 nm, for Mab 2 (B) to be 4.6 nm and for Mab 3 (C) to be 4.7 nm.
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Figure 3.27: Thermal Profiles of IgG 1 Antibodies Using Differential Scanning Calorimetry

second thermal transition at 78 QC and the third thermal transition at 84 °C. The thermal
scans of Mab 1, Mab 2 from 25 °C to 90 °C, in 10 mM Histidine, ± 150 mM NaCl, pH 6
were performed to assess any changes in the thermal stability with the addition of NaCl
(Figure 3.28). The "T onset" and the thermal transitions (Tm) for Mab 1 and Mab 2 in 10
mM Histidine, pH 6 are similar to the results seen in Figure 3.27. For Mab 1 in 10 mM
Histidine, 150 mM NaCl, pH 6 the "T onset" has decreased to 50 °C. There are now four
thermal transitions with the first at 68 °C, the second thermal transition at 72 °C, the third
at 77 °C and the final thermal transition at 85 °C. For Mab 2 in 10 mM Histidine, 150
mM NaCl, pH 6 the "T onset" has remained at 59 °C with much of the thermal profile
remaining the same including a thermal transition at 68 °C, a second thermal transition at
77 °C and a third thermal transition at 84 °C. The Fab and Fc regions are also labeled in
the figure based on results from scans taken for each of the isolated fragments. It is
important to note that there appears to be two distinct thermal transitions for the F(ab')2
region of Mab 1 in 0 and 150 mM NaCl, while the two distinct thermal transitions for the
Fc region only appear in the buffer containing 150 mM NaCl.
The thermal stability (ATm) for the F(ab')2 and Fc regions of Mab 1 and Mab 2
were then measured as a function of NaCl concentration and the results are seen in
Figure 3.29. The ATm for the F(ab'>2 region of Mab 1 (the two F(ab')2 thermal
transitions were monitored and labeled as Mab 1 Fab 1 and Mab 1 Fab 2) show that there
is little loss in the thermal stability from 0 to 150 mM NaCl. It is important to note that
the two F(ab')2 thermal transitions for Mab 2 had a similar ATm profile and were
therefore labeled as a single F(ab')2. The results of the ATm for the F(ab')2 region of Mab
2 seem to indicate that there is an apparent loss in the thermal stability as the NaCl
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Figure 3.28: Thermal Profiles of Mab 1 and Mab 2 Using Differential
Scanning Calorimetry as a Function of NaCl
Concentration
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Figure 3.28: The thermal profile of Mab 1, Mab 2 were characterized at a concentration
of 1.0 mg/mL in 10 mM Histidine, pH 6 and 10 mM Histidine, 150 mM NaCl, pH 6.
Scans were acquired using a 90 °C/hr scan rate spanning a temperature range from 25 °C
to 90 °C. The data was analyzed using Origin software in order to fit the thermal
transitions shown in red.
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Figure 3.29: Thermal Stability of Mab 1 and Mab 2 Fragments as a Function of NaCl Concentration

concentration is increased from 0 to 150 mM NaCl. The results of the ATm for the Fc
region of Mab 1 and Mab 2 show that there is equivalent loss in the thermal stability, for
the two antibody fragments, from 0 to 150 mM NaCl. It is important to note that the two
Fc thermal transitions for Mab 2 were monitored and labeled as Mab 2 Fc 1 and Mab 2
Fc 2, however, the two Fc thermal transitions for Mab 1 followed the same ATm and were
therefore labeled as a single Fc. These results appear to be consistent with there being a
specific charge effect on the Fc region with the addition of NaCl, leading to a decrease in
the thermal stability.
The thermal profile for the F(ab')2 and Fc domain of Mab 1, from 30 °C to 95 °C,
in PBS-CMF (phosphate buffered saline, calcium and magnesium free), were examined
and compared the intact antibody thermogram as a function of pH (Figure 3.30). The
thermograms for intact Mab 1 were compared with the F(ab')2 fragment at pH 7.2 and pH
4 (Figure 3.30 A). The pH 7,2 results show the two distinct thermal transitions for the
F(ab')2 fragments, along with the four thermal transitions for the intact Mab 1, as they
appear in Figure 3.28. The pH 4 results show a distinct shift in the thermal profile of the
F(ab')2 fragment from two thermal transitions (at 66 °C and 77 °C) to a single thermal
transition at 72 °C. The thermogram for the intact Mab 1 also shows a distinct shift from
four thermal transitions to only three distinct thermal transitions at 56 °C, 72 °C and 92
°C. The thermograms for intact Mab 1 were then compared with the Fc fragment at pH
7.2 and pH 4 (Figure 3.30 B). The pH 7.2 results show the two distinct thermal
transitions for the Fcfragments,along with the four thermal transitions for the intact Mab
1, as they appear in Figure 3.28. The pH 4 results show a distinct shift in the thermal
profile of the Fc fragment from 72 °G and 84 °C to 56 °C and 75 °C. The thermogram
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Figure 3.30: pH Dependent Domain Shifts in Mab 1
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Figure 3.30: The thermal profile for the F(ab')2 (A) and Fc domain (B) of Mab 1 were
examined as a function of pH, and overlayed with the intact antibody thermogram. The
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(pH 4) thermal conditions for most IgG molecules. The thermal profiles were
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for the intact Mab 1 also shows a distinct shift as previously described. These results
appear to be consistent with the results seen in Figure 3.29 where, at pH 4, there is higher
charge on Mab 1 and a decrease in the thermal stability as the electrical free energy is
reduced by unfolding (Stigter, 1990).

Non-Ideality Analysis
The non-ideality was measured using light scattering for the three IgG 1
antibodies as a function of NaCl concentration. The measurement was performed in a
buffer containing 10 mM Histidine, pH 6 with the addition of 50,100 and 150 mM NaCl.
The results of these measurements are shown in Figure 3.31, labeled in units of 10"4 molmL/g2. For Mab 1, all of the measurements were negative with a continued negative
trend in the non-ideality from -3.6 in 0 mM NaCl, to -2.7 in 50 mM NaCl and -24.1 in
100 mM NaCl. The non-ideality for Mab 1 was not able to be measured at 150 mM NaCl
due to viscosity limitation of the technique. It should be noted however that the nonideality was eventually measured (1 X) for Mab 1 at 250 mM NaCl to have a value of54.9 x 10"4 mol-mL/g2. For Mab 2, all of the measurements were positive with somewhat
of a positive trend in the non-ideality from 3.3 in 0 mM NaCl, to 3.1 in 50 mM NaCl, 9.0
in 100 mM NaCl and 6.8 in 150 mM NaCl. For Mab 3, all of the measurements were
positive but there was a slightly negative trend in the non-ideality from 20.5 in 0 mM
NaCl, to 18.5 in 50 mM NaCl and 12.9 in 150 mM NaCl and is consistent with a
shielding of charge-charge interaction with the NaCl.
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important to note that Mab 1 was not able to be measured at 150 mM NaCl due to viscosity limitations of the technique. Eventually, a
IX measurement for Mab 1 in 10 mM Histidine, 250 mM NaCl, pH 6, revealed an A2 of-54.9 x 10"4 mL-mol/g2.
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Figure 3.31: Non-Ideality (A2) Measured as a Function of NaCl Concentration

Viscosity Measurement
The viscosity and apparent optical density of Mab 1 was measured over a protein
concentration range of 1, 5,10,20, 30,40, 50, 55 and 60 mg/mL, at 4 °C and 25 °C in a
buffer containing 10 mM Histidine, 50 mM NaCl, pH 6 (Figure 3.32). The viscosity
appears to increase in a non-linear fashion with an increase in concentration at both 4 °C
and 25 °C (Figure 3.32 A). The apparent optical density (OD4oo) also appears to increase
in a non-linear fashion with an increase in concentration (Figure 3.32 B). However, after
10 mg/mL, the increase in the apparent optical density at 4 °C increased more rapidly
than the same sample measured at 25 °C.
The viscosity effects of NaCl on the three IgG 1 antibody samples were also
measured at a concentration of 5 mg/mL in a buffer containing 10 mM Histidine, pH 6
with 0, 50 and 100 mM NaCl (Figure 3.33). The results of the viscosity for Mab 1
appeared to increase in a non-linear fashion from 1.2 cP at 0 mM NaCl to 1.48 cP at 50
mM NaCl and 1.62 cP at 100 mM NaCl. The results of the viscosity for Mab 2 also
appeared to increase in a non-linear fashion from 0.94 cP at 0 mM NaCl to 1.02 cP at 50
mM NaCl and 1.07 cP at 100 mM NaCl. The results of the viscosity for Mab 3 again
appeared to increase in a non-linear fashion from 0.94 cP at 0 mM NaCl to 0.95 cP at 50
mM NaCl and 1.02 cP at 100 mM NaCl. The higher specific viscosity of Mab 1 is
consistent with protein-protein interactions in solution (Liu, 2005).
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Origin software to a non-linear line using the data points available.
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Circular Dichroism and Fluorescence Structural Analysis
The structural changes in Mab 1 were explored by the use of circular dichrosim
(along with fluorescence) in a buffer containing 10 mM Histidine, pH 6, ± 100 mM NaCl
(Figure 3.34). The near UV-CD data (examined over a wavelength range of 250 to 360
nm) in the buffer containing 0 and 100 mM NaCl, appear to be identical and overly
perfectly for Mab 1. As a secondary method of determining structural changes the
fluorescence of Mab 1 was also examined at an excitation wavelength of 280 nm and
emission spectra from 300 to 450 nm. As with the CD data, the fluorescence emission
spectra for Mab 1 also appear to be identical and overlay perfectly in the buffer
containing 0 and 100 mM NaCl. These results indicate that there are no significant
changes in the 2° or 3° structure with added NaCl.

Congo Red
Congo red (CR) was used to gain insight into the possibility of fibril formation
during the Mab 1 opalescence phenomenon as a function of protein concentration, NaCl
concentration and temperature (Figure 3.35). The concentrations of Mab 1 used in this
study were 1 and 10 mg/mL in a buffer containing 10 mM Histidine, pH 6 ± 50 mM
NaCl, with scans taken at 4 °C and room temperature. For the Mab 1 sample, run in the
buffer without NaCl, under all the conditions tested, the OD maximum was ~500 nm.
With the presence of NaCl in the buffer, the Mab 1 sample exhibited a slight "blue shift"
in the OD maximum from -500 nm to ~495 nm, under all conditions tested. It should be
noted that when the same analysis was performed on Mab 2 and Mab 3, under similar
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Figure 3.35: Congo Red Analysis of Mab 1
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Figure 3.35: The results of the congo red analysis is displayed as apparent optical
density versus wavelength. The concentrations of Mab 1 used in this study were 1
mg/mL and 10 mg/mL, in a buffer containing 10 mM Histidine, pH 6 ± 50 mM NaCI, at
room temperature and 4 °C. The Mab 1 samples that were run without NaCI are
represented by solid lines and the samples run with NaCI are represented by dotted lines.
The absorption spectra were acquired in 2 nm increments from 300 to 650 nm at a scan
rate of 300 nm/min. It is important to note that the same analysis was performed on Mab
2 and Mab 3 without significant differences in the scans with, and without NaCI.
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conditions, there was not a "blue shift" in the OD maximum with NaCl in the buffer.
These results are consistent with the conclusion that there is no fibril formation in Mab 1,
Mab 2 and Mab 3 under all of the conditions tested.

Urea Analysis
The ability for urea to break hydrogen bonds (and possibly disrupt the antibody
opalescence) was tested on Mab" 1 at a concentration of 5 mg/mL, in a buffer containing
10 mM Histidine, 100 mM NaCl, pH 6, using dynamic light scattering. In Table 3.2, the
results of the molecular weight and the % Mass are listed for urea concentrations of 200
mM (6000:1), 0.3 mM (10:1) and 0.03 mM (1:1), for up to three Rh peaks after one hour
(at room temperature) and then after 24 hours at 4 °C. At the urea concentration of 0.3
mM, the Mw of the most abundant peak (peak 1) decreased from 229 KDa (95.8% of the
total) to ~135 KDa (100% of the total) after one hour at room temperature and after 24
hours at 4 °C. The urea also appeared to completely eliminate peak 2 (0.2% of the total)
and peak 3 (4% of the total) that were apparent in the sample without urea. At the urea
concentration of 0.3 mM, the Mw of peak 1 also remained low at 134 KDa (100% of the
total) after one hour at room temperature. However, after 24 hours at 4 °C, the Mw of
peak 1 increased to 165 KDa (99.5% of the total) with an additional high molecular
weight peak re-appearing. At the urea concentration of 0.03 mM, the Mw of peak 1 was
higher, at 160 KDa, but remained at 100% of the total after one hour at room
temperature. However, after 24 hours at 4 °C, the Mw of peak 1 increased to 165 KDa
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100%

100%
99.5%

100%
99.6%

lOOmM NaCl + 200mM Urea 136
Z4hrs 4C
134
165

lOOmM NaCl + 0.3mM Urea

lOOmM NaCl + 0.3mM Urea
24hrs 4C

lOOmM NaCl +0.03mM Urea 160

lOOmM NaCl +0.03mM Urea 165
24hrs4C
NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

0.2%

1.6xl07
NA

%Mass

MWKDa

Peak 2

0.1x10"

NA

0.4x10"

NA

NA

NA

1.1x10"

MW KDa

Peak 3

0.4%

NA

0.5%

NA

NA

NA

4.0%

%Mass

Table 3.2: The effects of urea on Mab 1 at a concentration of 5 mg/mL, in a buffer containing 10 mM Histidine, 100 mM NaCl, pH 6,
were examined using dynamic light scattering. Urea at concentrations of 200 mM (6000:1), 0.3 mM (10:1) and 0.03 mM (1:1) was
introduced to Mab 1 and measured after one hour at room temperature, and then after 24 hours at 4 °C. Scans of the samples were
performed as ten, ten second scans that were globally fit for total of 100 seconds. The Mw was determined by comparison to globular
standards of similar Rh, and the %Mass represents a quantitative measure of the peaks relative abundance.

100%

lOOmM NaCl + 200mM Urea 135

%Mass
95.8%

MWKDa

Peakl

229

lOOmM NaCl

(diluted to 5mg/mL)

Sample Mab 1

Table 3.2: The Effects of Urea on Mab 1 with NaCl as Measured by DLS

(99.6% of the total) with an additional high molecular weight peak re-appearing, as seen
with the 0.3 mM urea concentration.
In addition to breaking hydrogen bonds, urea (0.3 mM) was compared to arginine
(200 mM) to examine its effect in lowering the viscosity of Mab 1 at a concentration of 5
mg/mL, in a buffer containing 10 mM Histidine, pH 6 ± 100 mM NaCl (Figure 3.36). In
addition to the measured viscosity (Figure 3.36 A), dynamic light scattering was also
employed to examine and compare the effects of arginine in the disruption of high
molecular weight species (Figure 3.36 B). The results of the viscosity of Mab 1 in the
Histidine buffer containing 100 mM NaCl increased from 1.2 cP (in 0 mM NaCl) to 1.62
cP. However, when 0.3 mM urea was added to the Mab 1 sample, the viscosity dropped
from 1.2 cP (in 0 mM NaCl) to 1.0 cP. Similarly, when 200 mM arginine was added to
the Mab 1 sample, the viscosity dropped from 1.2 cP (in 0 mM NaCl) to 1.07 cP.
The results of the dynamic light scattering measurements in the Mab 1 sample
containing 200 mM Arginine were similar to that seen in the sample containing 0.3 mM
urea. The high molecular weight species appeared to be completely disrupted, resulting a
single peak with a Mw of 143 KDa.

FTIR Structural Analysis
The results of the FTIR structural analysis of Mab 1, Mab 2 and Mab 3 indicate
that there is little secondary structural difference between the three antibodies in the
presence, or absence of 100 mM NaCl, at 4 °C and 20 °C. Figure 3.37 shows the IR
spectra for the most useful amide band in the analysis of the secondary structure of
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Figure 3.36: The Effects of Urea and Arginine on Mab 1 in NaCl as
Measured by Viscosity and Dynamic Light Scattering
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Figure 3.36: The viscosity of Mab 1 (5 mg/mL) in a buffer containing 10 mM Histidine,
pH 6 ± 100 mM NaCl, was measured to examine the effects of urea (10:1) and Arginine
(6000:1) (A). The same samples were then examined using dynamic light scattering at
25 °C, and the peak information displayed as Mw (KDa) and %Mass (B).

109

Figure 3.37: FTIR Structural Analysis of Mab 1, Mab 2 and Mab 3
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Figure 3.37: (A) The IR spectra of Mab 1 in a buffer containing 10 mM Histidine, pH 6
(2 green traces), 10 mM Histidine, 100 mM NaCl, pH 6 (yellow trace), Mab 2 (purple
trace) and Mab 3 (red trace) in a buffer containing 10 mM Histidine, 100 mM NaCl, pH 6
at 4 °C. (B) The IR spectra of Mab 1 in a buffer containing 10 mM Histidine, pH 6 (blue
trace) and 10 mM Histidine, 100 mM NaCl, pH 6 (black trace) along with an IgG 1
control in a buffer containing 10 mM Histidine, pH 6 at 20 °C.
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proteins, the amide I band, which occurs in the region 1600-1700 cm"1. In Figure 3.37
(Figure 3.37 A), at 4 °C, in a buffer containing 10 mM Histidine, pH 6 ± 100 mM'NaCl,
the three antibodies all show an asymmetrically shaped amide I band centered at a
maximum of ~1635 cm"1. This IR spectroscopic maximum is characteristically indicative
of secondary structure which is predominantly antiparallel P-sheet (Krimm, 1986). In
Figure 3.37 B, Mab 1 is further analyzed at 20. °C, in a buffer containing 10 mM
Histidine, pH 6 ± 100 mM NaCl, and the results also show an IR spectroscopic maximum
at 1635 cm"1. The IgG 1 control overlaid with Mab 1 in Figure 3.37 (B) was actually
Mab 2 in a buffer containing 10 mM Histidine, pH 6. It should be noted that the poor
sensitivity and low signal to noise ratio of Figure 3.37 (B) was due to an improper
alignment of the instrument which was corrected prior to the extensive analysis displayed
in Figure 3.37 (A).

Capillary Electrophoresis Studies
Capillary electrophoresis (CE) was employed as a technique to determine the
protein valence of the three IgG 1 antibodies and to relate this valence to the observed
solubility and apparent aggregation states. This approach measures the electrophoretic
mobility of the protein (u) with respect to that of a neutral marker that moves only with
the electroosmotic flow of CE. From the electrophoretic mobility, the effective or
apparent valence (Z*) is directly determined. The final Debye-Henry-Huckel Z (which is
independent of the counter-ion shielding, coupling of ionic flows and deformation of the
electric field in the vicinity of the protein) of the three IgG 1 samples was then calculated
using the software program ZUtilities, in order to examine the effects from incremental
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changes in the number of charged groups present on the surface of the proteins. It is
important to note that all subsequent references to protein valence will refer to the DebyeHenry-Huckel Z. Figure 3.38 shows the results of the CE analysis of the three digested
IgG 1 antibody F(ab')2 fragments in the buffer containing 100 mM MES, pH 6 (Figure
3.38 A) and 100 mM MES, 100 mM NaCl, pH 6 (Figure 3.38 B). The elution positions
for run A were, EOF: 4.388; Mab 1: 4.383; Mab 2: 4.396; Mab 3: 4.404, while the elution
positions for run B were, EOF: 22.587; Mab 1: 23.096; Mab 2: 24.621; Mab 3: 26.163.
These elution positions were then used to generate a protein valence for each F(ab')2
fragment with the results listed in Table 3.3. Along with the F(ab')2 fragments, the
protein valence was also measured by CE for the three intact IgG 1 antibodies in 100 mM
MES buffer, pH 6 ± 100 mM NaCl and ± 0.1 mM urea, with the results also listed in
Table 33. From the results listed for the F(ab')2 fragments, the protein valence is
negligible in the buffer without NaCl, then increases to 1.14 for Mab 1, 6.14 for Mab 2
and 9.38 for Mab 3 in the presence of 100 mM NaCl. Although the calculated valence
increased in the presence of NaCl, it was still lower than the expected charge based on
the amino acid sequence as calculated by Sednterp (Mab 1: 9, Mab 2: 18, Mab 3: 32).
For the intact IgG 1 antibodies, there was also a change in the protein valence when 100
mM NaCl was added to the buffer. For Mab 1, the protein valence decreased from 5.4 to
4.61 when NaCl was added while the protein valence for Mab 2 and Mab 3 increased in
the presence of NaCl from 8.9 to 9.77 and 11.38 to 13.04 respectively. As with the
F(ab')2 fragments, the calculated valence for the intact protein was lower than the
expected charge based on the amino acid sequence as calculated by Sednterp (Mab 1: 22,
Mab 2: 28, Mab 3: 42). Finally, the protein valence was determined for the three intact
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Figure 3.38: Capillary Electrophoresis Analysis of the IgG Antibody
F(ab') 2 Fragments

Figure 3.38: The digested F(ab')2 fragments were analyzed by CE in a buffer containing
100 mM MES, pH 6 (A) and 100 mM MES, 100 mM NaCl, pH 6 (B). The sample
concentrations were 0.569 mg/mL (Mab 1), 0.631 mg/mL (Mab 2) and 0.781 (Mab 3)
and were run along with an EOF marker with the elution profile monitored at 214 nm.
The run voltage for run A was 30 kV while the voltage for run B was 10 kV. The elution
positions for run A were EOF: 4.388; Mab 1: 4.383; Mab 2: 4.396; Mab 3: 4.404, while
the elution positions for run B were EOF: 22.587; Mab 1: 23.096; Mab 2: 24.621; Mab 3:
26.163.
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Table 3.3: The results of capillary electrophoresis for Mab 1, Mab 2 and Mab 3 (fragments and whole IgG 1) in two buffers: Buffer A
contained 100 mM MES buffer, 100 mM NaCl, pH 6. Buffer B contained 100 mM MES buffer, 10 mM NaCl, pH 6. Additionally, 0.1 mM urea
was also added into the two buffers.

Mab I F(ab")2
Mab 1 F(ab')2 + NaCl
Mab 1
Mab 1 + Urea
Mab 1 + NaCl
Mab 1 + NaCl + Urea
Mab2F(ab') 2
Mab 2 F(ab')j + NaCl
Mab 2
Mab 2 + Urea
Mab 2 + NaCl
Mab 2 + NaCl + Urea
Mab3F(ab')2
Mab 3 F(ab')2 + NaCl
Mab 3
Mab 3 + Urea
Mab 3 + NaCl
Mab 3 + NaCl + Urea

Hydrodynamic
Radius
4.6

Molecular Weight
(Daltons)
89:637

Table 3.3: Capillary Electrophoresis Results of Intact IgG 1 Antibodies and F(ab') 2 Fragments

IgG 1 antibodies in a buffer containing 100 mM MES, 0.1 mM urea, pH 6 and 100 mM
MES, 100 mM NaCl, 0.1 mM urea pH 6. The results of Mab 1 show that when urea was
added, there was a slight increase in the protein valence, from 5.4 to 6.05, in the buffer
without NaCl and 4.61 to 4.66, in the buffer containing 100 mM NaCl. The results for
Mab 2 show that when urea was added there was also a slight increase in the protein
valence, from 8.9 to 9.6, in the buffer without NaCl, but no appreciable change in the
protein valence of 9.77 in the buffer containing 100 mM NaCl. Lastly, for Mab 3, the
results show that when urea was added there also was an insignificant increase in the
protein valence, from 11.38 to 12.03, in the buffer without NaCl, but there was a slight
decrease in the protein valence, from 13.04 to 12.99, in the buffer containing 100 mM
NaCl.
The effects on the protein valence for the three antibodies upon the addition of
urea was somewhat expected due to the changes observed in the overall self-association
of Mab 1 in Table 3.2 and the change in viscosity as seen in Figure 3.36. These results
suggest that if urea can increase the overall charge on the IgG 1 antibody, the results may
lead to an increase in the overall charge-charge repulsion effects and could then alter the
observed protein opalescence phenomenon.
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CHAPTER VI

DISCUSSION
Electrostatic Forces Driving Protein Aggregation
In order to properly discuss protein aggregation, and specifically antibody
aggregation, it is important to first define and then to understand the fundamental forces
that drive these noncovalent, relatively weak intermolecular interactions. Intermolecular
attractions are attractions between one molecule and a neighboring molecule1. These
interactions take place as molecules approach each other with the strength of the
interactions varying with powers of the inverse of the distance. Each individually is very
weak, but all of these intermolecular interactions form networks whose energies are
additive and thus can make a significant contribution to binding when they are summed
over a molecule. These weak interactions are all essentially electrostatic in origin and
consist of point charges and permanent dipoles and non-polar, short-range interactions
encompassing van der Walls interactions and hydrophobic effects. Hydrogen bonds,
whose collective energy is considerably higher than most other noncovalent bonds, are
another important bond interaction between a hydrogen atom covalently bonded to an

1

The forces of attraction which hold an individual molecule together (for example, the covalent bonds) are
known as intramolecular attractions.
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electronegative atom and an adjacent electronegative acceptor group . A list of these
electrostatic forces is summarized in Figure 4.1. In addition to contributing to protein
aggregation, it is also important to mention that these interactions are critical in biological
systems as they are responsible for all molecular recognition and for determining and
maintaining the three-dimensional structure of proteins.
The most fundamental electrostatic interaction occurs between molecules which
each contain a net electrostatic charge. The energy of this polar interaction is described
by Coulomb's law as proportional to the product of the two charges divided by the
dielectric constant of the medium and the distance between them. If the two charges are
of opposite sign, the energy decreases as the molecules approach each other and is a
favorable interaction. If the charges are of the same sign, it is a repulsive effect and there
is an unfavorable interaction. As the interaction energy varies inversely with only the
first power of the distance, it is effective over relatively large distances.
The next fundamental electrostatic interaction is the dipole which occurs between
molecules that may not contain a net electrostatic charge but do have variations in their
net charge densities. Dipoles interact with point charges and other dipoles (and more
complex charge separations) with the orientation of each interaction determined by the
relative charge densities on each group. The energy of these polar interactions can be
determined by considering the individual charges of each molecule and calculating the
coulombic interactions among all of them. Dipole interactions are generally weaker than

2

The hydrogen bond is uniquefromother noncovalent interactions because the dependence of the bonds
energy on distance is fixed.
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Figure 4.1: Weak Forces Between Molecules
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Figure 4.1: The noncovalent interactions that occur with molecules and ions are listed.
All of these interactions are fundamentally electrostatic in nature and therefore depend on
the forces that electric charges exert on one another.

118

point charge interactions because both attractions and repulsions occur between the two
separated charges of each of the dipoles. Due to this combination of attraction and
repulsion, the energy of interactions depend inversely on the second to third power of the
distance between interacting molecules when they are in a fixed orientation and on the
sixth power when they arefreeto rotate in response to the interaction (Creighton, 1993).
Consequently, the electrostatic interactions between dipoles fall off much more rapidly as
the distance between them increases as compared to point charge interactions.
When molecules do not contain a point charge or a dipole, the resulting
interactions that occur are known as van der Waals interactions. They arise as a result of
an induced polarization effect on the molecule and can consist of three additional types of
interactions; those between two permanent dipoles (as previously discussed), a permanent
dipole and induced dipole and two dipoles of stochastic origin (also known as dispersion
forces). These ubiquitous non-polar interactions are close range and weak as the energy
of interactions depend inversely on the sixth power of the distance between interacting
molecules.
The most unique and perhaps most import of the noncovalent bonds in
biochemistry is the hydrogen bond. It is important because the structure and properties of
many biological molecules, and of water, are determined by the strength and
directionality of this bond. Although the energy of the individual hydrogen bond is weak,
the energy of a network of hydrogen bonds is considerably higher than that of most other
noncovalent bonds (Mathews and van Holde, 1996). The main component of the
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hydrogen bond is an electrostatic interaction which occurs between the dipole of a
covalently bonded hydrogen atom, in which the hydrogen atom has a partial positive
charge, and a partial negative charge on another electronegative atom (Creighton, 1993).
Unlike the previously described electrostatic interactions, the energy of the hydrogen
bond is defined as the center-center distance between the donor and acceptor atoms and
varies with distance as 1/r4 (Mathews and van Holde, 1996). Also, unlike other
noncovalent bonds, hydrogen bonds are highly directional where the bond tends to point
directly at the acceptor electron pair. This directionality of the hydrogen bond is
important to maintain an organized, regular biochemical structure in proteins and large
molecules (Mathews and van Holde, 1996).
In addition to the electrostatic interactions that were described, it is important to
note that there are also short range repulsions that eventually take place as molecules
approach each other. As molecules come near enough so that their non-bonding electron
orbitals overlap, the repulsion increases enormously because the electrons on the different
molecules cannot occupy the same part of space at the same time as another molecule as
stated by the Pauli Exclusion Principle. This repulsive energy is often said to increase
with the inverse of the 12th power of the distance between the centers of the two atoms
(Creighton, 1993). Because the repulsive energies rise so sharply, it is then possible to
describe molecules has having defined dimensions and occupying volumes that are not
able to be occupied by other molecules (Creighton, 1993). Individual molecules are
typically defined as spheres and the impenetrable volumes they occupy are known as van
der Waals radii. A visual depiction of this principle is illustrated in Figure 4.2.
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Figure 4.2: Noncovalent Interaction Energy Between two Approaching
Molecules
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Figure 4.2: The interaction energy between two approaching molecules is listed as a
function of distancefromtheir centers, r. The sum of the energy of attraction and the
energy of repulsion is seen as the total energy of interaction, U. As the particles approach
one another, the energy of attraction increases along with the energy of repulsion,
however, this occurs at different rates. The result is an overall energy of interaction that
is first dominated by long range electrostatic interactions until the distances approach the
van der Waals radii where the energy of repulsion increases rapidly.
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When attempting to lower electrostatic interactions between proteins, and the
subsequent aggregation states that can be formed, it is necessary to alter the free energy
of association. It has been show that electrostatic shielding is increased by increasing the
ionic strength of the buffer system, or by decreasing the cation size (Coleman, 1999). For
protein oligomerization involving "like" molecules, increasing the ionic strength can
drive dimerization (and higher order oligomerization) as it may mask the charge-charge
repulsion (the molecules repel since they have the same sign charge). On the other hand,
lowering the ionic strength of a buffer will decrease the dimerization caused by protein
self-association. For protein oligomerization involving charge-dipole and dipole-dipole
interactions (and other charge related forces), increasing the ionic strength will generally
decrease the strength of association by masking the favorable electrostatic interactions.
Any effects of the ionic strength involving hydrophobic interactions between proteins
tend to be indirect (e.g. a salt-induced change in structure that either exposes or hides a
hydrophobic patch) as water preferentially excludes any non-polar groups. Because
hydrophobic interactions are often not very strong, and are also energetically unfavorable
due to the loss of entropy, low concentrations of an amphiphile (such as Tween) can be
utilized to minimize the degree of interaction.
The unique self-association of Mab 1 has been examined in a variety of solvent
conditions and the results compared with two other homologous IgG 1 antibodies (Mab 2
and Mab 3). The self-association of Mab 1 resulted in an alteration of the overall
appearance of the protein solution and was described as being visually opalescent. The
degree of self-association was as a direct result of the ionic strength of the buffer solution
and the relative position of the buffer's anions and cations on the Hoffmeister series.
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Furthermore, the addition of Tween to the buffer system did not result in any changes in
the visual appearance of the Mab 1 solution as measured by the EP standards. The
resulting opalescence of the Mab 1 antibody was therefore satisfactorily described as
being electrostatic in origin through a combination of charge-dipole (minor) and dipoledipole (predominant) interaction, ultimately consisting of a non-mass-action driven selfassociation, which is freely reversible, involving mainly the CDR portion of the Fab
region.

Comparability of Mab 1,2 and 3
IgG 1 monoclonal antibodies are capable of extremely prodigious physiological
diversity while maintaining structures which are virtually identical. The common
structural features of an intact IgG 1 antibody include a Y-shaped molecular structure
composed of two "Heavy" and two "Light" chains. The base of the molecule is known as
the Fc region while the two arms of the molecule are known as the Fab region. The Fab
region consists of several domains including the VL, CL, VH and CHI domains, while the
Fc region contains two copies each of the Cm and CH3 domains. All of these domains
consist of about 100 residues, are homologous in their primary structure and are
independently folding structural units.
The region of the IgG 1 which is involved in the specific recognition of antigens
is located at the tips of the two Fab arms and is referred to as the complementarity
determining regions or CDRs. Different binding sites are generated with different amino
acid side chains in this region which consist of three irregular loops between the p-strands
of both the Light and Heavy chains. While these six CDR loops are involved in the
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complex interaction with the antigen, it is generally recognized that the Heavy chain
CDR provides the majority of binding specificity and energy. So based on the amino
acid differences that occur in the CDR region, it is important to know how structurally
comparable are the three IgG 1 monoclonal antibodies used in this study.
To assess the initial protein purity and overall comparability of Mab 1,2 and 3,
several characterization techniques were employed including SDS-PAGE, SEC-HPLC,
CEX-HPLC, peptide mapping and oligosaccharide analysis. Due to the impurities that
are formed during the CHO cellular expression system, and the fact that the newly
purified antibodies were at an initial concentration of-75 mg/mL, it was imperative to
fully characterize the purity and the initial association state of the antibodies prior to any
subsequent opalescence examination. Although this discussion will focus on the results
of the Mab 1 purity characterization, it should be noted that all three of the IgG 1
antibodies in this study displayed similar results and therefore it was concluded that they
were appropriate for further opalescence comparability studies.
SDS-PAGE: After the initial protein expression and purification, a gradient SDSPAGE was performed utilizing broad range SDS-PAGE markers. The two major
migrating species of Mab 1 in each of the reducing lanes of the gel were consistent with
that of an antibody light chain (-25 kDa) and heavy chain (-48 kDa), and each of the five
identically loaded lanes appear comparable to each other. As with the reducing gel, each
of the five identically loaded lanes in the non-reducing gel appeared to be comparable to
each other. The most prominent species on the gel is consistent with that of an IgG 1
monomer (-150 kDa) with minor bands appearing at -140, -120, -90 and -30 kDa.
Although still uncharacterized, it is believed that these other minor bands, present in the
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majority of all CHO expressed IgG 1 antibodies, are a combination of antibody fragments
and other low Mw species as well as a small amount of de-amidated protein.
SEC-HPLC: Size exclusion chromatography was employed to assess the overall
purity and comparability of the IgG 1 monoclonal antibodies in this study. As is evident
in the results, the profile of the chromatogram indicates that the majority of the material
(-98%) elutes as a single "monomer" peak for each of five purified Mab 1 samples
analyzed. The small amount of low Mw and high Mw species seen, were also present in
the Mab 2 and Mab 3 SEC chromatograms (data not shown). These results, along with
the subtle run to run variations seen in Figure 3.2 are considered normal and indicate that
the purity of the IgG 1 samples were comparable enough to allow for further opalescence
characterization.
CEX-HPLC: The IgG 1 monoclonal antibodies in this study were also assessed
by CEX-HPLC to determine the degree of basic and acidic species present after the final
cHA purification step. As previously stated in the results section, the relatively small
amount of basic and acidic species present in the chromatograms in Figure 3.3 is
considered typical for this degree of purification. Also, the variations that occurred from
each of the batches tested could be due, in part, to variations in the time required to
complete each of the numerous purification steps or variations of the analysis technique
itself. It should also be noted that similar results were seen during the CEX-HPLC
analysis of Mab 2 and Mab 3.
The two final steps used to assess the protein purity of the three IgG 1 antibodies
were achro-k peptide mapping and n-linked oligosaccharide analysis. The results of the
peptide mapping for Mab 1 indicated that the amino acid composition of the antibody
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was comparable for the three batches used in this characterization, in terms of peak
presence and peak height. Measuring the glycosylation levels are important because all
antibodies are glycosylated at conserved positions in their CDR regions, the presence of
specific carbohydrate groups can be critical for antigen clearance functions, and for
overall solubility. As the results indicated, the three Mab 1 samples did not appear to
have identical glycoform levels. The IgG 1 tested in batch two does have a lower
glycosylation level of the GO glycoform and a higher level of the Gl glycoform when
compared to the other two batches, but this difference is not typically considered
significant (Wright, 1997). Overall, the three Mab 1 batches that were tested, as well as
batches from Mab 2 and Mab 3, were comparable in terms of peak presence and percent
of total area for each peak.
DIFFERENTIAL SCANNING CALORTMETRY: Thermal denaturation of Mab
1, Mab 2 and Mab 3 was studied by differential scanning calorimetry in 10 mM
Histidine, pH 6 (Figure 3.27). The thermal profiles for each IgG 1 antibody shows three
transitions which indicate the presence of at least three domains (or groups of domains)
that exist under these conditions. These results are consistent with the known
morphology of an IgG 1 antibody which consists of a CHI domain in the Fab region and
two domains (CH2 and CH3) in the Fc region. Any differences in the thermograms seen
between the three IgG 1 antibodies may be due to differences in the flexibility of hinge
region for each (Vermeer, 2000). When the F(ab')2 and Fc fragments were isolated from
the pepsin digestion for Mab 1, the F(ab')2 fragment showed two distinct thermal
transitions at 66 °C and 77 °C and two distinct thermal transitions for the Fc fragment at
72 °C and 85 °C (Figure 3.30, pH 7.2). When the F(ab')2 and Fc fragments were isolated
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from the pepsin digestion for Mab 2, the F(ab')2fragmentshowed only one thermal
transition at 77 °C and two distinct thermal transitions for the Fcfragmentat 68 °C and
84 °C (data not shown). The pepsin digest of Mab 3 was not further characterized by
DSC. The DSC results show that the thermal transitions of thefragmentswere
comparable to the overall thermal transition profile of the intact IgG 1 for Mab 2 but not
for Mab 1. The thermal transitions for the Mab 1fragmentsdid not match the overall
thermal transition profile for the intact IgG 1 until characterized in the buffer containing
10 mM Histidine, 150 mM NaCl, pH 6 (Figure 3.28). The stability of the Fc region
appeared to be altered by the NaCl as there was only one visible thermal transition when
NaCl was not present and two distinct thermal transitions in the buffer containing 150
mM NaCl. Also, the results of the two thermal transitions for the Fab region of Mab 1
indicate that there is an independent folding domain present in Mab 1 that may not be
present in the Fab region of Mab 2. This independent folding domain may also benefit
from the enhanced flexibility of the hinge region (encompassing amino acids 216-231),
as is typically seen in the IgG 1 subclass, and could lead to increased interaction between
the two carboxy-terminal domains CH2 and CH3 in the Fc region. This interaction may
slightly destabilize one of the folding domains of the Fc region and account for the
apparent loss of the thermal transition when NaCl was not present. However, when NaCl
is present, the initial independent folding domain of the Fc region reappears at 72 °C as a
result of decreased interaction with the Fab region. This decreased Fab-Fc interaction
may then facilitate the electrostatic interactions of the Fab region of Mab 1 that occur
during the opalescence phenomenon.
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The effects of pH on Mab 1 were also analyzed by differential scanning
calorimetry at pH 7.2 and 4 on the intact antibody and the F(ab')2 and Fc fragments.
Although the samples were run in PBS-CMF (as previously described) the results showed
that the stability of Mab 1 was significantly altered at pH 4. At pH 7.2, the thermogram
of the intact Mab 1 was comparable to the thermogram seen in Figure 3.27. The
thermograms of the F(ab')2 and Fc fragments were also comparable to the thermogram in
Figure 3.28, in the buffer containing 150 mM NaCl. This is understandable as PBS-CMF
does contain a comparable NaCl concentration. However, at pH 4, there is a shift of the
intact Mab 1fromfour thermal transitions to only three distinct thermal transitions at 56
°C, 72 °C and 92 °C. The change in the number of thermal transitions of the intact Mab 1
is evident when the results of the F(ab')2 and Fcfragmentsare examined. At pH 4, the
F(ab')2fragmentdisplays a distinct shift in the thermal profile from two thermal
transitions (at 66 °C and 77 CC) to a single thermal transition at 72 °C while the Fc
fragment shifts from 72 °C and 84 °C to 56 °C and 75 °C. The results indicate that there
is a loss in the overall stability of Mab 1 at pH 4, indicating an overall loss of efficacy. In
addition, the loss of the thermal transition in the F(ab')2fragmentindicates that there is
decreased flexibility which would be another indication of decreased efficacy. From
these results it is inferred that pH and heat treatment influence the Mab 1 structure in
different ways. Temperature induced denaturation initially affects the Fab region, with a
thermal transition at 66 °C, whereas the first transition of the Fc domain is at 72 °C.
However, at pH 4, the first (and only) thermal transition of F(ab')2 is at 72 °C, while the
first thermal transition of the Fc region shifts dramatically to 56 °C. These results clearly
demonstrate that overall stability of the F(ab')2fragmentis more sensitive to heat
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treatment, while the overall stability of the Fc fragment is more sensitive to pH. The
results also show that pH (and therefore charge) plays an important role in the
aggregation mechanism following the unfolding of an IgG 1 antibody. The F(ab')2
fragment appears to have lost a thermal transition at pH 4, indicating a significant change
in the secondary structure. And while the two thermal transitions for the Fc fragment
were lower at pH 4, maintaining the two thermal transitions may indicate that the
resulting shift in the thermogram may be a result of a lesser change in the secondary
structure. There is also an additional thermal transition at 92 °C for the intact Mab 1 at
pH 4. While it has been shown that an IgG 1 is completely denatured at ~75 °C, a
fraction of the secondary structure elements remain which may be stabilized at the lower
pH (Vermeer, 2000). Overall, the DSC results indicate that the structure of the F(ab')2
fragment of Mab 1 appears to be more flexible as is indicated by the two thermal
transitions. Also, the structural stability is minimally altered with the addition of NaCl as
compared to the F(ab')2 fragment of Mab 2. These results would also indicate that the
NaCl induced opalescence phenomenon of Mab 1 is completely reversible since there is
little apparent change in the overall stability (and therefore the structure) with the
addition of NaCl. These results are also supported by the results of the serial dilution
study (Figure 3.20).

Mab 1 Self-Association is Electrostatically Driven
During the initial characterization of the forces driving the self-association of
Mab 1, EP standards were used to assign the degree of opalescence after the addition of
NaCl and Tween 80. Although subjective, the EP standards were used in Figure 3.8 (A)
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to assign a value to the visual appearance of Mab 1 over a NaCl concentration range of 0
to 8 mM. However, it was evident that at the concentration tested (65 mg/mL), the EP
value of Mab 1 (in 10 mM Histidine, pH6) was turbid even in the absence of NaCl. The
EP values assigned to the opalescence of Mab 1 quickly climbed from a value of <III (at
0 mM NaCl) to a value that was well off the visual scale (>IV) at only 8 mM NaCl. This
is a clear indication that the self-association of Mab 1 is, at least partly, influenced by
electrostatic interactions as the addition of NaCl is able to mask the charge-charge
repulsion. Also, the low concentration of NaCl required to mask the charge-charge
repulsion is also an indication that the overall charge on Mab 1 is relatively low.
The EP standards were also used to assess the ability of Tween 80 to prevent the
opalescence of the Mab 1 antibody in the absence of NaCl, at a concentration of 65
mg/mL in 10 mM Histidine, pH 6. It was clear from the results in Figure 3.8 (B), that
Tween 80 had little or no effect on the prevention of the antibody opalescence throughout
the concentrations of Tween 80, or the concentrations of Mab 1 tested. These results
indicate that the Mab 1 self-association was not affected by the addition of Tween 80,
suggesting that the predominant attractive forces driving opalescence are not hydrophobic
(non-polar) in nature.
EP standards also were used to assign the degree of opalescence of Mab 1 at a
concentration of 10 mg/mL and over a range of varying NaCl and pH conditions. From
the results seen in Figure 3.9, it can be concluded that the antibody opalescence increased
as the pH of the buffer approached that of the calculated isoelectric point (-7.8), across
all NaCl concentrations. These results are consistent with a charge dependent
aggregation, as the charge on the antibody at the isoelectric point would be theoretically
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neutral. In addition, the antibody displayed less opalescence at pH 4 and pH 6 at NaCl
concentrations of 0 and 2 mM. This is consistent with the antibody having a greater
overall charge at a pH further away from the isoelectric point, leading to charge-charge
repulsion. However, it also is observed that the effect of the pH on the antibody
opalescence appears to be lost at NaCl concentrations > 10 mM NaCl. These results
indicate that the overall charge on the antibody is relatively low and the 10 mM NaCl can
sufficiently and adequately mask the molecular charge. It should be noted that at pH 8,
the sample immediately precipitated out of solution upon the addition of 150 mM NaCl.
It was decided on the basis of these results, to conduct the remainder of the opalescence
studies in a buffer containing 10 mM Histidine, pH 6. These conditions were chosen on
the basis of published results showing that Histidine enhances the stability of humanized
IgG 1 antibodies in both aqueous and solid forms over a pH range of 5.5 to 6.5 (Chen B,
2003).
Although the EP standards were initially useful for assigning opalescence values,
it was concluded from the arbitrary and subjective nature of these early visual studies that
a more quantitative method for assessing opalescence would be useful. To this end, the
turbidity, as determined by the relative optical density of the protein solutions, was
measured against purified water at OD400. These OD400 values were then compared to the
OD400 values obtainedfromthe EP reference suspensions to allow proper categorization.
Ultimately, the assignment of the degree of opalescence became less important as the
focus of this work shifted from measuring the changes in the visual opalescent
appearance of the antibodies under varying conditions, to exploring the fundamental basis
for this phenomenon.
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ELECTRO-SEPARATION: In order to fully characterize the phenomenon of
antibody opalescence, it was initially deemed necessary to induce the opalescence in a
controllable manner, and if possible, to fractionate and collect the subsequent species.
The technique of electro-separation was devised after it was hypothesized that charge
may be the predominant factor driving the opalescence phenomenon in antibodies
(Whitesides, 2006). As previously described, the idea was to apply an electric field, to
which the sample would be introduced, and then to monitor and collect any visually
opalescent species that were formed for further characterization. Although the technique
was not successful (in the opinion of this researcher) and the results were not used to any
great extent, it did present some interesting findings that were worth considering. The
results from Figure 3.16 (A) clearly show that in the presence of an electricfield,and
under the conditions tested3, Mab 1 migrated toward the cathode and produced an
opalescent cloud whose protein concentration was ~5 X greater than the initial protein
concentration of 10 mg/mL. Migration of Mab 1 towards the cathode means that it
carries a net positive charge under these conditions. When the pH was measured at the
ends of the sample chamber it appeared as though the protons in the buffer had moved
against the electric field and were collecting near the anode. This migration of the
protons toward the anode may be explained by the Donnan Equilibrium effect in which
the charge of an "artificially concentrated"4 macro-ion is compensated for, in part, by a
reduced concentration of "like charged" ions and an increase in the concentration of ions
of opposite charge (Donnan, 1911). This explanation would also account for the severe
3

The sample was at a starting concentration of 10 mg/mL in a buffer containing 10 mM Histidine, pH 6.
Although there was no NaCl added to the buffer, there were counter-ions present in solution due to
previous filtration and titration steps.
In the complete explanation of the Donnans Equilibrium phenomenon, the "artificial concentration" of the
macro-ion is achieved through the use a semi-permeable membrane.
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imbalance of the ions discovered when measuring the conductivity at each end of the
chamber. The drop in the conductivity to 0.185 mS/cm at the cathode, as compared to
the measured conductivity at the anode of 0.86 mS/cm is consistent with the theory that
the high protein concentration at the cathode reduced the number or mobility of the
available anions in solution leading to a local minimally charged region where the
concentration of ions and their overall mobility is highly reduced5. This region of high
protein concentration then caused the migration of available ions toward the anode,
independent of charge, leading to a phenomenon described by Faraday as the
conductance per equivalent of electrolyte (Edsall, 1958). Simply stated, the loss of ions
in the region of the cathode lowered the equivalent conductivity. In addition, the high
protein concentration in the region of the cathode also led to an increase in the solution
viscosity which would resist the movement of ions in the electric field and contribute to
lower the conductivity (Edsall, 1958). This high protein concentration would also bind
any available counter-ions in solution further, thus decreasing their overall mobility.
When the same sample was run in a buffer containing 500 mM NaCl, but all other
conditions being the same, the results were very different. Figure 3.16 (B) shows that the
Mab 1 antibody produced an opalescent cloud that extended across the length of the
channel. And unlike the previous results, the pH measured at each end of the channel
reflect the expected migration pattern of ions in the buffer with the pH being more acidic
(pH 3) at the cathode and basic (pH 8.5) at the anode. The measured conductivity also
suggested that there was a balanced distribution of counter-ions in the electric field with a
measured value of 44.9 mS/cm at the cathode and 46.2 mS/cm at the anode. Although
5

It is important to note that the electrical current has to be the same throughout the entire length of the
device and therefore does not contribute to any localized alteration of the mobility.
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these results were not initially understood, it appears as though the Mab 1 antibody had
bound enough counter-ions to initialize the opalescence phenomenon and, due to the
excess number of unbound ions in solution, the remaining ions migrated as expected in
the electric field. Although any subsequent experimentation avoided the further
utilization of this technique, it was fairly evident from the results that more emphasis had
to be placed on the role of charge in the characterization of the antibody opalescence
phenomenon.
SALT INDUCED OPALESCENCE STUDY: To better understand the role of
salt in the induction of antibody opalescence, a series of experiments were performed to
explore the protein-salt and protein-protein interactions in buffers containing various
electrolytes and over a range of concentration. In general, it is understood that the effect
of salt on the solubility of proteins is a result of favorable electrostatic interactions
between the salt ions and the charged residues on the protein (Tanford, 1955). However,
in the case of antibody opalescence, it appears as though certain protein-salt interactions
are less favorable to protein solubility and more favorable to protein-protein interactions.
These protein-protein interactions then appear to lead to a state of self association that
resembles a liquid-liquid phase separation which manifested by an opalescent appearance
(Muschol, 1997).
When describing protein solubility as a function of the salt ions in solution, it is
also important to discuss the resulting charge on the molecule as a function of pH.
Protein solubility is generally a strong function of pH and the solubility is a minimum at
the isoelectric point of the protein as the net charge is zero (Tanford, 1955). However, in
concentrated salt solutions, the electrostatic interactions between the proteins are
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minimized and the subsequent protein-protein interaction does not depend on the net
charge, and therefore, does not depend on pH (Curtis, 1998). In considering the pH
dependence on protein-protein interaction, it is not immediately clear as to whether the
short range electrostatic interactions are the driving force or whether the protein-salt
interactions need to be modeled independently (Curtis, 1998). The dependence of protein
solubility on the salt type has been described by the Hofineister series, but this
dependence cannot be explained fully by considering the effect of the salt ions alone. It
is known that the salting out effectiveness is also due to the ability of the salt to either
assist or disrupt the structure making ability of water (Collins, 2006). Therefore, to
adequately predict protein solubility, both of these factors must be considered when
deriving a model of the salt effect on protein solubility and opalescence.
In the results of the visual opalescence studies, a series of salts were used on Mab
1, in a buffer containing 10 mM Histidine, pH 6 at a protein concentration of 63 mg/mL.
It is important to note that this concentration was chosen because it represents the typical
storage concentration of Mab 1 after final purification6. The vials in Figure 3.17 (A)
suggest that although all of the salts used in this study appear to produce an opalescent
effect to some degree, including the control, NaCl produced the most opalescence after 1
hour at room temperature. While 100 mM Na2HP04 and 100 mM CaCl2 were
specifically chosen as alternative salts to determine whether it was the sodium ion or
chloride ion that had a greater effect on the antibody opalescence, the results were
somewhat inconclusive. It is apparent from the results in Figure 3.17 (A) that Mab 1 will
preferentially bind anions in solution, leading to opalescence formation. However, a
6

The Mab 1 antibody was obtained through an industrial collaboration where it is produced for use as a
biological therapeutic.
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more detailed understanding of the anions involved would be needed to explain why this
was not observed when Mab 1 was exposed to Na2HP04 and CaCb.
One explanation as to why Na2HP04 and CaCh did not contribute to the
opalescence as strongly as NaCl could be provided by the Hofrneister series. Although
the exact mechanism of this effect is not known, it most likely depends on the interaction
of the ions with the surrounding water molecules (Collins, 1997). High-lyotropic-series
salts (kosmotropes) are higher up in the Hofrneister series and are thought to alter the
relatively ordered structure of liquid water and subsequently lead to changes in its surface
tension when present in the concentration range of 0.01 to 1 M (Hofrneister, 1888)
(Creighton, 1993) (Curtis, 1998). Low-lyotropic-series salts (chaotropes) are thought to
break the structure of the surrounding water molecules (relative to bulk water) as a result
of the large size of the ion and its weak interaction with water (Curtis, 1998). The
Hofrneister series for cations and anions are;
Lyotropic -> Chaotropic
CATIONS: NH4+ > K+ > Na+ > Li+ > Mg + > Ca2+ > guanidinium
ANIONS: S042"> HP042"> acetate > citrate > tartrate > Cl"> N03"> C10 3 > I" > C104">
SCN"
The effectiveness of cations and anions are usually independent and additive, with
the anion having the larger effect (Creighton, 1993). It is generally accepted that the ions
in the series which balance the two effects are Na+ and CI", so NaCl is considered to be
neutral in this respect. Following this explanation, it can be theorized that for CaCh, the
CI" anion bound to the antibody, but was potentially offset by the highly chaotropic
nature of the Ca2+ cation, leading to decreased opalescence. Consequently, with the
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Na2HP04 salt, the HP042"anion bound to the antibody and was not offset by the effects of
the Na+ cation. In the case of the Na2HP04 salt, the HPO42" anion may have had a less
favorable electrostatic interaction to the antibody as compared to CI", possibly due to its
larger size altering the surface charge density, leading to the delay in opalescence and the
eventual gel formation (Figure 3.17 B) (Tanford, 1955) (Collins, 2006).
A further examination to measure the degree of Mab 1 opalescence as a function
of NaCl concentration was performed and the results presented in Figure 3.18. In the
initial study (Figure 3.18 A) the seemingly linear increase in the apparent OD40o from 0 to
20 mM NaCl, while the concentration of Mab 1 remained at 30 mg/mL, strongly
indicates the presence of a polydisperse, Mie scattering system (Nassau, 1983). In Figure
3.18 (B), the linear increase in the apparent OD400 did not appear to continue past 20 mM,
and ultimately began to decrease after a NaCl concentration of 50 mM. Initially, the
results were somewhat puzzling considering the results seen in the earlier NaCl induced
opalescence studies, however, it was eventually realized that the Mab 1 antibody exposed
to NaCl concentrations above 20 mM, formed two distinct phases at the top and bottom
of the tube. Since the tubes were opaque in color, it was not initially evident that the top
phase was clear and the bottom phase was highly opalescent. From the electro-separation
studies, it is understood that the region of protein opalescence contains a higher overall
concentration. It is for this reason that the OD400 appeared to drop for Mab 1 above 20
mM NaCl as the sample was removed for testing from the top of the tube. However,
even with the inaccuracies of the initial NaCl opalescence study, it can clearly be seen
from the comparative results with CaCb that the opalescence of Mab 1 was driven to a
much greater extent with NaCl. These conclusions are consistent with the position of
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NaCl on the Hofmeister series where the overall effect of either Na+ or CI" is not offset by
their individual nature.
To further explore the phase differences of the NaCl driven opalescence of Mab 1,
a study was performed under conditions similar to the previous experiment, except this
time in clear 15 mL conical tubes, with Mab 2 as the control. The results seen in Figure
3.19 (A) clearly display the distinct phases of Mab 1 in 25 and 50 mM NaCl, and to a
lesser extent, with the 100 mM NaCl. The tube containing Mab 1 in 150 mM NaCl
formed a highly opalescent, homogenous phase that resembled a state of initial gel
formation (Champagne, 2000). It can also been seefromFigure 3.19 (B) that the Mab 2
control remained clear throughout all of the NaCl concentrations.
Following the results of the electro-separation experiment, similar studies were
then performed on the distinct phases formed in the Mab 1 NaCl induced opalescence
experiment. Concentration, chloride ion content, conductivity and pH were measured for
each phase (if applicable) and the results listed in Table 3.1. The results for Mab 1 in 0
mM NaCl were nearly as expected due to the fact that there was no apparent phase
separation. While the results of the conductivity, pH and even the chloride ion content
were expected, the concentration taken at the bottom of the conical tube was higher than
expectedfromthe initial 30 mg/mL starting concentration. An explanation is that this
may be caused by the low concentration of chloride ions in solution from the initial
titration of the Histidine buffer, driving the beginning of a slight phase separation. These
results suggest that Mab 1 is very susceptible to opalescence formation even in the
presence of very low NaCl concentrations. The same concentration, chloride ion content,
conductivity and pH measurements taken for Mab 1 in 25, 50 and 100 mM NaCl show an
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even more interesting trend. Although it was expected that the concentration and
chloride ion content would be greater in the opalescent region at the bottom of the tube, it
was not anticipated that the results of the conductivity and pH would closely mimic the
trends seen in the electro-separation experiment. In all three cases, the conductivity was
lower and the pH was slightly higher in the opalescent phase. These results were similar
to the results encountered in the electro-separation experiment, even though there was no
external electric field to drive the opalescence phenomenon. This suggests that although
the external electric field greatly enhanced the rate of opalescence formation of Mab 1, it
did not artificially induce the phase separation, or the resulting concentration of anions in
the opalescent phase and protons in the non-opalescent (or clear) phase. It also appears
evident that the conductivity of the Mab 1 solution was altered to a similar extent in the
naturally occurring phase separation as it was in the electro-separation induced
opalescence. The results of the Mab 1 sample at 150 mM NaCl were also similar to the
results of the electro-separation experiment at 500 mM NaCl. There was no apparent
phase separation but rather, a single homogenous and highly opalescent phase which
appeared to be mimicking the turbidity produced at the early onset of thermally induced
gel formation (Champagne, 2000).
In an attempt to compare the concentration and NaCl dependence of Mab 1, Mab
2 and Mab 3, the effective turbidity profile was measured for each using the apparent
OD4oo. The results seen in Figure 3.20 indicate that OD400 for Mab 2 and Mab 3 remained
linear with an increase in concentration and in the presence of 0 and 50 mM NaCl. In
general, a linear increase in the turbidity with an increase in concentration indicates that
there is minimal protein-protein self assembly (Timasheff, 1986). In addition, a graph of
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OD4oo/concentration vs. concentration for Mab 2 and Mab 3 produced a straight line (data
not shown). As a result, it can be concluded that increase in the apparent OD400 for Mab
2 and Mab 3 can be attributed solely to the increase in concentrations of the individual
solution components, where essentially all of the components exist in monomelic subunit form (Stockmayer, 1950) (Eckhardt, 1994) (Paliwal, 2005). The results of the
apparent OD400 for Mab 1 were clearly non-linear as compared to Mab 2 and Mab 3. It
has been described by Berne that the non-linear measure of turbidity is a direct result of
randomly oriented protein polymerization (Berne, 1974). Furthermore, it was described
that a linear increase in the turbidity due to protein polymerization follows the RayleighGans approximation only if it satisfies four criteria. These criteria are (1) the assembled
structure must have the geometry of rigid rods composed of optically isotropic
monomeric subunits, (2) the rods must be randomly oriented in solution
(thermodynamically ideal), (3) they must be monodisperse, and (4) their thickness must
be small relative to the wavelength of light, and the length of the rod. Following these
criteria, it can be concluded that the measured non-linearity of the apparent OD400 for
Mab 1 as a result of the increase in concentration, in a buffer containing 50 mM NaCl
(and to a lesser extent in the buffer containing 0 mM NaCl) can be attributed to a
cooperative self-association (thermodynamically non-ideal) that is not rod shaped and
overall, non-linear. Also, because it has been shown that the degree of opalescence is
dependent on the concentrations of chloride ions in contact with Mab 1, it stands to
reason that the sample disrupted by continuous gentle mixing had a greater degree of
non-linearity in the apparent OD400 as compared to the undisturbed, phase separated
sample measured from the bottom of the tube. It should also be noted that the Mab 1
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sample in 50 mM NaCl that was continuously mixed, formed a homogeneous, highly
viscous, highly opalescent phase at concentrations above -30 mg/mL. Finally, the results
also indicate that the non-linear self-association of Mab 1 is fully reversible as all of the
apparent OD400 measurements were performed as dilutions from a stock solution of 80
mg/mL for the phase separated sample and -30 mg/mL for the continuously mixed
sample.
NON-IDEALITY ANALYSIS: One of the few techniques capable of providing
an experimental measure of weak protein-protein interactions or chemical potential
differences between the solvent and the solute is the second virial coefficient. This
technique was used to explore how the IgG 1 monoclonal antibodies deviatedfromideal
behavior with the addition of NaCl, in order to better interpret what type of electrostatic
interaction was occurring. As previously stated, for protein oligomerization involving
"like" molecules, increasing the ionic strength can drive dimerization (and higher order
oligomerization) as it may mask the charge-charge repulsion (the molecules repel since
they have the same sign charge). Simply stated, the measured second virial coefficient
for this type of interaction would involve an initial net repulsive effect (or positive second
virial coefficient) at low NaCl concentration and would be expected to decrease as NaCl
was added. On the other hand, for protein oligomerization involving charge-dipole and
dipole-dipole interactions (and other charge related forces), increasing the ionic strength
will generally decrease the strength of association by masking the favorable electrostatic
interactions. Again, simply stated, the measured second virial coefficient for this type of
interaction would involve an initial net attractive effect (or negative second virial
coefficient) at low NaCl concentration and would be expected to increase as NaCl was
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added. The results of the non-ideality measured as a function of NaCl concentration is
seen in Figure 3.31. Mab 1 has an initial negative second virial coefficient at 0 mM NaCl
and appears to display a slight increase until 50 mM NaCl. This measured behavior
would directly support protein oligomerization involving charge-dipole and dipole-dipole
interactions. At 100 mM NaCl, there is a precipitous drop in the second virial coefficient.
A description of this behavior has been given by Scatchard who has shown that salts bind
to proteins and upon binding, lowers the net charge and the electric double-layer
repulsion (Scatchard, 1950). Subsequently, this net attractive protein-protein interaction
at higher salt concentrations can be attributed to a drop in the distance between
molecules, resulting in more collisions and a lowering of the interaction energy. It should
be noted that for protein solutions where the second virial coefficient is less than -8 x 10"4
mL- mol/g2, amorphous precipitation occurs because the protein-protein attractions are
sufficiently strong that they do not allow for adequate time for molecules to orient
themselves to form crystals before forming an amorphous agglomerate (Curtis, 1998).
Mab 2 and Mab 3 both have an initial positive second virial coefficient at 0 mM NaCl
and continue to have a positive second virial coefficient until reaching 150 mM NaCl.
These results are consistent with there being an overall charge-charge repulsion rather
than a charge-dipole or dipole-dipole interaction as seen with Mab 1.

Opalescence as a HMW Phase Separation
In the classical works of Willard Gibbs, a phase was described as any part of a
system which is homogeneous in all respects. Alternatively stated, a phase is not
necessarily a large region visually distinguishable from its neighbor (Tanford, 1961).
142

This discussion so far has largely presented the opalescence phenomenon as being
confined to a single homogeneous liquid phase. However, the phenomenon is believed to
be a result of a liquid-liquid phase separation in which the antibody is in equilibrium
between two contiguous phases. This section describes the conventional methods
employed to isolate and characterize each of the two phases.
In order to correctly describe antibody opalescence as a phase separation, it is
important to first understand that the chemical potential of the Mab 1 monomer (along
with each of the components of the system) must individually have the same value in
every phase of the system. In addition, it is important to point out that this condition can
apply only to the components and not to species which cannot be transferred
independently from one phase to another (Tanford, 1961). Once an opalescent phase
separation has occurred and the components have achieved chemical equilibrium (a state
in which the free energy reaches a minimum value) the system can be studied in a variety
of ways. As it is important to first isolate each phase prior to characterization, size
exclusion chromatography was employed. Also, as antibody opalescence is an optical
phenomenon, multi-angle light scattering was used for characterization after the SEC
separation. However, size exclusion chromatography did not adequately allow for the
isolation of each phase so batch multi-angle light scattering was employed along with a
free solution separation technique known as field flow fractionation. Sedimentation
velocity was used as an alternative free solution separation technique for separation and
to have an orthogonal technique to FFF-MALS characterization. Finally, dynamic light
scattering was employed in an attempt to characterize each of the phase components
without employing a "conventional" method of separation.
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SIZE EXCLUSION CHROMATOGRAPHY-MALS: The results of the SECMALS experiment measuring the effect of NaCl on the self association state of Mab 1 is
seen in Figure 3.10. It is evident that at 10 mM Histidine, pH 6, the Mw distribution of
the Mab 1 antibody (at -57 minutes) consists of approximately 98% monomer with a
second peak (at -47 minutes) containing 2% dimer. A third peak (-32 minutes) was
attributed to shedding of the column's silica matrix caused by pressurefromthe HPLC
injection. Results for the Mab 2 and Mab 3 antibodies were consistent under all NaCl
concentration tested by SEC-MALS. However, Mab 1 did differ from both Mab 2 and
Mab 3 in that the pressure of the HPLC gradually increased after each injection,
regardless of the initial NaCl concentration, ultimately limiting the total number of
injections to -25 before reaching the upper pressure limit of the SEC column. These
results indicate that some of the Mab 1 antibody was retained on the guard column or the
SEC column itself. It is important to note that although the Mab 1 antibody was initially
in a buffer containing 10 mM Histidine, pH 6, the mobile phase of the SEC-MALS
analysis was in a buffer containing 10 mM Na2HPC<4,100 mM NaCl, pH 7.15. This
higher ionic strength mobile phase was used to limit non-specific interactions and to
follow the protocol established for separations performed with this type of SEC column.
Therefore the Mab 1 antibody was inadvertently exposed to a buffer containing 100 mM
NaCl for the entire 75 minute HPLC separation regardless of the initial
formulation/storage buffer condition. And although the % mass recovery calculated after
each 100 ug injection was close to 100% (data not shown), the gradual pressure increase
of the HPLC system clearly indicated that some material was retained on the column.
The results also indicate that Mab 1 is more sensitive to NaCl induced aggregation than
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Mab 2 and 3 and that the opalescent phase may consist of a high Mw species at a very
low concentration. The results also indicate that a typical SEC-MALS analysis was not
adequate to fully separate and characterize the effect of NaCl on the antibody
opalescence phenomenon. Therefore, a "batch" characterization technique was explored
to further analyze the opalescence phenomenon and the resulting HMW species in
solution.
BATCH-MALS: The technique chosen to characterize the higher order
associated species present in the Mab 1 sample was batch-MALS. This technique utilizes
the MALS detector, the same as with the SEC-MALS technique, but does not employ
SEC column to fractionate the sample. The Mab 1 samples are simply injected into the
MALS instrument as a sample "plug" and weight averaged molecular weight (Mw) is
determined (Wyatt, 1993).
The results of the Mab 1 sample in a buffer containing 10 mM Histidine buffer,
pH 6, and over a concentration range of 0.1 to 1 mg/mL (Figure 3.11) show that the Mw
calculated for each of the five concentrations is higher than that of an antibody monomer
(-150 kDa) but less than that expected for a dimer (-300 kDa). Also, the Rg for each of
the five concentrations examined was between 11 and 14 run. These results are peculiar
because, assuming a globular model, there should not be any angular dependence for an
IgG 1 antibody with a radius of-5.1 for a monomer and -6.8 for a dimer, at the
wavelength of light used (Wyatt, 1993). These results are consistent with there being a
very small quantity of a HMW species in solution. The concentration of this additional
species has to be very low given the observed angular dependence is small, and the
measured Mw is not much greater than the monomer. The lack of any concentration

145

dependence (Figure 3.11) suggests that the aggregate is irreversible over the time scale of
these experiments. These batch-MALS results are consistent with the previous
observations that Mab 1 contains a small quantity of large, irreversible aggregate.
Although the results of the batch-MALS were not shown for Mab 2 and Mab 3, there was
no evidence of HMW species present in any of the conditions tested.
The results of the Mab 1 sample in a buffer containing 10 mM Histidine buffer,
150 mM NaCl, pH 6, and over a concentration range of 0.1 to 1 mg/mL are seen in
Figure 3.12. As with the previous analysis, these results show that the Mw calculated for
each of the five concentrations is higher than that of an antibody monomer but less than
that expected for an antibody dimer. However, unlike the previous analysis the resulting
Rg for each of the five concentrations examined was significantly higher, between 50 and
64 nm. These results can also be interpreted as there may be an additional HMW species
in solution but the concentration of this additional species may be slightly higher due to
the increased effect on the final angular dependence of the light scattering. In theory, the
HMW species formed in the low ionic strength buffer may have a similar Rg but these
species did not influence the overall results as strongly due to their lower concentration
and the sensitivity of the technique. As with the previous analysis, there does not appear
to be any concentration dependence on the formation of the HMW species over the
concentrations examined as the Rg and Mw do not change with an increase in
concentration, and the resulting Mw is consistent with that expected of an antibody
monomer with a small amount of dimer present. This apparent lack of very large
aggregates at the concentrations tested indicate that low order associations are not
significant contributors to the opalescence and that there is a higher order, possibly more
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cooperative process. Overall, it can be concluded that the HMW material measured by
batch-MALS is irreversible over the time scale of these measurements, the Mw does not
change with an increase in the ionic strength and the Rg appears to increase with the
addition of NaCl. Unfortunately, due to the sensitivity of this technique and the lack of
resolution, it is impossible to quantify the HMW material or to assign a conformation.
Therefore a free solution separation technique was employed in an attempt to quantify the
HMW material present in solution.
FIELD FLOW FRACTIONATION-MALS: Previous analysis of the higher order
associated Mab 1 antibody species was limited due to the potential interaction with the
matrix of the SEC column or the lack of resolution in the batch-MALS technique. Field
flow fractionation was therefore employed along with MALS to examine the apparent
HMW material formed by Mab 1 in the presence of NaCl, in the absence of any
"stationary phase". Figure 3.13 shows the results of the separation of Mab 1 in a mobile
phase containing 10 mM Histidine, 100 mM NaCl, pH 6 with a 50 ug injection. The
results indicate that in addition to the antibody monomer peak, there is a very broad peak
consisting of HMW material (106 to over 108 Daltons) with a large Rg (20 to 200 nm)
and that the concentration of the HMW material was almost non-existent as compared
with that of the monomer peak. Due to the resolution of the field flow fractionation, the
HMW species that were initially discovered using batch-MALS, were able to be
separatedfromthe antibody monomer peak and subsequently characterized. These
results indicate that the HMW species that are formed are somewhat discrete in size as
the results were reproducible through several injections. In addition, the results also
support the theory that antibody opalescence is a high order process that can involve a
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very small amount of the total protein concentration. When a similar study was
performed for Mab 2 and Mab 3, the elution profile consisted only of the monomer/dimer
peaks with no HMW material present.
SEDIMENTATION VELOCITY STUDIES: Sedimentation velocity analysis
was performed on the Mab 1 antibody in order to examine the concentration or NaCl
dependence. As an orthogonal technique to FFF-MALS, sedimentation velocity does not
utilize a "stationary phase" and therefore would not limit the characterization to
molecules that would be compatible to the specific matrix utilized, as with size exclusion
chromatography. The Mab 1 antibody was analyzed at three concentrations (0.1, 0.5 and
lmg/mL) in a buffer containing 10 mM Histidine, pH 6, ± 150 mM NaCl. These
concentrations were chosen to span the linear range of the absorption optics in the XL-A
ultracentrifuge and the NaCl concentrations were chosen to closely mimic the effects
seen in the FFF-MALS analysis. The results in Figure 3.14 (0 mM NaCl) and Figure
3.15 (150 mM NaCl) both show that the majority of the species present in solution had a
Mw consistent with that of an antibody monomer. Also, throughout all of the conditions
tested, the only other species present in solution had a Mw that was consistent with that
of a dimer and was less than 1% of the total peak area. Although the upper concentration
range was limited with this technique, the results appeared to indicate that the only
species in solution besides the monomer was a dimer, and that the percent of the dimer
did not change with an increase in concentration or the addition of NaCl. It should also
be noted that there was nearly 100% mass recovery based on the total peak area
calculated after each run. Similar results were seen in all of the sedimentation velocity
runs performed on Mab 2 and Mab 3 under the same conditions. Again, these results are
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consistent with the batch-MALS technique that the antibody opalescence phenomenon
consists of a higher order, possibly cooperative process.
DYNAMIC LIGHT SCATTERING: Dynamic light scattering was employed to
study thefreesolution, association state of the antibodies when NaCl is added. As a
result, the polydispersity of each measured association state was calculated and quantified
as a function of peak area, and the molecular weight was determined for each as a
function of the Mw to Rh model for a globular association. The results for Mab 1 are
seen in Figure 3.21 and indicate that the association state is highly dependent on the NaCl
concentration. In the buffer containing 10 mM Histidine, pH 6,0 mM NaCl, Mab 1
appears to consist of nearly 100% monomer as indicated by the Mw determination of 147
KDa and the low polydispersity (as seen by the width of the histogram peak). There is
also an additional peak in the histogram but due to the low concentration (less than 0.1%)
the software algorithm identified this peak as negligible. In the buffer containing 10 mM
Histidine, pH 6 with 100 mM NaCl, it can clearly be seen that Mab 1 shifts from a purely
monodisperse, monomer state, to that of polydisperse, largely monomer-dimer state
(~95.8%). This monomer-dimef state is indicated by the resulting Mw determination of
229 KDa, which is a weighted average of the monomer Mw (-147 KDa) and the dimer
Mw (294 KDa). It is difficult to determine the percentage of monomer and dimer from
these results, however, since the final Mw determination is a weighted average, and the
Mw of 229 KDa is roughly between the two association states, it can be concluded that
there is likely less than 50% dimerization. There are also two other polydisperse, higher
order associated states in solution at a Mw of ~1.6 x 107 KDa (0.2%) and 0.1 x 1012 KDa
(4.0%) which may correspond to those species first identified by the batch-MALS results.
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When dynamic light scattering was used to measure the NaCl dependence of Mab 2 and
Mab 3, the results indicate that both antibodies maintained a relatively monodisperse,
monomelic association state (Figure 3.22 and 3.23). There was a small degree of
polydispersity associated with the Mab 3 monomer in the buffer containing 10 mM
Histidine, 100 mM NaCl, pH 6, however, the Mw of 141 KDa closely matched the
monomer Mw of 131 KDa in the buffer containing no NaCl, indicating a relatively small
degree of any higher order association. It is important to note that there was an additional
peak seen in some of the histograms but as described for the Mab 1 results, the software
identified the concentration of the peaks as negligible.
Dynamic light scattering also was used to determine the temperature dependence
of Mab 1 association as a function of NaCl concentration. The results in Figure 3.24
indicate that at each of the concentration tested, the addition of 150 mM NaCl lowered
the apparent thermal stability of the antibody by ~5 °C as indicated by an increase in the
Rh. For both concentrations, there was also a decrease in the apparent Rh with an
increase in temperature, by approximately 2 nm. It is important to note that the Rh
measurements compared in this dynamic light scattering analysis were systematically
higher than the 5.1 nm expected for that of a monomeric IgG 1 antibody using a globular
Mw to radius model. This can be explained by the fact that the solvent viscosity was
corrected for based on the temperature dependence but was not corrected for due to
changes in the ionic strength7 and protein concentration. As previously described, the
results of the temperature dependence of Mab 1 as a function of NaCl concentration can
be explained as an apparent lowering of the overall free energy of the system that
7

It has been shown that the extent of expansion of Rg and Rh for proteins is inversely proportional to the
ionic strength of the buffer (Tanford, 1955).

150

accompanies the mixing of a solutionfromits components in their pure state (Tanford,
1961). These theories of the transfer offreeenergies were also described in detail by
Timasheff s preferential interaction model that provides a thermodynamic treatment of
protein stability as a function of solvent-solute interactions (Timasheff, 1992). However,
since the effect of NaCl on the protein stability as a function of solvent-solute interaction
is considered to be neutral, it can be theorized that the overall lowering of thefreeenergy
of the system can be attributed to the formation of components other than that of the
"pure" monomer state.

Mechanism of HMW Phase Separation
To better understand the association state and mechanism of the antibody
opalescence phenomenon, a series of non-conventional techniques were utilized. While
attempts were made to disrupt the antibody opalescence and to explore possible structural
changes in the antibody monomer through the addition of NaCl, it was the direct measure
of the protein charge by capillary electrophoresis that provided the most fundamental
insight. The measurement of the antibody valence provided a system property that
allowed for a direct correlation between charge and protein stability. It was this insight
that also allowed a direct measure of the correlation between the solvent conditions and
the onset of antibody opalescence.
THERMAL STABILITY: Differential Scanning Calorimetry (DSC) provides
information on the thermal stability of a protein under different solvent conditions and in
the case of multi-domain proteins such as antibodies, it has the additional advantage of
providing information on the behavior of the individual domains. It has been shown that
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there is a direct correlation between the stability of an antibody domain in solution and
the relative thermal stability as obtained by DSC (Wen, 2007). Differential Scanning
Calorimetry (DSC) was used to measure the thermal stability of Mab 1 and Mab 2
fragments as a function of NaCl concentration (Figure 3.29). The DSC scans for the
F(ab')2 fraction of Mab 1 indicated that there was little loss in the thermal stability from 0
to 150 mM NaCl. These results are consistent with there being a stable structural
conformation of the F(ab')2 fraction of Mab 1 even in the presence of 150 mM NaCl. It
could be argued that the results for the thermal transition of the F(ab')2 fractions are
consistent with the proposed electrostatic model of a dipole-dipole or charge-dipole
interaction within the Fab region of Mab 1. With the addition of NaCl, the electrostatic
interactions would be lowered and there would be minimal change in the overall protein
stability. The results of the thermal stability of the F(ab')2 fraction of Mab 2 show a drop
in the ATm, indicating that there is a change in the structural stability with the addition of
NaCl. These results for the thermal transition of the F(ab')2 fractions are consistent with
a loss in the electrostatic free energy in the presence of a high salt solution. Studies have
shown that there is a considerable decrease in the electrostatic free energy if salt ions are
allowed to penetrate into the interior of the protein (Tanford, 1955). This effect is greatly
enhanced when thefixedcharged of the protein are located in the interior as is the case
with antibodies (Tanford, 1955). Also, in biological systems, the electrostatic free energy
is supplemented by specific ion effects (Whitesides, 2006). Although these effects are
incompletely understood, the data suggests that the IgG 1 antibodies specifically bind
chloride ions and these interactions may affect the local dielectric constant of the protein
further altering its temperature stability. The same studies were performed on the Fc
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regions of Mab 1 and Mab 2 and the results show that there is an equivalent loss in the
thermal stability with the addition of NaCl. These results were expected as there is a high
degree of homology between the two Fc regions.
VISCOSITY AND STRUCTURAL ANALYSIS: The viscosity of Mab 1 was
measured as a function of protein concentration, and then along with Mab 2 and Mab 3,
measured as a function of NaCl concentration. Viscosity was utilized in the
characterization of the antibody opalescence phenomenon due to its unique ability to
quickly and accurately measure protein-protein interactions over a range of
concentrations and solvent conditions. The viscosity and the apparent optical density
(OD400) of Mab 1 was determined over a concentration range of 1 to 60 mg/mL at 4 °C
and 25 °C. The samples were prepared in a buffer containing 10 mM Histidine, 50 mM
NaCl, pH 6 and the results of the viscosity measured in units of centipoise. The results
show that the viscosity of Mab 1 is highly dependent on the protein concentration and
increases non-linearly with increasing antibody concentration at both 4 and 25 °C (Figure
3.32 A). The apparent optical density (OD400) of Mab 1 also increases in a non-linear
fashion; however, the increase appears to be slightly faster at 4 °C vs. 25 °C. This
indicates that Mab 1 under these conditions behaves as a non-Newtonian fluid. Since
non-Newtonian fluids often contain several micro structural species that are made of
large and elongated aggregates, rather than smaller uniform non-interacting monomers,
this result suggests that Mab 1 may undergo self-association (Liu, 2005). However, the
non-linearity in the viscosity is predominantly observed at higher protein concentrations
suggesting that these micro-structural aggregates are also fully reversible and only form
at higher protein concentrations. The results from the measured apparent optical density
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also suggest that these micro-structural aggregates are temperature dependent, appearing
to form more readily at decreased temperatures. This would indicate that the forces
driving the temperature dependent aggregates are entropic rather than enthalpic in origin.
The viscosity of Mab 1 is also dependent on the concentration of NaCl. Figure 3.33
shows the result of Mab 1, Mab 2 and Mab 3 at 5 mg/mL in a buffer containing 10 mM
Histidine, pH 6 with 0, 50 and 100 mM NaCl. As the concentration of NaCl increased,
the viscosity of each antibody appears to increase slightly, and in a non-linear fashion,
with Mab 1 increasing the most. Mab 1 also appears to begin to level off at the higher
NaCl concentrations. Additionally, NaCl does not appear to have a significant impact on
the conformation of Mab 1. Structural characterization using near UV-CD and
fluorescence (Figure 3.34) as well as FTIR (Figure 3.37), in the presence of 0 and 100
mM NaCl, indicate that Mab 1 has essentially the same conformation in solution, both at
4 °C and 20 °C . These results suggest that electrostatic interactions play a major role in
causing the increase in the viscosity of the Mab 1 solution. These results also suggest
that with the addition of NaCl, the viscosity and the resulting opalescence of Mab 1 is as
a result of higher order associations which are fully reversible at lower concentrations or
though the removal of the NaCl.
CONGO RED: Congo red (CR) has been the subject of many studies due to its
ability to bind amyloid fibrils and induce a characteristic shift in the maximal absorbance
from -490 to -540 nm (Kim, 2003). Although it has not been fully elucidated, the
binding mechanism has been proposed to be intercalation of the CR molecules between
the antiparallel 0-pleated sheets of amyloid fibrils or alignment of the CR molecules

Temperature dependence on the structure of Mab 1 in 0 and 100 mM NaCl was examined by FTIR alone.

154

along thefibrilaxis by electrostatic interactions (Kim, 2003). Because of these findings,
and the theory that the possible mechanism of Mab 1 opalescence is as a result of higher
order linear association, it was proposed that congo red might be used to support this
mechanism of association. However, when congo red was introduced to Mab 1 at
concentrations of 1 and 10 mg/mL, in a buffer containing 10 mM Histidine, pH 6 ± 50
mM NaCl, at room temperature and at 4 °C, the results were not initially clear. Even
though the Mab 1 samples containing NaCl were visually opalescent, there was not a "red
shift" in the absorbance spectra but rather a slight "blue shift" in the OD maximum
(Figure 3.35). The observed blue shift would indicate that CR did not successfully bind
to Mab 1 even in the presence of the antibody opalescence phenomenon. Initially, the
conclusion was that there was not a red shift because of the lack of anyfibrilstructure
formation by Mab 1 with the addition of NaCl. However, this did not fully explain the
blue shift in all of the Mab 1 buffers containing NaCl. Previous studies have shown that
the structural features of CR strongly suggest that electrostatic interactions were
primarily responsible for the binding of CR. Furthermore, it was speculated that the
negatively charged sulfate groups on the CR were specifically important for binding to
proteins (Heegaard, 2000). These insights led to the conclusion that CR was not able to
bind to Mab 1 due to the lack of any specific fibril structure and possibly because any
available binding sites would already be occupied by chloride ions or another Mab 1
antibody during the opalescence phenomenon. These results also suggest that there are
site specific binding site(s) on Mab 1 as there is a red shift due to the binding of the CR
when NaCl is not present.
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UREA ANALYSIS: The ability of urea to alter the self-association
characteristics of Mab 1 were examined over a range of NaCl and urea concentrations.
Although the exact mechanism of protein interaction and denaturation by urea is
unknown, it was theorized that since urea is a highly polar molecule, and has a dielectric
increment of +2.79, it could be used to disrupt the dipole-dipole self-interactions of Mab
1. In homogeneous environments, the energy of the electrostatic interaction (AE)
between two molecules (A and B) is simply the product of two charges divided by the
product of the distance between them (rAB) and the dielectric constant (D):

where e is the charge on the electron and Z(A,B) is the number of such charges on each
atom. The results were measured by DLS and are seen in Table 3.2. The initial results
were clear that high concentrations of urea (6000:1) could disrupt the self-association of
Mab 1 caused by the addition of 100 mM NaCl. This was determined by the lower
average molecular weight in peak 1 and the complete elimination of the high molecular
weight material represented by peak 2 and peak 3. At lower urea concentrations (10:1),
similar effects were initially seen but the average molecular weight of peak 1 did increase
after 24 hours and there was a small amount of high molecular weight material that also
had formed. When the urea concentration was lowered to 0.03 mM (1:1), the results
indicated that the average molecular weight of peak 1 did not represent a "pure"
monomer (similar to the results seen in the 10:1 urea concentration study) however, there
was no high molecular weight material formed until after 24 hours. These results are
consistent with the theory that there is a site specific protein-urea interaction and that
9

From: Cohn & Edsell, Proteins, Amino Acids and Peptides, 1943

156

there is probably more than one binding site on Mab 1 (as the average Mw of peak one
was higher than a monomer, indicating some dimer formation). From the results, it is
impossible to determine the number of possible binding sites that are available on Mab 1
but because of the well known dimeric structure of IgG 1 antibodies, it can be speculated
that there should be two possible sites in the F(ab')2 region which an electrostatic dipole
interaction could occur. This multiple binding sites were apparent by the non-linearity of
the OD400 when measuring the dilution effect of Mab 1 in Figure 3.20. It is also evident
from this study that a low concentration of urea (1:1) is sufficient to alter the free energy
of association of Mab 1 by occupying at least one of the binding sites. It should be noted
that the mean circulating concentration of urea found in the blood of normal individuals
is typically 4 mM. This would indicate that in vivo, antibody self-association would be
negligible for Mab 1, and potentially for other similarly behaved IgG 1 antibody
therapeutics.
In addition to urea, arginine has also been shown to suppress protein aggregation
and protein-protein or protein-surface interactions (Arakawa, 2007). While the
mechanism of these effects have not yet been fully elucidated, it was theorized that
arginine may also serve to disrupt the NaCl induced opalescence of Mab 1. One
explanation for ability of arginine to disrupt the self-association of Mab 1 may be due to
its high dielectric increment of+6210. The effects of urea and arginine on NaCl induced
Mab 1 opalescence were measured by viscosity and dynamic light scattering (Figure
3.36). Without the addition of urea or arginine, Mab 1 opalescence was readily induced
with the addition of 100 mM NaCl as is evident by the increase in HMW material
measured by DLS and the increase in the solution viscosity from 1.2 to -1.6 centipoise.
10

From: Cohn & Edsell, Proteins, Amino Acids and Peptides, 1943
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As previously described, urea was successful in disrupting the antibody opalescence
formed when Mab 1 is exposed to buffer containing NaCl as is evident by the loss of any
HMW material measured by DLS and the slight lowering of the solution viscosity. The
slight loss in viscosity with the addition of NaCl also fits the electrostatic model that Mab
1 interactions are both dipole-dipole and charge-dipole in nature. While urea binds to
Mab 1 and blocks the majority of the dipole-dipole interactions, the remaining chargedipole interactions are further masked with the addition of NaCl, resulting in a slightly
lower solution viscosity. Similar effects on Mab 1 are seen with the addition of arginine.
However, for the effects to occur, the concentration of arginine was 200 mM which is
significantly higher than the 0.3 mM urea concentration. These results indicate that
although arginine may disrupt the HMW material formed at the onset of the opalescence
phenomenon, the interaction with the antibody is relatively weak and the interactions
may be different from that of urea.
CAPILLARY ELECTROPHORESIS: In order to determine the net charge (Q) or
valence (Z) on the three IgGl antibodies, capillary electrophoresis (CE) was employed
over a variety of buffer conditions. Understanding the net charge is important because it
is a fundamental physical property that contributes to the proteins solubility, stability, and
its ability to interact with other proteins (Chase, 2008). The net charge values are also
important in the processes that lead to the separation and purification of proteins. In
addition, the net charge also influences the electrophoretic mobility of proteins in
solution, a fact which will be utilized when measuring the valence of the three antibodies
by CE. It is important to note that a protein's valence is a system property and not a
property of the molecule. It is for this reason that a direct measure of the actual protein
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valence was necessary to make accurate inferences concerning the role of charge in a
protein's behavior.
Both experimental and theoretical models suggest that the net charge on a protein
can influence the rates of protein-protein association and enzymatic catalysis
(Whitesides, 2006). Although not fully understood, it has also been suggested that there
is a direct link between net charge and the second virial coefficient (A2) (Neal, 1998). It
is known empirically that if there is a net attractive force between proteins in solution and
that if the value of the second virial coefficient is too negative, then proteins will
aggregate and precipitate rather than crystallize. However, if the proteins have a net
repulsion (a positive second virial coefficient) the solution is stable and crystallization
does not occur (Neal, 1998) (Elcock, 2001) (Paliwal, 2005). Since it has been shown that
the aggregation state for Mab 1 (and to a lesser extent Mab 2 and Mab 3) is dependent on
NaCl, it was suggested that the valence may also be altered in the presence of NaCl, and
therefore used as a predictive tool.
The results of the CE experiment are listed in Table 3.3 for the three antibodies in
a variety of conditions. For each antibody, the charge was calculated based on the amino
acid sequence (for the whole molecule and the F(ab')2 fraction) and then compared to the
measured valence. For the F(ab')2 fraction of Mab 1, the valence was -0.05 in the buffer
without NaCl and 1.14 when NaCl was present. These values represented a large
discrepancy from the calculated charge of 9. Although further conclusions were difficult
for the valence of the fractionated species, as the second virial coefficients were not
measured, it should be noted that the changes in the valence were appreciably greater for
Mab 2 (0.01 to 6.14) and Mab 3 (0.2 to 9.38) with the addition of NaCl. For the intact
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Mab 1, the measured valence was 5.4 in the buffer without NaCl and 4.61 when NaCl
was present. These values also represented a large discrepancy from the calculated
charge of 22 for the intact antibody. It was therefore theorized that there may be a link
between large deviations of the measured valencefromthe calculated charge and the
protein's stability. To test this theory, both the intact Mab 2 and Mab 3 as well as the
F(ab')2fractionswere similarly tested. It was shown that these values also exhibited
large deviations of the measured valencefromthe calculated charge. Subsequently it was
theorized that IgG 1 antibodies may all exhibit an unequal charge distribution within the
interior of the molecule in order to remain biologically relevant. Because of this, relative
comparisons of the measured valence were then made between each of the three
antibodies. Since Mab 2 and Mab 3 did not show strong NaCl dependence, the change in
their measured valence in the presence of NaCl was compared to that of Mab 1. It was
show that while Mab 2 and Mab 3 showed an increase in their valence with the addition
of NaCl, Mab 1 showed a decreasefrom5.4 to 4.61. These results correspond well with
the measured second virial coefficients for each in Figure 3.31. Correspondingly, in the
presence of urea (which was shown to disrupt the aggregation state of Mab 1) there was
an increase in the measured valencefrom5.4 to 6.05 without NaCl present. When the
same measurements were made with Mab 2 and Mab 3 with the addition of urea, the
results showed a lower overall increase in valence for both. When the valence was
measured in the presence of urea and NaCl, there was a slight increase of 4.61 to 4.66 for
Mab 1, no increase for Mab 2 and a decrease from 13.04 to 12.99 for Mab 3. These
results match the loss in the aggregation state for Mab 1 when measured by viscosity
(Figure 3.36) and dynamic light scattering (Figure 3.36 and Table 3.2) in the presence of
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urea. Corresponding viscosity and dynamic light scattering measurements were not
performed for Mab 2 and Mab 3 due to the lack of NaCl dependence on the formation of
HMW species as seen in Figure 3.22 (Mab 2) and Figure 3.23 (Mab 3). From the results,
it was evident that under the conditions tested, there was good agreement between the
measured valence and the measured second virial coefficient, viscosity and dynamic light
scattering results for Mab 1. In addition, it should be stated that directly measuring the
valence of an IgG 1 antibody is of particular importance as the measured valence does
not correspond to the expected valence based on the amino acid composition.

Predicting Behavior of Antibodies to Phase Separate
When attempting to predict the behavior of antibody therapeutics to phase
separate, it is essential to utilize techniques that directly measure first principle properties
such as mass, charge, shape and size, optical properties and functional properties. In
addition, each of the techniques must be capable of relating the measured value to a
property of interest such as stability, solubility and ability to interact with other
molecules. This study has utilized many techniques to measure the characteristics of
phase separation of Mab 1, but only three techniques stand out as wholly predictive tools;
differential scanning calorimetry, non-ideality and the direct measure of the protein
valence by capillary electrophoresis.
The technique of differential scanning calorimetry was essential for determining
the thermal stability for the three IgG 1 samples in different pH and buffer conditions.
Understanding the effects of these various conditions on the thermal stability, and what
trends they follow, for various antibody candidates will aid in formulation, development
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of analytical methods, selection of process conditions and the investigation of incidents,
such as the opalescence phenomenon, for these important therapeutics. DSC was an
important tool in determining three important factors in the investigation of the
opalescence phenomenon of Mab 1. The first was that the Fab region of Mab 1 had two
distinct thermal transitions which were not NaCl dependent. Second, the Fab region in
Mab 1 was stable in the presence of NaCl (unlike Mab 2 and Mab 3) which gave an
insight into the potential reversibility of the opalescence phenomenon when NaCl was
removed. The third was that NaCl appeared to alter the stability of the CH2 carboxyterminal domain located near the hinge region on the Fc which led to the theory that this
alteration may have increased the overall flexibility of the Fab region.
The electrostatic interactions between antibody therapeutics are often sufficiently
weak that their study through the use of conventional structural techniques becomes
problematic. Of the few techniques capable of providing experimental measures of weak
protein-protein interactions, perhaps the most useful is the measure of the non-ideality or
second virial coefficient. Throughout this study, measuring the second virial coefficient
provided a predictive tool which was used to determine the NaCl and concentration
dependence of the three antibodies. These measurements were also crucial in the
determination the type of electrostatic interactions of Mab 1 that were responsible for the
opalescence phenomenon. In addition, the second virial coefficients provided an insight
as to the structural characteristics of the Mab 1 self-association. It has been shown that
protein solutions with a second virial coefficient less than -8 x 10-4 mL-mol/g2 will not
have time to orient themselves but will form an amorphous agglomerate (Curtis, 1998).
This phenomenon was readily observed with Mab 1 and the second virial coefficient
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measurements allowed a good prediction of the antibody to form a clear liquid-liquid,
liquid-solid or visually opalescent phase transition.
Of the three techniques used to predict the behavior of antibodies to phase
separate, perhaps the antibody valence measurement by capillary electrophoresis proved
to be the most sensitive. The most noticeable feature of the three antibodies, when
measured by capillary electrophoresis, was the discrepancy between the measured
valence and the calculated valence based on the amino acid sequence. Because of this
discrepancy, it was necessary to make relative comparisons between the valence
measured for Mab 1 and those measured for Mab 2 and Mab 3 when relating charge to
solution behavior. Experimental evidence suggests that the extent of deviation of the
measured valence from the calculated valence corresponds well with the measured
second viral coefficients when determining an antibodies deviation from ideal behavior.
Finally, a plot was constructed for each to compare the activation energy of approach for
Mab 1 using the calculated valence (based on the AA sequence) and the measured valence
by CE (Figure 4.3)11. The plots depict the electrostatic interaction energy between two
molecules as a function of distance and could be used to predict the energy of attraction
depending on the measured valence of a molecule and the resulting influence from added
excipients that may change the dielectric increment of the buffer. It is clearly evident
from the plots that the activation energy of approach for Mab 1 at a predicted charge of
20 (Figure 4.3 A) is greater than that of Mab 1 at the actual measured valence of 5
(Figure 4.3 B). The decreased activation energy of approach for Mab 1, using the

11

The program ElectroGraph was written by Dr. Thomas Laue and is available through BITC
(www.BITC.unh.edu)
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Figure 4.3: The activation energy of approach was theoretically determined for Mab 1 using the calculated valence of-20 (based on
the AA sequence) (A) and using the measured valence by CE of ~5 (B). The graphs depict the interaction energy between two
molecules as a function of distance. As the energy values increase, the overall energy of interaction is unfavorable and as the energy
values decrease, the overall energy of interaction becomes more favorable.

Figure 4.3: The Activation Energy of Approach for Mab 1

measured valence, indicates that as the distances between the two molecules decrease,
there will a greater likelihood of intermolecular protein interaction, as was observed.
Although it is a relatively new technique, and there are few studies to corroborate these
results, as more protein valence measurements are made, the relationship of charge to
other physical properties such as solubility and stability will become more apparent.

Conclusion
The results of this study indicate that the opalescence phenomenon observed with
Mab 1 is a result of a salt induced, non-mass-action driven self-association which is
mainly entropic in origin. Although the opalescence phenomenon has been observed
with the addition of other salts, including Na2HPC>4 and CaCh, it is driven primarily by
the presence of NaCl in the buffer. This is thought to be due to the preferential binding
of the CI" ions by Mab 1 without an excessively kosmotropic influence by the Na+ ions.
The resulting self-association of the Mab 1 antibody is thought to be electrostatic in
origin and exists through a combination of long-range polar interactions such as chargedipole (minor) and dipole-dipole (predominant)u. The interactions appear to involve
mainly the CDR portion of the Fab but may also exist through multiple binding sites
throughout the Fab region. These intermolecular interactions appear to be facilitated
through the enhanced flexibility of the independent folding domain present in the Fab
12

It should be noted that the electrostatic free energy of this interaction involves other noncovalent
interactions whose individual contributions may be weak, but they are additive and serve to stabilize the
interaction through a significant contribution when summed over the antibody.
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region of Mab 1. In addition, theflexibilityof this Fab folding domain may also benefit
from the NaCl induced destabilization of the CH2 carboxy-terminal domain located near
the hinge region on the Fc. When the self-association occurs, it results in either a liquidliquid or liquid-solid phase transition and can be clear or cloudy depending on the degree
of non-ideality. When the measured second virial coefficient is > -8 x 10"4 mL-mol/g2,
the phase transition is clear indicating an ordered structure, however, when the second
virial coefficient is < -8 x 10"4 mL-mol/g2, the phase transition appears cloudy because
the protein-protein interactions are sufficiently strong as they do not allow for adequate
time to orient themselves. Although it is typically visually apparent, the resulting
opalescence phenomenon appears to exist as only a small fraction of fairly discrete high
molecular weight material when analyzed by FFF-MALS. The Mab 1 self-association
also appears to be freely reversible upon the removal of NaCl which is thought to be due
to the finding that the Fab region of Mab 1 is minimally destabilized with the addition of
NaCl as shown by the DSC results. The NaCl induced self-association of Mab 1 also
appears to be cooperative in nature as is indicated by the non-linearity of the OD400 and
viscosity data. Furthermore, the addition of 0.03 mM urea (1:1) is sufficient to disrupt
the opalescence phenomenon of Mab 1, indicating that the interaction with urea is site
specific and consists of a dipole-dipole interaction. It is important to note that the
average circulating levels of urea in the serum of normal individuals is ~4 mM (MacKay,
1927). The urea study also supports the theory that that there is more than one urea
specific (dipole-dipole) binding site on Mab 1 as the average Mw of peak measured by
dynamic light scattering was higher than that of a monomer, indicating some dimer
formation. Finally, there was an appreciable discrepancy between the measured valence
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by CE and the calculated valence based on the amino acid sequence. Although this
discrepancy was seen with all three of the IgG 1 antibodies in the study, the extent of
deviation from the calculated valence for Mab 1 was unique in the conditions that are
known to drive the opalescence phenomenon. As these deviations appeared to
correspond well with the measured second virial coefficient, it has been proposed that the
direct measure of the valence may be an important new tool when determining an
antibodies deviation from ideal behavior.
Based on the finding of this study, a mechanism of the Mab 1 opalescence
phenomenon has been proposed (Figure 4.4). As NaCl is added to Mab 1, and if the
second virial coefficient is > -8 x 10"4 mL-mol/g2, the antibody self-associates through a
site specific interaction located on the CDR region of the Fab. This self-association
occurs slowly so that the molecules have enough time to orient themselves. The result is
a clear liquid-liquid phase transition that if left long enough, will form a clear gel. The
other path occurs if the second virial coefficient is < -8 x 10"4 mL-mol/g2 when NaCl is
added. This self-association occurs rapidly so that the molecules do not have enough
time to orient themselves. The result is a cloudy or opalescent liquid-liquid phase
transition. This phase transition differs from the first as it will not go on to form a solid
gel but will eventually form an amorphous agglomerate.
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Figure 4.4: Proposed Mechanism of the Mab 1 Opalescence
Phenomenon
Mabl

+ NaCI
A2<-8xlQ-4 mL-mol/g2

A2>-8xlO"4mL-mol/g
\

Figure 4.4: When NaCl is added to Mab 1 through Path A, and the second virial
coefficient is > -8 x 10"4 mL-mol/g2, the antibody self-associates via the CDR region with
enough time for specific orientation. The result is a clear liquid-liquid phase transition.
When NaCl is added to Mab 1 through Path B, and the second virial coefficient is < -8 x
10"4 mL-mol/g2, the antibody self-associates via the CDR region without enough time for
specific orientation. The result is a cloudy or opalescent liquid-liquid phase transition.
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"Chasing a Ghost"
Addressing the Aggregation/Opaiescence
Relationship in an IgG 1 Antibody
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* It all started innocently enough with "Mab 1" ;
• The importance of antibody therapeutics
(differing perspectives)
* Opalescence vs. aggregation
• Initial characterization
* Hypothesis and Action Plan
» Proposed model of assembly
• Conclusions
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IgG t Antibody

• There are 4 human IgG subclasses
• IgG l~43-75% of total IgGs
• Over 90% homologous
• Responds to proteins,
polysaccharides and antigens
• Serum cone. 9.5-12.5 mg/mL
• Serum K life ~23 days
• Dimer held together by 2
disulfide bonds (hinge region)
• One folding domain in Fab and
two in Fc region
• Can be cleaved by Pepsin and
Papain
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1890: Emil Behring published a paper demonstrating that diphtheria antitoxin serum could
protect against a lethal dose of diphtheria toxin
1906: Paul Ehrlich proposed antibodies may be used as "magic bullets" to target diseases
1929: "nothing may be hoped for at present in respect to a successful therapy from this
direction"
1974: The first monoclonal antibody made: Spl, a mouse IgM antibody specific for SRBC, by
Kohlerand Milstein, published in 1975
1986: ORTHOCLONE OKT3, the world's first therapeutic murine monoclonal antibody
approved for human use
2002: Humira, the world's first fully human therapeutic antibody approved for human use
2003: Antibody products with 125 mg/mL concentration approved for human use (Xolair)
Today: >20 mAb and Fc fusion protein products approved, » 1 0 0 development programs,
sophisticated delivery devices, 200 mg/mL formulation approaches published
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total mAb sales
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1995

1998

2001

?
2004

2007

2Q0& $22 billion
2010; $30 billion estimated

IMS Rffidas, Dee 2002, Data Monster Apr 20P8
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Dose to)

Biocgic

Company

Launch

RitlKSI

GenentecKRoche

1997

2.3
0.5

Synagis

Medlmmuna

1996

Remicade

JSJ

1998

2

Enbrel

Amgen

1936

2.6

Hercepii

Genentech/Roche

1998

3

Humira

AIM

2002

1

Raptiva

Genentech

3003

1

XoSair

Genentedi

2003

6

Erbilux

ImClone/BMS

2004

2.2

Avastin

Genentedi

2004

12

Orencia

BMS

2005

'10

Tysabri

Biogenldec

2006

3.9

Avg.Cwe

<2g/yr

>5g/yr

'Estimates based on company websites

Substantial efforts to improve yield
(tons per year)
IV route is preferred as it allows for
high concentration and rapid
systemic availability
IV route is not convenient for
patients so SC is preferred
Average patient requires weekly
doses of ~130mg (145 lb patient)
Max volume for SC is ~1.5 mL
Increased Mab concentration issues:
• Stability issues (aggregation)
• Safety concerns (efficacy! and
immunogenicity risks)
• Increase in viscosity (process and
delivery concerns)
- . . • • • .
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Effects of Protein Aggregates: An Immunologic Perspective
Submitted Matth 3, 200«: Mceptal: May- 24, 2006: Published: August 4,2006
Amy S. Rosenberg1
'Food and Drug Administration, Center for Drug Evaluation and Research, Bethesda, MD
EVIDENCE FOR THE ROLE OF PRODUCT
AGGREGATES IN INDUCTION OF J MMUNE
RESPONSES TO THERAPEUTIC PROTEIN PRODUCT:
CLINICAL STUDIES
Clinically, evidence that aggregates in therapeutic protein
products had profound effects on immunogenicity was
apparent from very early studies.
MEASUREMENT OF PRODUCT AGGREGATES/HIGH
RISK C H A N G E S FOR A G G R E G A T E G E N E R A T I O N

Protein aggregates in therapeutic protein products are almost
exclusively assessed by a size exclusion chromatography
(SEC) method. While sensitive, this method has critical
flaws, including failure of some liijjh WW specie* to penetrate the gel. 1 hus, methods 01 iiinpifi.il to M-C need to be
' employed to ai,f*s-, product a;j;.:ri,'LM;es,
flu A-XPS -tuuniul VMM*: H(.l| \rlitk> W (htl|>:'<:""tt.aap»j.i»i:^ ;
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This may refer to
• Analytical Ultracentrifugation
• Field flow fractionation
• Dynamic light scattering
• Static light scattering
• others

-'

••'

•

Definition of aggregate: /t mass or body of units or parts
somewhat loosely associated with one another*
• Factors leading to aggregation
• Genetic mutations
• Glycosylation
• Proteolytic degradation
• Oxidation
• Deamidation
• Excluded volume effects

• If we have accounted for all off these factors...
• Why do we still encounter opalescence?

Is opalescence really tft# same "issue" as aggregation?
"Webster's Revised Unabridged, 1913Edition
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„LC

Fractionated
species

H*-»l—
ftaltifing

•SEC showed only monomer/dimer/fractionated species
•SDS page showed only monomelic protein
•Tyndall beam technique (Ph. Eur, 1980)
•A = Formulation buffer (10 mM Histidine, pH 6)
•B = Mab 1 at 60 mg/mL, >99% monomer (EP I)
•C = EP II standard
•D = EP III standard
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NaCI (1M) or Polysorbate 80 (0.5%, 10%) stock solutions
spiked into Mab1 at 65 mg/mL protein concentration

mm..
Concentration
of NaCI
(mM)
0
1
2
3
4
5
6
7
8

Theoretical
%PS80

Sample
Volume
(ML)
3000
3003
3006
3009
3012
3015
3030
3060
3120
3240
3480
3500
3520

0
0.0005
0.001
0.0015
0.002
0.0025
0.005
0.01
0.02
0.04
0.08
0.16
0.32

Appearance
(E.P.2.2.1)
Oil
Oil
III

<rv
<IV
<IV
IV
IV

Theoretical Protein
Appearance
Cone. Based on
(E.P. 2.2.1)
Increased Vol. (mg)
Oil
65.0
OH
64.9
64.8
Oil
64.8
OH
Oil
64.7
64.7
Oil
64.4
Oil
63.7
ON
Oil
62.5
60.2
OH
56.0
Oil
55.7
on
55.4
OH

>rv

* As little as ZmM added NaCI increased level of opalescence
• Added Potysorbate 80 had no effect on level of opalescence
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TOwl Ks&i&isttofi of Mabf (1S0mM NaCI)

5-

3.7S-

4-

3.00-

i

0.163 mg/mL
0.540 mg/mL
0.971 mg/mL

3-

I!
I

0.113 mg/mL
0.420 mg/mL
- 0.936 mg/mL

2.25-

1
» 1.50o

1-

^h- I

I
0.00.

02

.... 4

6

8

10

12

14

2

4

6

8

10

12

(Sj, J Svedbergs

[s^J Svedbergs

Samples appeared homogeneous
with only ~3%HMW

Samples appeared very
homogeneous with only - 1 %
HMW

All samples run in 10 mM Histidine buffer pH
6 150 mM NaCI . .
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ily of the balk drug substance or formulated suJotkwis (7). In
an attempt to understand the origin of th« opalescence of
antibody solutions al high coDeerjliaiian, especially lis relationship to noncavalem association, an IgGl antibody (148.9
kDa) was iimstigaied over a JOtMold cwia-otratton range
<0,5->5fl Dig/ml), Solutions erf this antikxly had an increasingly
m«|p«eimt artrtca.-i.nce in the concentration ranee S-!W ms#

Opalescent Appearance of an Igtil
Antibody at High Concentrations
•and Its Relationship to
Noiieovalent Association

(0.5-50 mg/ml). Solutions of this antibody had an increasingly
opalescent appearance in the concentration range 5-50 mg/
ml, which persisted even after filtration through a 0,«-|j.m
Xa-eivat Detxmtitr IS, 2003; atceptrd March IS, 2004
sterilizing filter, suggesting that opalescent appearance was
Purpose. Iberapeutic MitibotJict are often formulated at a higl
not caused by large filterable particles. It was also noted that
eraHratkm where (buy may hivean nfutaient appear;
MuppaUa Suknmar, u Brandon I.. D o j W
Jessica L O w d * , ' snd ADen H. PefeaV'

ofrtiBttudyiiluiinilenlmvlltie mi^'onf lhis»pali.>iiEifact.',esfvcun< large molecules at nigh concenlrjli.in 18) or IS II a conseits reiatioiKhip to rwnecvalent asradauim and physical stability
quence of noncovafenl association at high concentrations''
Mttkod%. The lurtiduy and (be association stare of ao IgG 1 antibody Determination of the association state of lha molecule di
« r e invesiigtued as a fuBttitm of ronccntratioa am) tEmperalurt reedy at Ihc high concentration i* most relevant to assess its
anngsnaic and dyiuarec light srstt^rinfi.nefdiulMiietrielTirbkiity, and
impact on the stability and biopharrnaceulicat properties: yet.
analytical tttoerantrifugatioit
HewlH. The antibody hud im-reaujigly .Jpafettvitl appeatnacu in the it is convplkated by the limitations of various tnMnwxmtuI
<on&a>t rationrange5-50 iwAnl, The opaksconce was giealtr at to- techniques and the potential nonidcality effects. For example,
frigorated (craft-uaurc Nit nee readily rovcrsihk uptm warming to the high refractive index c-t absorbancc at these high concen•vona Icmpeiarmc, Turbidity mcauiicd al ;S"*C was lincni oitb ttin- trations mokes the application of analytical ttlttaccntrifugavemration, as expected Ira Rajfeid* scalier in Ibe ab&mBe of asso- tiorj difficult (9-Vtl. Similarly, the use of size exclusion chrociation. In the canccntrauon range t-A) inj/tnj, the wcicht average matography is limited by the dilution and peak broadening
rodcfolar weights were dose to dial expected for a moaoilei. Zioyn that occurs, and the interaction of the antibody with the col-

Conclusions. The results indicate that opalescent appearance is not
due to self-association but is a simple consequence of Rayleigh scatter. Opalescent appearance did not result in physical instability.
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The observerj opalescence seen in tgG 1 rnotecules is due to a specific alteration
in the thermodynamic equilibrium of the system and that this alteration was
leadingto a discrete higher order associated species...
ACTiOW PLAIW
1. Are there HMW species present
2. Can we induce opalescence "artificially"

3.
4.
5.
6.
7.

Can other salts induce opalescence
How does opalescence of Mab 1 compare to other Mabs
Are the HMW species reversible
Is Mab 1 structurally unique
Is the non-ideality of Mab 1 opalescence unique

8. Is viscosity enhanced from opalescence
9. Any structural changes to Mab 1 from NaCI
10. Possibility of fibril formation
11. Can we prevent opalescence

12. Does opalescence alter the valence
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.~can we predict
opalescence?

%

-^^^mmmmaBmM

Batch Muiti-Angle Light Scattering
No NaCl

M C

Mattered «

»

tSQmMNaCl

n
'k~-*~*—

i-iA^.

Tone (min)

Cone
0.1 mg/mL
6.25 mg/mL
0.5 mg/mL
0.75 mg/mL
1.0 mg/mL

Mass
195kDa
182 kDa
176'kba
172 kDa
169'kba

Radius
14 nm
11 nm
11 nm
12 nm
12 nm

Cone
Mass
Radius
10.1 mg/mL T82kDa 64 nm
0~25 mg/mL 172 kDa 50 nm
0.5 mg/mL 174 kDeP 56 nm
I0.75 mg/mL 160 kDa 52 nm
fl.d mg/mL 162 kDa 52 nm

All samples run in 10 mM Histidine buffer pH 6 1 ISO mM NaCl

field Flow Ftactionation-MALS
Inflow
•

Inflow
(<>««ri'

Field

im
—iilil

—

Exploded View
I 4 - U p p e r Plate

„%=
pjl ajgP^B | i | aer M ' »«^—Membrane

~n i i i i l i ™
Crossflow
A large aggregate peak was present... > 200 nm and 10 MDa!
* " 3 : •' ^V
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"Electroseparation"
• 15 mL conical tube modified with
#00 stoppers with electrodes
• MablatlOmg/mlinHistidine
buffer ± 500 mM NaCI
• Constant voltage (80 volts) was
applied until current was steady
• Power turned off and 10 ui. of
sample removed at each port
• Samples diluted {1:10) and
measured (OD^o.pH ami
conductance)
• Results gave insight into CI" ion
binding

'--•*•«—is-uBMii

y.. Ojn y/'f 'indue-1. vf/ztittCgute
.. —..,_-,^
+

^^VW^M^Lit

v.i,-,,iM^maMUkimmiiltitiM

Membrane
/

-10 mM NaCI

Conductivity: 0.86 mS/cm
pH:5.46

r

I cathode

I anode

' Protons?! Conductivity: 0.185 mS/cm
pH:7.14
500 mM NaCI

Conductivity: 44.9 mS/cm
pH: 3

Conductivity: 46.2 mS/cm
pH: 8.5

' An opalescence cloud appeal at the cathode (reformed when field reversed)
' ton and concentration imbalance (5X greater concentration at cathode)
Protonsmoved against the E field due to Donnan effect (suggests that Mat) 1 binds Ct"
during opalescence phenomenon)
Concentrate* and torn balanced in 500 mMNaCt
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fJun az}).?r •$&& 'iMkts®®
Com.

NajHPO,

*-5W

NaCI

"•"*•?

«*.

je
-a»

"rm

itttWr-L
Overnight at 2-8 °C

•
«
*
*

Mab 1 concentration was ~60 mg/ml In 10 mM Histidine, pH 6 ±, 100 mM salt
NajHPQ, and CaCI;, were chosen to determine the effects of Na* and C|Samples prepared and examined after 1 hour and then overnight
NaCI was most opalescent and formed a solid get after 24 hours {Na2HPO„ also formed
a gel after 2 weeks}
• the highly chaotropfc nature of Caa" and large size of HP04J" may have Interfered
with/delayed opalescence (NaCI considered "neutral")
kosmotropic

Citrate3>succinate2 >sulfate2> acetate">CI' >Br->l">SCN"
N(CH3)4*> IMH4*>Na+>Ca »• >Mg ** >Guadiniunr>

4. Mow ifozi Q:fteil£-j£giJgg Mfti0«)

s

. chaotropic

&MM!M

Observation 1 : Mab i with varying amounts of NaCI

•

OmM

II

25mM

50mM

lOOmAA

150mAA

Observation 2: Mab 2 with varying amounts of NaCI
f5^'.--:l£7r--"" , T? : --' '

OmM

25mM

J

50mM

lOOmM

150mAA

All samples contained lOmM Histidine, pH 6.0, ~30mg/ml

.:-•*•—**X****&tmlUt
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*• Sample dialyzed from OmM to
lOQmM back to OmM NaCI,
visually opalescence was
reduced
OmM

DLS Data: Peak 1 64.4% to 99.2%

lOOmM

Mab 1 lOOmM Nad

* "This material can also be
filtered out using a 0.2um filter
(data riot shown)

-iBT —"
,, Mab 1 OmM NaCI

I

DLS Data: Peak 1 64.4% to 100%

•Opalescence eventually
returned!

(.*•

i»33

E£»-U

13N

5 mg/mL, lOmM Histidine, pH 6.0
'-

l.i
1.4
1.1'

*

•
•>
&
•w
^
«
»>

Mab 2 SOmM
Mab ^ bOrnM
Mab 1 OmM
Mab 2 OmM
Mab 3OmM
Mab 1 SOmM mixed
Mub t SOniM Bolton

'

IfMr winir i-i"inl

.•^^..-••—-'-'•.

•A dilution study was
performed on Mab 1, Mab 2
and Mab 3 in 3 buffer
containing 10 mM Histidine,
pH6s5©mMNaCl

0.1

•Samples measured 0D 400 to
assess degree of association

'
4.
•
Cane (miftiL)

•Linear profile indicates
minimum protein-protein
self assembly
flS'li'-'

A

' Mab 1 self-association appeared to be completely reversible
• Dilution profile of Mab 1 (top and bottomj was non-linear indicating
cooperativity (non-mass action driven}
When Mab i was mixed, it became highly vtseousand opalescent at only 30
mg/mL possibly indicating that the Cr Eons were continuously re-introduced

•
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•

fl
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»
B» /
Wk.S
50mM

a<?ir •fi;y-aV,';^rtffl

Qlffmetttml Smtmmg Cahrimetiy
• Pepsin cleaved F(ab')2
fragments were analyzed for
Mab 1,2,3 and Maes not in

Mab 2 (001)
Mab 2 (002)

11

* Mab 1 dearly shows 2 distinct
transitions

Mab (NIS)

5

Mab 3
* Mab 3 appears to also have 2
transitions...less opalescent

Mabl
Mab (NIS)

• Greater structural flexibility
far lab region of Mab-1 and
Mab 3

Mab (MS)

• Could be used; as a predictive
tool-.

Temperature (°C)
1.5 mg/mL, 10 mM Histidine, pH 6.0
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Fc

Fob

'

Fab 2

•
a

0.0 <

Mab 2
Mab1

v

I«

" " " " ' * •

* ^ -

-

°~ °" ™-~w.

^ ^
t

.

IJ>

0

•

Mab 2

;

MaM

,

20

40

'

s

*%

Fc2

TaV*.
(CDR)

N

S

fc -z-o

60

60

100

120

V

.3.0

FabV^'

c

140

Fc1
(CH2)

%
V

•

• 1%V *
20

40

60

Fc

80

100

120

140

1

«

mMNoCI

mMNoCI

• LWetoKirttrte»mal stability for the Fab region of (Wabl with addition of NaCI
• Stabilityof Fab region may be responsible for reversibility of opalescence
• There is saeqpiwalent toss ins thermatstabiRty for the Fc region
• of NaCtmayaltowfor
: Theatteredstabilityof the Fcregfon and independent foiding domain of the Fab
region may ba responsible for the enhanced protdr^rotein interactions
1.5 mg/mL, 10 mM Histidine, pH 6.0
&
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Second V'mai Coefficient
4

Dissociation
Ideal (Theta Solvejit)

.

g

Association

0

«BW2WC

*B. H. ^Jour^ofPHys.

2

4

6

8

10

c (mg/ml)

Mem. (1946)

£™2J£5K^ «
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Sample
30

—«— Mufti
—fH Mufti
—•— Mab.»

rJ^20

Mob 1 OmM NaCI
Mob 1 50mM Nad
Mobl lOOmMNoCI
Mob 2 OmM NaCI
Mob 2 50mM NaCI
Mob 2 lOOmM NaCI
Mob 2 150mM NaCI
Mob 3 OmM NaCI
Mob 3 50mM NaCI
Mob 3 150mM NaCI

•
:

i °[

1

(H

2 -io

\ '

tM

<

<

\

1
t

20
-30

ORIM

50mM lOOtiM 150mM
NaCI

A*
[10 « mol-ml/g8]
-3.6
-2.7
-E4.1
3.3
3.1
9.0
6.8
20.5
18.5
12.9

Stigtemcreaseii»A2 with the addition of NaCI??
(Indicative of charge-dtpole ami dipole-dipole interaction)
At IQQ RiM NaCf, the A2 dropped precipitously (A2 < -8 x 10 4 mL-mol/g2)
• Mab 2 and Mab 3 continued to have a positive Ajuntil reaching 150 MM NaCI
(Indicative of apt overall charge-charge repulsion)

••'•-•
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J

I

:1

•

•

,

il

J-3-i
10

20

•

• 25C«4<

30

40

50

60

0

Concentration (dig/iii.)

.

10

20

'

• 25CU*

,

.

30

40

— i —

50

Concentration (mj/iii)

• Viscosity of Mao 1 is predominantly non-linear at higher concentrations (>40mg/mL)
• Non-linear increase in viscosity is consistent with protein-protein Interactions
• Increase in viscosity is faster at 4 Vindicating that the interaction is predominantly
entropic in origin
l O m M Histidine, 5 0 m M NaCI, pH 6

A.v- :•; ^ ^ M : -

_

.._...

:

• . . . . . . . • . • . • • • - - • -/-•:,••:

wfiisam^ammMmmsa,

^:\^:^J^JA^^^^di^^^li^k^i^

€kculmr Dklhmism emef Fbmumsmnm
hfarUV-CD

Fluorescence (Bote @SSQm}

• lOOrMNba
Q OiMNtaO

t i . 3 0 O 3 2 O 3 4 ) 3 H ) 3 a O « O 4 2 O

WfavElength(rm)

Wwelenglh(mj)

There appears t o be no significant change in the 2° or 3° structure of
Ivlab 1 with the addition of NaCt
4 mg/mL, 10 mM Histidine, pH 6.0

100 mM NaCI
- . • ^ . - ^ ^ ^ a ^ ^ ^ j
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CR will binttamytotd fibrils and shift 0 0 from ~490nm to ~540nm
Wafelsamptes were opatescent and giving a "blue shift"?
Believed that CR binds due to electrostatic interaction of negative charged sulfate group
Mab 1 may bind CR when ^taQ is not present but cannot bind when CI ions occupy
specific binding sites
Mab
Mab
Mab
Mab
Mab
Mab

1
1
1
1
1
1

• NaCI
(10 m g / m L )
(10 m g / m L ) • N a C I
(4 degrees C )
(4 degrees C) * N a C I

Electron Microscopy
(Genentech 2005)
300

3S0

400

450

500

550

S00

650

W avelength (nm)

1 and 10 mg/mL, lOmM Histidine, pH 6.0

50 mM NaCI
. , •*'.,•>.,,

..•.i_IJT.Vr±i=J-^
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r
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1-(i

D = D +SC

4»
•

i

e

----=<-_-.

•~--v-:

lOOmJft N o C I
1 0 0 m f,', N a C I » 0 . 3 i » I W

.:_---;_:;.;—

•

NoCI [mM]
Peak 1

Peak

Peak

Mob!

MWOM

SMasi

MWUM

lOOmMNoCI

22»

S5.8*

1.6x10

0.2*.

lOOmM NoCI * 0.3mM
Urea

134

100%

IMA

IMA

143

100%

lOOmM NaCI * 200mM
Arginfne

NaCI

0

ETOH
Glycerol
Mannitol

-2.6
-2.6
-2.6

Sucrose
Dioxane

-7.6
-8.3

Urea

+2.7

G l y c i n e (anhydride)

-10
+22.6

MWEDa
1.1x10
IMA

8
M"1

Material*
Urea

4.0%
NA

Glycine

jll

Viscosity c

_^-'''"
_„...>-'

+71
+62
+345

*Cohn & Edsall, Proteins, amino acids and Peptides. 1943
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31

'eakl

Sample Mab 1
{diluted to Smg/ml)

'eak2

'eak3

UWKDa

(Mass

WNKDa

KMass

UWKDa

KMass

lOOmMNaCI

US

)S.B%

l.6xl(P

1.2%

1.1x10"

1.0%

IDOmM Nad* 200mM Urea

I3S

100%

M

<iA

IM

VA

lOOmM Nad *200mM Urea
!4hrs4C

136

100%

V4

M

IM

VA

lOOmM NaCI * 0.3mM Urea

134

U»«

IM

HA

U

IU

[65

19.5*

m

«*

1.4x10"

3.5*

•00%

M

M

«A

IKA

'6000:1)

'10.1)
WOmM NaCI *0.3mM Urea
l4hrs4C

lOOmM NaC1*0.03mM Urea 160

'1:1)
lOOmM NaCI *0.03mM Urea
l4hrs4C

16S

19.6*

M

<IA

1.1x10"

1.4%

" Urea can btocfe opalescence at a ratio of 1:10 and inhibit opalescence at 1:1
• Urea is highly polar and may bind to dipole(s) on Mab 1
« Mab 1 appears to contain more than Idipole as some dimer still forms
'
* Average circulating levels of urea in blood is ~4mM(lgG 1 cone. Is ~10mg/mL)

.1

5 mg/mL, lOmM Histidine, pH 6.0
ri.VrlM

I'ii [ '^•i••i^'^

I

-/'.
^^A^MePa^it^^B
Ospmry Elettn^wresis

Z* =

z^z

DTe

•
•
•
•
•
•

z* is the effective or apparent valence
u is the mobility
kB is Boltzmann's constant
T is the absolute temperature.
By is the translational diffusion coefficient
e is the elementary charge of proton

•K is the inverse Debye length
• a is the sum of Stokes radii (Rs + Ri)
• f(ica) is Henry's function (unitless)

^WAUHI^SIUUM
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« . 00 VZ

rjp*ti&&J)£&-&J&?$f#,^^

Molecular Weight Hydrodyaamic
Oaltoas)
Radius

Calculated Charge
(based on AA seq)

Mad U i a b - . Mab l F f a b ^ + NaCI
Mv.b I
Mab 1+TJna
M.ib 1
-\,Li
Mab 1+NaCI-f-Urra
Mob :i-(.ib-|..
M.ib 2 F f a b T , * ! V a a

«.-.!»

;.i

Mab 2 -*- Urea.
Mah
Mab 2 + N i C l + IIraa
XI.ibiF(ab) :
Mab 5 Flab 1 ),* N a d
Slab 3
Mab 3 + Urea
Mab3-NaCI
MabJ+NaCl-rUrra

a-,.

92.5S3

4.7

32

i.43.900

5.1

42

I

0.22

1.14

2.32
O.Si
0.S4

6.95
10.1
4.86
0 '-1

U9
3.4J
3.68

6.14
SC
9.6

] ";,-;

a .'

176

9.77

COS
1.79
4.36
4.61
2.35
2.34

02
938
11.38
12.03
13.04
12.99

• The measured charge is far tower than the calculated charge (AA sequence)
• This charge discrepancy may be due to unequal charge distribution in the interior of
antibodies to remain "biologtcallY relevant"
• The decrease in valence for WFabl containing NaCI matches Aj measurements
*- The addition of urea slightly increases the charge for Mab 1
0.5mg/mL, 10 mM NaCI, lOOmM MES, pH 6.0 100 mM NaCI 0.1 mM urea

34
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Calculated Valence (22):

Measured Valence (5.4);

w

•re-.

• The activation energy of approach was determined for calculated and
measured valence of Malt 2 using ElectroGraph' as a function of distance (nm)
• The graphs dearly indicates that the tower measured valence would be more
susceptible to non-ideal behavior
The program ElectroGraph was writte• by Tom Laue and is available through BITC (www.BITC.unh.eduJ,
'-•••'•
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• Opalescence is due to salt induced non-mass-action driven self-association which is
mainly entropic in origin
• Opalescence has been induced by other salts including Na2HP04 and CaCI2 but it is
driven predominantly by NaCI
• The self-association is thought to be electrostatic in origin and exist through
interactions such as charge-dipole (minor) and dipole-dipole (predominant)
• The interactions involve mainly the CDR region (there may be multiple sites)
• The intermolecular interactions appear to be facilitated by enhanced flexibility of Fc
region and the independent Fab folding domain on Mab 1
• Opalescence phemomenon is a liquid-liquid or liquid-solid phase transition and can be
clear or cloudy depending on A2
• The opalescence phenomenon appears to be a relatively small fraction of discrete
HMW material which is freely reversible (liquid-liquid phase)
• The reversibility is believed to be due to the findings that the Fab region is not
appreciably destabilized with the addition of NaCI
• A ratio of 1:1 urea to protein is adequate to disrupt the opalescence of Mab 1
• There is a discrepancy between the measured and calculated valence of IgGl
antibodies and this may be used as a predictive tool of non-ideal behavior

...we msw have fmzih* cmx$& SSK "ghost"
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